
<html lang="en"     class="pb-page"  data-request-id="6a17f69d-e7af-402a-8639-90a0bb883027"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm200799p"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors" /></meta><meta name="dc.Creator" content="William  Guerrant" /></meta><meta name="dc.Creator" content="Vishal  Patil" /></meta><meta name="dc.Creator" content="Joshua C.  Canzoneri" /></meta><meta name="dc.Creator" content="Adegboyega K.  Oyelere" /></meta><meta name="dc.Description" content="Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest. Agents which can modulate multiple targets may have ..." /></meta><meta name="Description" content="Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest. Agents which can modulate multiple targets may have ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 13, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200799p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200799p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200799p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200799p" /></link>
        
    
    

<title>Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200799p" /></meta><meta property="og:title" content="Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0006.jpeg" /></meta><meta property="og:description" content="Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest. Agents which can modulate multiple targets may have superior utility and fewer side effects than current single-target drugs. To explore the prospect in cancer therapy of a bivalent agent that combines two complementary chemo-active groups within a single molecular architecture, we have synthesized dual-acting histone deacetylase and topoisomerase II inhibitors. These dual-acting agents are derived from suberoylanilide hydroxamic acid (SAHA) and anthracycline daunorubicin, prototypical histone deacetylase (HDAC) and topoisomerase II (Topo II) inhibitors, respectively. We report herein that these agents present the signatures of inhibition of HDAC and Topo II in both cell-free and whole-cell assays. Moreover, these agents potently inhibit the proliferation of representative cancer cell lines." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200799p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200799p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200799p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200799p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200799p&amp;href=/doi/10.1021/jm200799p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1465-1477</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201139r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201127y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Guerrant">William Guerrant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vishal++Patil">Vishal Patil</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+C.++Canzoneri">Joshua C. Canzoneri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adegboyega+K.++Oyelere">Adegboyega K. Oyelere</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>School of Chemistry and Biochemistry, <sup>‡</sup>Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 404-894-4047. Fax: 404-894-2291. E-mail: <a href="/cdn-cgi/l/email-protection#6d0c02140801081f082d0a0c19080e0543080918"><span class="__cf_email__" data-cfemail="74151b0d11181106113413150011171c5a111001">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200799p&amp;href=/doi/10.1021%2Fjm200799p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1465–1477</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 19, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 March 2011</li><li><span class="item_label"><b>Published</b> online</span>13 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200799p" title="DOI URL">https://doi.org/10.1021/jm200799p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1465%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DWilliam%2BGuerrant%252C%2BVishal%2BPatil%252C%2BJoshua%2BC.%2BCanzoneri%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D4%26contentID%3Djm200799p%26title%3DDual%2BTargeting%2Bof%2BHistone%2BDeacetylase%2Band%2BTopoisomerase%2BII%2Bwith%2BNovel%2BBifunctional%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1477%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200799p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3077</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">97</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200799p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Guerrant&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;Patil&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;C. Canzoneri&quot;},{&quot;first_name&quot;:&quot;Adegboyega&quot;,&quot;last_name&quot;:&quot;K. Oyelere&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1465-1477&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200799p&quot;},&quot;abstract&quot;:&quot;Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest. Agents which can modulate multiple targets may have superior utility and fewer side effects than current single-target drugs. To explore the prospect in cancer therapy of a bivalent agent that combines two complementary chemo-active groups within a single molecular architecture, we have synthesized dual-acting histone deacetylase and topoisomerase II inhibitors. These dual-acting agents are derived from suberoylanilide hydroxamic acid (SAHA) and anthracycline daunorubicin, prototypical histone deacetylase (HDAC) and topoisomerase II (Topo II) inhibitors, respectively. We report herein that these agents present the signatures of inhibition of HDAC and Topo II in both cell-free and whole-cell assays. Moreover, these agents potently inhibit the proliferation of representative cancer cell lines.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200799p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200799p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200799p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200799p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200799p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200799p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200799p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200799p&amp;href=/doi/10.1021/jm200799p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200799p" /></input><a href="/doi/pdf/10.1021/jm200799p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200799p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200799p%26sid%3Dliteratum%253Aachs%26pmid%3D22260166%26genre%3Darticle%26aulast%3DGuerrant%26date%3D2012%26atitle%3DDual%2BTargeting%2Bof%2BHistone%2BDeacetylase%2Band%2BTopoisomerase%2BII%2Bwith%2BNovel%2BBifunctional%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D4%26spage%3D1465%26epage%3D1477%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jmcmar.2012.55.issue-4/production/jmcmar.2012.55.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Strategies to ameliorate the flaws of current chemotherapeutic agents, while maintaining potent anticancer activity, are of particular interest. Agents which can modulate multiple targets may have superior utility and fewer side effects than current single-target drugs. To explore the prospect in cancer therapy of a bivalent agent that combines two complementary chemo-active groups within a single molecular architecture, we have synthesized dual-acting histone deacetylase and topoisomerase II inhibitors. These dual-acting agents are derived from suberoylanilide hydroxamic acid (SAHA) and anthracycline daunorubicin, prototypical histone deacetylase (HDAC) and topoisomerase II (Topo II) inhibitors, respectively. We report herein that these agents present the signatures of inhibition of HDAC and Topo II in both cell-free and whole-cell assays. Moreover, these agents potently inhibit the proliferation of representative cancer cell lines.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>§</span> Author Contributions</h4><p class="last">These authors contributed equally to the manuscript.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several rational pharmacological strategies, including vaccination, gene therapy, immunotherapy, and new target identification and validation, have emerged for the treatment of metastatic diseases. Despite these progresses, chemotherapy remains the primary treatment of choice for most cancer cases. However, almost all chemotherapeutic agents suffer from severe toxicities and other undesirable side effects. To address these problems, the cancer medicine of the future will incorporate, within a single molecule, elements that allow for simultaneous targeting of multiple cancer-fighting targets while maintaining lower side effects.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> This realization has continued to spawn immense efforts in the literature. Studies aimed at identifying multivalent ligands as promising pharmacological tools that may be more efficacious for various human diseases than highly selective single-target drugs are ongoing in several academic and pharmaceutical laboratories.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> A subset of these studies has revealed that balanced modulation of a small number of targets may have superior efficacy and fewer side effects than single-target treatments.<a onclick="showRef(event, 'ref1 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref7 ref8">(1, 7, 8)</a></div><div class="NLM_p">Epigenetic control has become widely accepted as a mechanism for cell regulation.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Specifically, histone deacetylase (HDAC) is a class of epigenetic enzymes that has generated much interest in cancer therapeutics literature. HDACs are known to associate with many oncogenes and tumor suppressors, leading to altered expression patterns, and have consequently become attractive targets for small-molecule inhibition.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Histone deacetylase inhibitors (HDACi) have been shown to cause growth arrest, differentiation, and apoptosis in tumor cells and in animal models by inducing histone hyperacetylation and p21<sup>waf1</sup> expression.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14-17)</a> Additionally, modulation of activities of HDACs alters the activity of a diverse range of proteins, many of which are attractive therapeutic targets themselves, including p53, E2F, tubulin, and Hsp90.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18-22)</a> HDAC inhibition has been clinically validated as a therapeutic strategy for cancer treatment with the FDA approvals of suberoylanilide hydroxamic acid (SAHA) and romidepsin (FK-228) for treatment of cutaneous T cell lymphoma.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> However, a large number of the currently known HDACi have elicited only limited in vivo antitumor activities and have not progressed beyond preclinical characterizations.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> HDACi that modulate the functions of additional intracellular targets, other than the various HDAC isoforms, may be able to ameliorate many of the shortcomings of current inhibitors.</div><div class="NLM_p">Because of the presence of large hydrophobic patches at the HDAC surface rim,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> it is conceivable that appropriate conjugation of the surface recognition group of a prototypical HDACi to other hydrophobic antitumor pharmacophores could furnish a new class of bifunctional agents. To date, there exist a few examples of this subtype of bifunctional HDACi derived compounds.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> Expansion of the repertoire of such bifunctional compounds could lead to broad acting, therapeutically viable anticancer agents.</div><div class="NLM_p">An attractive starting point for a secondary target is the topoisomerase class of enzymes (Topo I and Topo II), which are validated targets for many small molecule inhibitors including clinically useful anthracyclines such as doxorubicin (DOX) and daunomycin or daunorubicin (DAU) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and camptothecins such as irinotecan and topotecan.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Topo inhibitors elicit anticancer activities primarily by stabilizing the DNA–enzyme cleavable complex through intercalation between DNA base pairs. However, DNA does not exist as a naked structure in the nucleus. It is noncovalently associated with histones to form the nucleosomes which make up chromatin subunits. Agents, such as HDACi, that induce hyperacetylation of histone proteins complexed with DNA could increase the accessibility of DNA within chromatin and consequently potentiate the anticancer activities of Topo inhibitors.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> Moreover, recent observations have shown that HDAC1, HDAC2, and Topo II colocalize in vivo as part of functionally coupled complexes.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> These evidence suggest simultaneous Topo and HDAC inhibition could be a viable alternative approach in cancer therapy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of anthracycline antibiotics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We disclose herein small molecules with dual acting Topo II–HDAC inhibitory activities. We found that many of these conjugates more potently inhibited HDAC and Topo II activities compared to SAHA and daunomycin, standard HDACi and Topo II inhibitors, respectively. Additionally, a subset of these compounds exhibited potent whole cell antiproliferative activities against representative breast, lung, and prostate cell lines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design Rationale</h3><div class="NLM_p">Anthracyclines are one of the most thoroughly studied classes of anticancer agents with copious structure–activity relationship (SAR) data to aid the design and characterization of new anthracycline-containing compounds.<a onclick="showRef(event, 'ref39 ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41 ref42 ref43 ref44">(39-44)</a></div><div class="NLM_p">Specifically, <i>N</i>-benzylated anthracyclines, such as <i>N</i>-benzyl doxorubicin (AD-288)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), have enhanced Topo II inhibitory activities, reduced cardiotoxicity activity, and reduced susceptibility to the Pgp-mediated multidrug resistance.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> We postulated that introduction of the HDACi via <i>N</i>-benzylation of the DAU amino group would be compatible with Topo II inhibition and possibly engender the positive attributes of <i>N</i>-benzylated anthracyclines to the resulting conjugates. In turn, the anthracycline moiety could serve two other purposes: (i) as a surface recognition cap group, allowing favorable orientation of hydroxamic acid within the zinc binding pocket of HDAC, and (ii) as a delivery vehicle, because the transport of the anthracycline via proteasome could facilitate nuclear accumulation of HDACi.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> On the basis of the forgoing, we designed two classes of conjugates: a direct DAU–SAHA conjugate and DAU–triazolylaryl hydroxamate conjugates (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The later conjugates were inspired by our previous studies which revealed that triazole moiety could be incorporated in lieu of amide bond as a surface recognition connecting group in prototypical HDACi.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of dual-acting Topo II–HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Crucial to the successful synthesis of all the conjugates described in this report is the reductive amination reaction between DAU and appropriate aldehyde intermediates <b>5</b> and <b>10a</b>–<b>d</b> (Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Synthesis of aldehyde intermediate <b>5</b> started with the coupling of 4-aminobenzyl alcohol <b>1</b> to suberic anhydride <b>2</b> to give benzyl alcohol <b>3</b>. To assess the suitable oxidizing agent for conversion of alcohol <b>3</b> to aldehyde <b>4</b>, we employed MnO<sub>2</sub>, PCC, and Dess–Martin periodinane (DMP) oxidation. All yielded the desired aldehyde, with DMP giving the optimum yield among them. To synthesize the protected hydroxamate <b>5</b>, we coupled <b>4</b> to <i>O</i>-trityl hydroxylamine using standard EDC coupling chemistry. Interestingly, the amide bond of compound <b>4</b> was also susceptible to nucleophilic attack and led to a substantially lower yield under this condition. Using TBTU as coupling reagent resulted in the same outcome. Gratifyingly, the use of isobutylchloroformate (IBCF) as a coupling reagent gave coupled requisite product <b>5</b> in 66% yield within 2 h. Longer reaction times did not improve the yield and led to degradation of product. Reductive amination with DAU hydrochloride was the major hurdle in making the DAU–SAHA conjugate. Initial investigation with NaBH<sub>3</sub>CN as a reducing agent with acetonitrile–water solvent system at room temperature led to a complex reaction mixture. Employing a nonaqueous solvent system, as well as a milder reducing agent such as NaBH(OAc)<sub>3</sub>, did not produce any detectable amount of product. Previous studies in the literature indicated that generation of free amine by addition of base and elevated temperature might promote the imine formation.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> Indeed, adding Hunig’s base to reductive amination reactions between DAU and aldehyde <b>5</b> in the presence of NaBH<sub>3</sub>CN at 70 °C gave the desired coupled product <b>6</b>, albeit in low yield. Reducing the reaction temperature to 50 °C and below worsened the yield, as did employing NaBH(OAc)<sub>3</sub> as a reducing agent. The deprotection of the acid sensitive trityl group of compound <b>6</b> was accomplished by treatment with the Lewis acid boron trifluoride etherate.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> This led to the removal of the trityl group to give the desired conjugate <b>7</b> in good yield without any need for further purification.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the SAHA-Based Dual-Acting Topo II–HDAC Inhibitor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the SAHA-Like, Triazole-Based Topo II–HDACi</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Similar chemistry was applied for the synthesis of triazole-based conjugates. The synthesis of requisite aldehydes <b>10a</b>–<b>d</b> started with Cu-catalyzed cycloaddition of 4-ethynylbenzaldehyde <b>8</b> with trityl-protected azido hydroxamates <b>9a</b>–<b>d</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reductive amination of triazole aldehydes <b>10a</b>–<b>d</b> with DAU proceeds facilely at room temperature in aqueous solvent system to give the triazole-based conjugates <b>11a</b>–<b>d</b> in slightly improved yield compared to conjugate <b>6</b>. Boron trifluoride etherate deprotection of the trityl group of <b>11a</b>–<b>d</b> yielded the desired triazole-based conjugates <b>12a</b>–<b>d</b> in good to excellent yields.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In vitro HDAC Inhibition</h3><div class="NLM_p">We first tested the HDAC inhibition activity of compounds <b>7</b> and <b>12a</b>–<b>d</b> against crude HeLa cell nuclear extract HDACs using a cell free assay (Fluor de Lys) as previously described.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Overall, these compounds showed inhibition activities against HeLa cell nuclear extract HDACs, which are comparable to or exceed that of the standard SAHA (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It is particularly interesting that <b>7</b> has identical anti-HDAC activity to SAHA. This result suggests that the attachment of DAU does not impair the interaction between the HDACi component of the conjugate and the HDAC enzyme outer surface residues. It is also conceivable that the conjugate may adopt a conformation whereby the anthracycline moiety can contribute positively to the interaction with the crucial active site or surface residues. All triazole-linked conjugates potently inhibit HeLa cell nuclear extract HDACs with IC<sub>50</sub> in the low to midnanomolar range. Among these conjugates, <b>12a</b> is the least active, closely followed by <b>12d</b>, which is about 20-fold more potent. Compounds <b>12b</b> and <b>12c</b> have the most potent anti-HDAC activity, with a slight preference for the six methylene-linked <b>12c</b>. Interestingly, the triazole-linked compound <b>12b</b> is 40-fold more potent than the amide-linked <b>7</b> despite their similar linker length. Relative to the standard SAHA, <b>12c</b>, the most potent compound in this series, is 70-fold more potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The foregoing results showed that these conjugates followed a trend similar to that which we noted for the previously reported, structurally unrelated, triazole-based HDACi.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro HDAC Inhibition</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">HDAC 1/2<br /></br>IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">HDAC 1<br /></br>IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HDAC 6<br /></br>IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">HDAC 8<br /></br>IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">65.0</td><td class="colsep0 rowsep0" align="center">38 ± 2</td><td class="colsep0 rowsep0" align="center">27 ± 2</td><td class="colsep0 rowsep0" align="center">1989 ± 156</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DAU</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">64.7</td><td class="colsep0 rowsep0" align="center">47 ± 3</td><td class="colsep0 rowsep0" align="center">20 ± 1</td><td class="colsep0 rowsep0" align="center">220 ± 21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="center">89.9</td><td class="colsep0 rowsep0" align="center">4600 ± 240</td><td class="colsep0 rowsep0" align="center">555 ± 36</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">54 ± 3</td><td class="colsep0 rowsep0" align="center">30 ± 2</td><td class="colsep0 rowsep0" align="center">4,129 ± 421</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="center">0.9</td><td class="colsep0 rowsep0" align="center">8 ± 0.4</td><td class="colsep0 rowsep0" align="center">20 ± 0.4</td><td class="colsep0 rowsep0" align="center">710 ± 43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="center">4.2</td><td class="colsep0 rowsep0" align="center">11 ± 0.4</td><td class="colsep0 rowsep0" align="center">19 ± 1</td><td class="colsep0 rowsep0" align="center">379 ± 37</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Inhibition was assayed using the Biomol HDAC Fluorimetric Assay/Drug Discovery Kit.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Data obtained through contract arrangement with BPS Bioscience (San Diego, USA; <a href="http://www.bpsbioscience.com" class="extLink">www.bpsbioscience.com</a>).</p></div></div></div><div class="NLM_p last">To obtain evidence for the HDAC isoform selectivity, we tested these dual acting Topo II–HDACi conjugates against selected recombinant HDACs–HDAC 1, HDAC 6 and HDAC 8. The pattern of the anti-HDAC activities of these compounds against HDAC 1 and HDAC 6 is similar to what we observed for the HeLa cell nuclear extract HDACs with few exceptions. Specifically, compounds <b>7</b> and <b>12b</b> have indistinguishable activity against HDAC 1 and HDAC 6 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Additionally, <b>12a</b> which has midnanomolar IC<sub>50</sub> against HeLa cell nuclear extract HDACs is almost inactive against HDAC 1 (IC<sub>50</sub> = 4.6 μM)while it maintains decent activity against HDAC 6 (IC<sub>50</sub> = 0.6 μM). We are not exactly sure of the cause of this disparity. In general, these compounds are weaker inhibitors of HDAC 8 with the exception of <b>7</b>, whose anti-HDAC 8 activity is only about 4-fold less than its anti-HDAC 1 activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These data suggest that <b>7</b> is a more indiscriminate inhibitor of these sets of HDACs while the rest of the conjugates are more selective.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Molecular Docking</h3><div class="NLM_p">To obtain information on the structural basis of the observed disparity in the HDAC inhibitory activity of these compounds, we performed molecular docking using a validated molecular dock program (AutoDock)<a onclick="showRef(event, 'ref48 ref52'); return false;" href="javascript:void(0);" class="ref ref48 ref52">(48, 52)</a> Docking analysis was performed on a HDAC 1 homology model built from human HDAC 2 X-ray structure 3MAX coordinates.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> We chose to dock the compound which had the least HDAC inhibitory activity (<b>12a</b>) and the compound which had the best HDAC inhibitory activity (<b>12c</b>) to delineate the basis of the ∼600 fold activity difference between the two. Additionally, we performed docking on compound <b>7</b> because of its distinct structural feature compared to <b>12a</b>–<b>12c</b>.</div><div class="NLM_p">Interestingly, compound <b>12a</b> and <b>12c</b>, differing only in linker length, do not bind to the same pocket but instead localize to two different pockets (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). For six-methylene-linked compound <b>12c</b>, the hydroxyl group of the daunosamine sugar could potentially make hydrogen bonding contact with the guanidinium group of Arg270 and the linker region could facilitate the presentation of the hydroxamic acid to the catalytic zinc by entering through the top of the hydrophobic channel that leads to the active site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Figure S1c, d">Supporting Information Figure S1c, d</a>). In addition, two of the hydroxyl groups from the anthracycline ring of <b>12c</b> could take part in the H-bonding interaction with the backbone carbonyl group of Arg270 and the N–H group of Gly272. Possibly to accommodate the shorter linker length, <b>12a</b> loses the H-bonding interaction between the hydroxyl group of its daunosamine sugar and the enzyme’s Arg270. Although other hydroxyl groups of the <b>12a</b> anthracycline ring make potentially compensatory H-bonding contacts with the phenolic group of Tyr201 and the backbone carbonyl groups of Gly207 and Pro206 (See <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Figure S1a, b">Supporting Information Figure S1a, b</a>), its binding pocket is more solvent-exposed, compared to the binding pocket of <b>12c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked structure of Topo II–HDACi conjugates at HDAC 1 active site. (a) Superposition of low energy conformations of <b>12a</b> (teal) and <b>12c</b> (pink). (b) Overlay of low energy conformations of <b>12c</b> (pink) and <b>7</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>7</b> binds close to the same pocket as <b>12c</b>; it however derives its binding affinity through different sets of interactions. Unlike <b>12c</b> which enters the active site associating with the top of the hydrophobic channel, <b>7</b> traverses the same channel more closely associated with residues on the opposite side of the channel (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Consequently, the daunosamine hydroxyl group of <b>7</b> could not interact with Arg270 in a similar way as that of <b>12c</b>. In lieu of this interaction, the anthracycline ring of <b>7</b> may engage in other H-bonding interactions with the backbone carbonyl groups of Gly272, Gly268, and Thr304 on the enzyme surface rim (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Figure S1e, f">Supporting Information Figure S1e, f</a>). These apparent differences in the binding orientation at the enzyme surface rim could account for the disparity in the potency of compounds <b>7</b>, <b>12a</b>, and <b>12c</b> against HDAC 1.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Topoisomerase II Decatenation</h3><div class="NLM_p">We performed a cell-free DNA decatenation assay to determine the Topo II inhibition activity of these Topo II–HDACi conjugates. We used kinetoplast DNA (KDNA), a catenated network of mitochondrial DNA seen in trypanosomes, to quantify the conjugates’ Topo II inhibition activity according to a literature protocol.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> illustrates the results obtained from this study. KDNA and decatenated KDNA marker (lanes 1 and 2, respectively) were used as controls. Treatment of KDNA with Topo II within 10 min at 37 °C resulted in an extensive DNA decatenation (lane 3). As expected, addition of 50 μM DAU to the decatenation experiment resulted in a severe impairment of DNA decatenation (comparing lanes 3 and 4). Relative to DAU, <b>12a</b> and <b>12d</b> have lower Topo II inhibition activity, with the worst overall inhibition shown by <b>12a</b>, the conjugate with a four-methylene linker (lanes 7 and 8). Conjugates <b>12b</b> and <b>7</b> inhibited Topo II activity at comparable levels to that of DAU at the same drug concentration (lanes 6 and 9, respectively). However, compound <b>12c</b> had an enhanced Topo II inhibition activity relative to DAU, resulting in a near total inhibition at 50 μM (comparing lanes 4 and 5). These results show that the Topo II inhibition activity of DAU is tolerant of an appropriate attachment of HDACi groups and, as in the case of <b>12c</b>, such groups could further enhance Topo II inhibition activities of anthracycline derivatives. The molecular basis of the HDACi linker length-dependent enhancement of Topo II inhibition of these dual-acting conjugates is not entirely clear. It is plausible that the placement of the HDACi group of these conjugates within DNA minor grooves, through the daunosamine sugar,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> could further promote drug–DNA association, thereby enhancing the stability of the biologically relevant drug–DNA–Topo II ternary complex. Interestingly, <b>12c</b> also has the most potent inhibition activity against HDAC 1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). It is exciting to observe that a single compound could embody optimum anti-HDAC and Topo II inhibition activities under these cell-free conditions.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Topoisomerase II decatenation assay. Lanes 1–3: (1) KDNA, (2) decatenated KDNA marker, (3) KDNA and Topo II. Lanes 4–9: KDNA, Topo II, and 50 μM (4) DAU, (5) <b>12c</b>, (6) <b>12b</b>, (7) <b>12d</b>, (8) <b>12a</b>, (9) <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Cell Growth Inhibition</h3><div class="NLM_p">Cell viability experiments were performed to probe for the prospect of biological activity of these compounds in the cellular milieu. Three human cancer cell lines were used to quantify IC<sub>50</sub> values for these compounds. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> shows the IC<sub>50</sub> values of each compound for all cancer cell types studied. The positive control compounds DAU and SAHA inhibit the proliferation of these tumor cell lines with IC<sub>50</sub> similar to the values in the literature.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> DAU displays cell line dependent cytotoxicity that varies by as much as 10-fold among these three cell lines while SAHA shows no such cell line dependent effect (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Bifunctional compounds <b>12a</b>–<b>d</b> show linker length dependent antiproliferative activities that closely matched their anti-HDAC activities. Among the three transformed cell lines investigated, these compounds decreased the viability of DU-145 the most, while they are least cytotoxicity against MCF-7. Although less pronounced than that seen with DAU, these compounds display cell line-dependent cytotoxicity as well. Nevertheless, the micromolar IC<sub>50</sub> values and the traction with anti-HDAC activities suggest that HDAC inhibition is the dominating mode of antiproliferative activities of compounds <b>12a</b>–<b>d</b>. Specifically, the antiproliferative activities of <b>12c</b> and SAHA, compounds with similar linker length, are virtually indistinguishable against DU-145 and SK-MES-1 cell lines. This finding is surprising because <b>12c</b> displays the most potent HDAC and Topo II inhibition activities. Interestingly, compound <b>7</b>, a true hybrid between SAHA and DAU, showed the best cytotoxicity of all the bifunctional compounds across all cell lines, possessing submicromolar activities. In fact, the cytotoxicity of <b>7</b> closely rivals that of DAU, and they are equipotent against MCF-7. This is contrary to the trend seen in the cell-free assays. The potentiation of the activity of <b>7</b> within the cellular environment could be due to many factors, including the predominance of the Topo II inhibition character in dictating the bioactivity of <b>7</b>, the indiscriminate inhibition of multiple HDAC isoforms, or an alternative mechanism(s) that is unrelated to the inhibition of the activities of either target.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cell Viability Assay</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center" char="±">DU-145<br /></br>IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">SK-MES-1<br /></br>IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">MCF-7<br /></br>IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.47 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.99 ± 0.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="char" char="±">5.39 ± 1.02</td><td class="colsep0 rowsep0" align="char" char="±">15.3 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">24.5 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="char" char="±">1.61 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">4.68 ± 0.75</td><td class="colsep0 rowsep0" align="char" char="±">13.4 ± 1.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="char" char="±">2.92 ± 0.31</td><td class="colsep0 rowsep0" align="char" char="±">3.31 ± 0.23</td><td class="colsep0 rowsep0" align="char" char="±">10.6 ± 0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="char" char="±">2.06 ± 0.33</td><td class="colsep0 rowsep0" align="char" char="±">2.61 ± 0.11</td><td class="colsep0 rowsep0" align="char" char="±">14.8 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DAU</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.002</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.95 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">2.12 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">2.42 ± 0.38</td><td class="colsep0 rowsep0" align="char" char="±">2.50 ± 0.61</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values are the average of two experiments performed in triplicate. IC<sub>50</sub> values were determined using the MTS assay (Promega).</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Histone Hyperacetylation and p21<sup>waf1</sup> Expression</h3><div class="NLM_p">To gain a better perspective of the molecular mechanism of the antiproliferative activities of these dual-acting inhibitors, we probed the effect of their exposure on the intracellular status of p21<sup>waf1</sup> (p21) protein in DU-145 prostate cancer cells. p21 has been shown to be upregulated in response to HDACi treatment, as well as in a p53-independent response to DOX.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> We dosed inhibitors at concentrations near the determined IC<sub>50</sub> in DU-145 and evaluated protein expression status using Western blotting (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). We controlled for equivalent protein loading using antiactin antibody (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, bottom panel). As expected, SAHA results in marked upregulation of p21, even at 2.5 μM (top panel, lanes 2 and 3). However, neither DAU nor <b>7</b> shows noticeable upregulation in p21 expression compared to control levels (top panel, comparing lanes 4–7 to lane 1). This trend is reversed with<b>12b</b>, as a dose-dependent upregulation of p21 expression was observed (top panel, lanes 8 and 9). Relative to SAHA, however, the extent of p21 upregulation by <b>12b</b> is lower, although both were dosed at the same concentrations. Because these experiments were done at the IC<sub>50</sub> of the respective compounds, these results may indicate that <b>7</b> and <b>12b</b> derived their cytotoxic activity primarily through Topo II and HDAC inhibition, respectively. Alternatively, the cytotoxic activity <b>7</b>could be due to perturbation of other intracellular HDAC inhibition markers.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Immunoblot detection of cellular HDACi Markers. DU-145 cells were dosed for 24 h at the indicated concentrations to probe for acetylated histones H4 and H3, and p21<sup>waf1</sup>. Actin was also probed to show equal loading of protein. Lane: (1) control; SAHA (2) 2.5 μM, (3) 5 μM; DAU (4) 0.1 μM, (5) 0.5 μM; <b>7</b> (6) 0.5 μM, (7) 1 μM; <b>12b</b> (8) 2.5 μM, (9) 5 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further investigate into the prospect of distinct mechanisms of action for <b>7</b> and <b>12b</b>, we probed for histone acetylation status in DU-145 cells exposed to the same drug concentrations used for p21 immunoblotting. Intracellular histone acetylation status is a more direct indicator of class I HDAC inhibition. SAHA shows a strong histone H4 acetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, second panel, lanes 2 and 3), while DAU and <b>7</b> display moderate dose-dependent change in acetylation at the concentrations tested (2nd panel, lanes 4–7). Compound <b>12b</b> shows a strong H4 acetylation, with levels close to that of SAHA, at both concentrations (2nd panel, lanes 8 and 9). The trend of the drug induced perturbation of the acetylation state of H3, in core histones purified by acid extraction of DU-145 cell nuclear extract, is similar to what obtained for H4. Relative to the control, we observed distinct H3 hyperacetylation in DU-145 cells exposed to the same drug concentrations used for H4 immunoblotting (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, third panel). These results provide evidence supporting the involvement of intracellular HDAC inhibition as part of the mechanisms of bioactivity of the dual acting compounds <b>7</b> and <b>12b</b>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Tubulin Acetylation</h3><div class="NLM_p">Additional data was sought in order to clarify the mechanisms involved in the antiproliferative activities and to delineate the disparity in enzyme inhibition versus antiproliferative activity. Tubulin was chosen as a target because it is acetylated by the cytoplasmic HDAC6,<a onclick="showRef(event, 'ref21 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref21 ref61 ref62">(21, 61, 62)</a> for which <b>7</b> and <b>12b</b> had nearly identical inhibition. Interestingly, inhibitionof HDAC6-associated tubulin acetylation has been shown to enhance the cytotoxicity of DNA-damaging agents.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> While most HDACi induce p21<sup>waf1</sup> overexpression, inhibition of tubulin deacetylation is compound specific,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> potentially allowing for differentiation between the mechanisms and potencies of <b>7</b> and <b>12b</b>. Because tubulin acetylation in response to HDACi is a relatively early event,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> we dosed DU-145 cells for 4 h with inhibitors at either IC<sub>50</sub> concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) or a high concentration (∼5× IC<sub>50</sub>). Immunoblotting revealed highly varied levels of tubulin acetylation among the inhibitors. DAU induced the lowest levels of acetylation, with IC<sub>50</sub> concentration showing levels comparable with control and only a slight increase in response to higher concentration of drug (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, lanes 1–3). Compound <b>7</b> induced moderate levels of acetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, lanes 4 and 5), while <b>12b</b> caused robust acetylation at 5× its IC<sub>50</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, lanes 6 and 7). p21 expression at 4 h remained low across all compounds tested, with no discernible induction relative to control (data not shown).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tubulin acetylation in response to TopoII–HDACi. DU-145 cells were dosed for 4 h with: (1) control (0.1% DMSO), (2) DAU 90 nM, (3) DAU 500 nM, (4) <b>7</b> 130 nM, (5) <b>7</b> 500 nM, (6) <b>12b</b> 1.31 μM, (7) <b>12b</b> 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Intracellular Topoisomerase II Inhibition</h3><div class="NLM_p">To obtain information about the intracellular fate of Topo II upon cell exposure to these dual-acting agents, we used an immunoblotting kit to assay compound-induced Topo II inhibition in an intracellular environment (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> DU-145 cells were dosed with drug concentrations corresponding to cell growth inhibition IC<sub>50</sub>s, while the control cells were dosed with vehicle (0.1% DMSO). The relative levels of stabilized Topo II–DNA cleavage complexes were determined for a 30 min drug treatment, as described by the manufacturer. Within this period, the control cells showed no significant amounts of Topo II inhibition, evidenced by the low levels of Topo II associated DNA (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a, lane 1). Cells treated with DAU and <b>12b</b> contained high levels of Topo II–DNA cleavage complexes, with <b>12b</b> showing a significantly higher amount (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>a, lanes 2 and 4, respectively). This result suggests that <b>12b</b> could derive its cytotoxic activity, in part, from intracellular Topo II inhibition. Conversely, the levels of Topo II–DNA cleavage complexes in cells exposed to <b>7</b> is indistinguishable from that of the control cells (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, lane 3), suggesting a minimal contribution of Topo II inhibition to the cytotoxic activity of <b>7</b> within this period. This observation is surprising in light of the seemingly contradictory moderate effect of <b>7</b> on H4 hyperacetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), tubulin acetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), and its potent cell growth inhibition activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Intracellular Topo II Inhibition. DU-145 cells were probed for stabilized DNA–Topo II cleavage complexes upon (a) 30 min treatment; (b) 72 h treatment with bifunctional compounds: (1) control, (2) 90 nM DAU, (3) 130 nM <b>7</b>, (4) 1.6 μM <b>12b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To elucidate any contribution Topo II inhibition could be adding to long-term inhibition of cell proliferation, Topo II cleavage complexes were assayed after 72 h of treatment with compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b). As expected, DAU treatment results in significant inhibition of Topo II activity relative to control levels (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b, comparing lanes 1 and 2). Compound <b>7</b> shows a measured increase in Topo II inhibition relative to control levels (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>b, comparing lanes 1 and 3). Interestingly, we observed a drastic drop in the levels of stabilized Topo II–DNA cleavage complexes upon cell exposure to <b>12b</b> for 72 h (comparing lane 4 of parts a and b of Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). This result suggests that the Topo II inhibition activity of <b>7</b> increases with time while that of <b>12</b> decreases. The persistence of the stabilized Topo II–DNA cleavage complexes over a longer period indicates that Topo II inhibition may contribute significantly to the mechanism of the antiproliferative activity of <b>7</b>.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cellular Localization</h3><div class="NLM_p">HDAC1 and Topo II are cell nucleus-localized targets of these bifunctional compounds, while HDAC6 is cytoplasmic. To probe if cell penetration issues could be one of the alternative reasons for the difference in the potencies of compounds <b>7</b> and <b>12b</b>, we used confocal microscopy to visualize their intracellular localization (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). We exposed DU-145 cells to 1 μM of DAU, <b>7</b> and <b>12b</b>. After 4 h incubation time, cells were monitored at 488 nm, the excitation wavelength (λ<sub>ex</sub>) of DAU, and we observed clear differences in the intracellular distribution profiles of the tested compounds. In agreement with previous study in the literature,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> DAU is localized within the nuclear and perinuclear regions of DU-145 cells. Although it shows a less nuclear localization, compound <b>7</b> is more widely distributed within the cytosol, with evidence for perinuclear localization in similar manner to that of DAU. In contrast, <b>12b</b> shows a highly diminished intracellular distribution, with the bulk of the compound trapped in vesicle-like bodies within the cell (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The relatively poor intracellular distribution of <b>12b</b> could be due to low cell membrane penetration or an enhanced pump-induced efflux of compound from within the cell.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> We obtained a similar result with a lung tumor derived A549 cells (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Figure S2">Supporting Information Figure S2</a>). These results show that <b>7</b> and <b>12b</b> have different intracellular residency, which may affect access to their targets and consequently offer additional insight into underlying factors that could contribute to the disparity in the in vitro potency of these compounds.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cellular localization of dual-acting inhibitors. (a) DAU, (b) <b>7</b>, (c) <b>12b</b>. DU-145 cells were dosed at 1 μM for 4 h with indicated compounds and visualized by confocal microscopy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38548" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38548" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is evidence for the synergistic effect of combined Topo II and HDAC inhibitors on cancer.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, this synergy is schedule dependent, hence traditional combination therapy involving Topo and HDAC inhibitors may be complicated by the inherent pharmacokinetic disadvantage of two separate drugs. To critically delineate the benefits of simultaneous Topo and HDAC inhibition in cancer therapy, it will be of interest to identify agents that possess Topo and HDAC inhibition activities within a single molecule. Toward this end, we have created dual-acting Topo II–HDAC inhibitors. A subset of these compounds potently inhibits the proliferation of representative cancer cell lines. When subjected to target-specific screening, these agents present both HDAC and Topo II inhibition signatures under cell-free conditions and in in vitro cell cultures. This observation suggests that the cytotoxic activities and potency of these dual-acting compounds could be dictated by either of the two antitumor pharmacophores. Specifically, results from HDAC and Topo inhibition studies, and p21, acetyl-H4, and acetyl-tubulin immunoblots highlight compound <b>7</b> as a moderate, yet sustained modulator of several intracellular targets important in tumor etiology. This may explain the superior antitumor activity of compound <b>7</b> relative to the other dual acting agents disclosed in this study. It is, however, instructive to emphasize that the target validation experiments described herein are performed under different conditions at different incubation periods, so parsing out the specific contributions of the two targets to the bioactivity of these agents may not be direct.</div><div class="NLM_p last">Another target-independent factor which influences the bioactivity of the anthracycline-derived dual-acting agent is their cell uptake and/or residency. In fact, diminished intracellular residency, occasioned by multidrug resistance protein (MRP) mediated efflux, is one of the problems of an anthracycline based chemotherapy regimen.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Compound <b>12b</b> shows a rapid onset of HDAC and Topo II inhibition activities which may be quickly lost due to diminished intracellular residency. The poor intracellular distribution of <b>12b</b> may suggest that the triazole-containing compounds <b>12a</b>–<b>d</b> are prone to efflux, in a similar manner to the anthracycline template. Alternatively, it may be that <b>12a</b>–<b>d</b> are not easily taken up into the cell. Either of these limitations would compromise the bioactivity of <b>12a</b>–<b>d</b> and may explain their less than optimal cytotoxic activity, despite evidence for potent inhibition of Topo II and HDACs. Nevertheless, the amide-containing compound <b>7</b> is a lead that merits additional study due primarily to its good intracellular distribution and potency that rivals DAU. It will be of interest to know how <b>7</b> fares with respect to common deleterious side effects that have plagued anthracycline therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41252" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41252" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Materials and General Methods</h3><div class="NLM_p">Suberic acid, 4-aminobenzyl alcohol, and 4-ethynylbenzyl alcohol were purchased from Sigma–Aldrich. Anhydrous solvents and other reagents were purchased and used without further purification. Analtech silica gel plates (60 F254) were used for analytical TLC, and Analtech preparative TLC plates (UV 254, 2000 μm) were used for purification. UV light was used to examine the spots. Silica gel (200–400 Mesh) was used in column chromatography. NMR spectra were recorded on a Varian-Gemini 400 magnetic resonance spectrometer. <sup>1</sup>H NMR spectra were recorded in parts per million (ppm) relative to the peak of CDCl<sub>3</sub>, (7.24 ppm), CD<sub>3</sub>OD (3.31 ppm), or DMSO-<i>d</i><sub>6</sub> (2.49 ppm). <sup>13</sup>C spectra were recorded relative to the central peak of the CDCl<sub>3</sub> triplet (77.0 ppm), CD<sub>3</sub>OD (49.0 ppm), or the DMSO-<i>d</i><sub>6</sub> septet (39.7 ppm) and were recorded with complete heterodecoupling. Multiplicities are described using the abbreviation: s, singlet; d, doublet, t, triplet; q, quartet; m, multiplet; and app, apparent. High-resolution mass spectra were recorded at the Georgia Institute of Technology mass spectrometry facility in Atlanta. The purity of all tested compounds was established by HPLC to be >95%. HPLC analyses were performed on a Beckman Coulter instrument using a Phenomenex RP C-18 column (250 mm × 4.6 mm), eluting with solvent A (0.1% formic acid–water) and solvent B (0.1% formic acid–acetonitrile) at a gradient of 5–50% over 30 min, with detection at 498 nm and a flow rate of 1 mL/min. Sample concentrations were 250 μM, injecting 50 μL. <i>O</i>-Trityl-protected hydroxamates <b>9a</b>–<b>d</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> 4-ethynylbenzaldehyde <b>8</b>,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> and suberic anhydride <b>2</b><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> were prepared according to literature protocol.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 8-(4-(Hydroxymethyl)phenylamino)-8-oxooctanoic Acid (<b>3</b>) -</h4><div class="NLM_p last">To a stirring solution of suberic anhydride <b>2</b> (1.0 g, 6.40 mmol) in THF (15 mL) was added (4-aminophenyl)methanol <b>1</b> (0.78 g, 6.34 mmol), and resulting mixture was stirred at room temperature for 1 h. Ethyl acetate was added (60 mL), followed by washing with water (2 × 50 mL), brine (1 × 40 mL). Organic layer was dried on Na<sub>2</sub>SO<sub>4</sub> and solvent evaporated under reduced pressure to give crude compound <b>2</b>, which was purified by column chromatography (silica, CH<sub>2</sub>Cl<sub>2</sub>–MeOH (step gradient, 0–10% methanol) to give 0.92 g of compound <b>3</b> (52%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.25–1.32 (4H, m), 1.49–1.61 (4H, m), 2.21 (2H, t, <i>J</i> = 7.2 Hz), 2.29 (2H, t, <i>J</i> = 8.0 Hz), 4.42 (2H, s), 5.10 (1H, s), 7.23 (2H, d, <i>J</i> = 8.4 Hz), 7.54 (2H, d, <i>J</i> = 8.8 Hz), 9.84 (1H, s), 12.0 (1H, s). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 24.4, 25.0, 28.3, 28.4, 33.6, 36.3, 62.5, 118.5, 126.6, 136.7, 137.7, 170.7, 174.1. HRMS (MALDI) calcd for C<sub>15</sub>H<sub>21</sub>NO<sub>4</sub>Na [M + Na]<sup>+</sup> 302.1363; found 302.1343.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 8-((4-Formylphenyl)amino)-8-oxooctanoic Acid (<b>4</b>)</h4><div class="NLM_p last">To a stirring solution of alcohol <b>3</b> (1.71 g, 6.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was added Dess–Martin reagent (3.898 g, 9.19 mmol) at 0 °C. The reaction mixture was stirred for the next 16 h at room temperature. The reaction was quenched by adding an aqueous solution of saturated sodium bicarbonate and saturated sodium thiosulfate (1:1, 40 mL) with stirring for 15 min. Methanol–CH<sub>2</sub>Cl<sub>2</sub> 1:9 (70 mL) was added after the cessation of bubbling. The organic layer was isolated, washed subsequently with sodium bicarbonate–sodium thiosulfate mixture (1:1, 40 mL), brine (40 mL), and dried on Na<sub>2</sub>SO<sub>4</sub>. Solvent was evaporated under reduced pressure, and the crude product was purified by column chromatography using CH<sub>2</sub>Cl<sub>2</sub>–methanol (step gradient, 0–12% methanol) to give 1.10 g of compound <b>4</b> (65%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.24–1.30 (4H, m), 1.47 (2H, p, <i>J</i> = 7.2, 15.6 Hz), 1.56 (2H, p, <i>J</i> = 7.2, 14.0 Hz), 2.17 (2H, t, <i>J</i> = 7.6 Hz), 2.33 (2H, t, <i>J</i> = 7.2 Hz), 7.77–7.83 (4H, m), 9.84 (1H, s), 10.28 (1H, s), 11.99 (1H, s). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 24.3, 24.7, 28.3, 28.4, 33.6, 36.4, 118.6, 130.8, 131.0, 144.8, 172.0, 174.4, 191.5. HRMS (EI) calcd for C<sub>15</sub>H<sub>19</sub>NO<sub>4</sub>[M + H]<sup>+</sup> 277.1314; found 277.1315.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-(4-Formylphenyl)-<i>N</i>-(trityloxy)octanediamide (<b>5</b>)</h4><div class="NLM_p last">Carboxylic acid <b>4</b> (0.30 g, 1.07 mmol) was dissolved in anhydrous THF. <i>N</i>-Methylmorpholine (0.12 mL, 1.07 mmol) was added to the solution. The reaction mixture was then cooled down to −15 °C and stirred for 5 min. Isobutylchloroformate (0.14 mL, 1.07 mmol) was added, and the mixture was stirred for 10 min at −15 °C. <i>O</i>-Tritylhydroxylamine (0.29 g, 1.07 mmol) was added, followed by 2 more equiv of <i>N</i>-methylmorpholine. Stirring continued for 15 min at −15 °C and 2 h at room temperature. Afterward, the mixture was poured into CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and water (50 mL). The organic layer was separated and extracted three times in each case with water, sodium bicarbonate solution (5%), and water. After washing with brine and drying over Na<sub>2</sub>SO<sub>4</sub>, solvent was evaporated in vacuo. Column chromatography with eluent system CH<sub>2</sub>Cl<sub>2</sub>–acetone (step gradient, 0–12% acetone) gave 0.37 g of compound <b>5</b> (66%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.10–1.21 (4H, m), 1.44–1.51 (2H, m), 1.73–1.77 (2H, m), 7.23–7.35 (15H, m), 7.78–7.84 (4H, m), 9.84 (1H, s), 10.16 (1H, s), 10.29 (1H, s). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 24.7, 28.3, 31.9, 36.4, 55.1, 91.5, 118.6, 127.4, 128.9, 130.9, 142.6, 144.6, 170.4, 172.1, 191.2. HRMS (ESI) calcd for C<sub>34</sub>H<sub>34</sub>N<sub>2</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 557.2207; found 557.2219.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Daunorubicin-<i>N</i>-benzyl-4-amino-8-oxo-<i>N-(</i>trityloxy)octanediamide (<b>6</b>)</h4><div class="NLM_p last">A solution of daunorubicin (0.07 g, 0.12 mmol), aldehyde <b>5</b> (0.07 g, 0.12 mmol), and diisopropylethylamine (0.03 mL, 0.25 mmol) in DMF (2.5 mL) and MeOH (2.5 mL) was heated at 70 °C for 3 h and then allowed to cool to room temperature. Sodium cyanoborohydride (0.03 g, 0.50 mmol) was added, and stirring was continued at 70 °C for additional 24 h and allowed to cool at ambient temperature. The reaction was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and 5% NaHCO<sub>3</sub> (25 mL). The two layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 30 mL). The combined organic layer was washed with water (2 × 30 mL) and brine (1× 20 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was evaporated off and crude was purified on preparative TLC plates, eluting with mixture of CH<sub>2</sub>Cl<sub>2</sub>–MeOH (12:1) to give 0.05 g of compound <b>6</b> (38%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.93–0.98 (3H, m), 1.04–1.21 (8H, m), 1.38–1.53 (4H, m), 1.60–1.64 (2H, m), 1.71–1.75 (2H, m), 2.06–2.18 (4H, m), 2.24 (3H, s), 2.80–2.98 (3H, m), 3.15 (1H, d, <i>J</i> =4.4 Hz), 3.57 (1H, s), 3.67–3.70 (1H, m), 4.05 (1H, q, <i>J</i> = 6.4, 12.8 Hz), 4.91 (1H, t, <i>J</i> = 4.4 Hz), 5.21 (1H, s), 5.42 (1H, s), 7.17 (2H, d, <i>J</i> = 8.4 Hz), 7.25–7.34 (15H, m), 7.42 (2H, d, <i>J</i> = 8.0 Hz), 7.58–7.62 (1H, m), 7.85–7.87 (2H, m), 9.70 (1H, s), 10.12 (1H, s). <sup>13</sup>C NMR (CD<sub>3</sub>OD, 100 MHz) δ 17.0, 24.7, 25.1, 25.5, 28.4, 29.6, 30.0, 30.9, 33.1, 34.8, 37.2, 49.7, 52.5, 56.5, 66.6, 66.7, 67.9, 69.7, 100.8, 111.1, 111.3, 118.3, 119.6, 119.8, 120.7, 127.7, 128.0, 128.6, 128.9, 134.2, 134.3, 135.3, 135.6, 137.2, 141.0, 155.7, 156.3, 160.9, 171.5, 186.5, 186.8, 211.8. HRMS (MALDI) calcd for C<sub>61</sub>H<sub>64</sub>N<sub>3</sub>O<sub>13</sub> [M + H]<sup>+</sup> 1046.4439; found 1046.4415.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Daunorubicin-<i>N</i>-benzyl-4-amino-8-oxooctahydroxamic Acid (<b>7</b>)</h4><div class="NLM_p last">To a solution of trityl-protected compound <b>6</b> (0.025 g, 0.024 mmol) in CH<sub>2</sub>Cl<sub>2</sub>–MeOH (1:1, 4 mL) was added BF<sub>3</sub>·OEt<sub>2</sub> (0.05 mL) at room temperature. The reaction mixture stirred for 30 min at room temperature. Reaction was quenched by addition of water (25 mL) and 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The aqueous layer was isolated, and its pH was adjusted to 8–9 by addition of satd NaHCO<sub>3</sub>. This aqueous layer was then extracted with 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic layer was washed with satd brine and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under reduced pressure. Trituration of crude product with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) gave pure 0.013 g of <b>7</b> (68%) as red solid. Retention time 6.46 min (solvent gradient: 5–60% solvent B over 20 min). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz) δ 1.28–1.33 (9H, m), 1.50–1.60 (4H, m), 1.79–1.85 (1H, m), 1.93–1.94 (1H, m), 2.04–2.12 (2H, m), 2.23–2.30 (3H, m), 2.34 (3H, s), 2.85–3.08 (5H, m), 3.69–3.83 (3H, m), 3.97 (3H, s), 4.18–4.23 (1H, m), 5.04 (1H, s), 5.40 (1H, s), 7.22 (2H, d, <i>J</i> = 7.6 Hz), 7.39 (2H, d, <i>J</i> = 8.4), 7.47 (1H, d, <i>J</i> = 8 Hz), 7.74 (1H, t, <i>J</i> = 8 Hz), 7.82 (1H, d, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub> with drops of CD<sub>3</sub>OD, 100 MHz) δ 17.2, 24.7, 26.2, 26.3, 29.5, 29.6, 30.4, 33.2, 33.5, 36.4, 37.6, 53.3, 54.4, 57.0, 67.5, 68.2, 71.1, 77.2, 101.7, 111.8, 112.1, 115.3, 119.8, 120.3, 121.0, 121.2, 128.3, 130.1, 135.3, 135.4, 136.0, 136.8, 139.2, 155.9, 157.1, 162.0, 172.5, 174.1, 187.3, 187.7, 213.5. HRMS (MALDI) calcd for C<sub>42</sub>H<sub>50</sub>N<sub>3</sub>O<sub>13</sub> [M + H]<sup>+</sup> 804.3343, found 804.336, and calcd for [M + Na]<sup>+</sup> 826.3163, found 826.3153.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Representative Procedure for Cu(I)-Catalyzed Cycloaddition Reaction: <i>O</i>-Trityl-4-formylphenyltriazolylpentahydroxamate (<b>10a</b>)</h3><div class="NLM_p">5-Azido-<i>O</i>-tritylpentahydroxamate <b>9a</b> (0.15 g, 0.37 mmol) and 4-ethynylbenzaldehyde <b>8</b> (0.06 g, 0.49 mmol) were dissolved in anhydrous THF (10 mL) and stirred under argon at room temperature. Copper(I) iodide (9 mg, 0.05 mmol) and Hunig’s base (0.1 mL) were then added to the reaction mixture, and stirring continued for 24 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and washed with 1:4 NH<sub>4</sub>OH–satd NH<sub>4</sub>Cl (3 × 30 mL) and satd NH<sub>4</sub>Cl (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude product was purified by flash chromatography (CH<sub>2</sub>Cl<sub>2</sub>–acetone, gradient 12:1, 10:1, 8:1) to give 0.16 g of <b>10a</b> (82%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.13–1.20 (2H, m), 1.49–1.56 (2H, m), 1.82 (2H, t, <i>J</i> = 7.2), 4.27 (2H, t, <i>J</i> = 6.8 Hz), 7.24–7.28 (15H, m), 7.97 (2H, d, <i>J</i> = 8.8 Hz), 8.05–8.07 (2H, d, <i>J</i> = 8.4 Hz), 8.68 (1H, s), 9.99 (1H, s), 10.23 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 20.0, 29.2, 30.1, 50.0, 93.4, 120.8, 125.8, 127.7, 128.0, 128.8, 130.2, 135.5, 136.3, 140.8, 146.1, 176.2, 191.6. HRMS (MALDI) calcd for C<sub>33</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub>Na [M + Na]<sup>+</sup> 553.2210; found 553.2191.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>O</i>-Trityl-4-formylphenyltriazolylhexahydroxamate (<b>10b</b>)</h4><div class="NLM_p last">Reaction of 6-azido-<i>O</i>-tritylhexahydroxamate <b>9b</b> (0.24 g, 0.58 mmol) and 4-ethynylbenzaldehyde <b>8</b> (0.09 g, 0.69 mmol) as described for the synthesis of <b>10a</b>, followed by purification using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–acetone, gradient 12:1, 10:1, 8:1) gave 0.19 g of <b>10b</b> (61%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.92–0.99 (2H, m), 1.19–1.26 (2H, m), 1.70–1.78 (4H, m), 4.30 (2H, t, <i>J</i> = 6.8), 7.26–7.29 (15H, m), 7.96 (2H, d, <i>J</i> = 8.0 Hz), 8.05 (2H, d, <i>J</i> = 8.4 Hz), 8.72 (1H, s), 9.99 (1H, s), 10.15 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) 22.2, 25.5, 29.6, 30.7, 49.9, 93.1, 120.8, 125.7, 127.6, 127.9, 128.8, 130.1, 135.4, 136.3, 140.7, 141.6, 146.0, 176.5, 191.5.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>O</i>-Trityl-4-formylphenyltriazolylheptahydroxamate (<b>10c</b>)</h4><div class="NLM_p last">Reaction of 7-azido-<i>O</i>-tritylheptahydroxamate <b>9c</b> (0.30 g, 0.70 mmol) and 4-ethynylbenzaldehyde <b>8</b> (0.09 g, 0.70 mmol) as described for the synthesis of <b>10a</b>, followed by purification using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–acetone, gradient 12:1, 10:1, 8:1) gave 0.25 g of <b>10c</b> (65%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.96–1.17 (6H, m), 1.71–1.78 (4H, m), 4.34 (2H, t, <i>J</i> = 7.2 Hz), 7.24–7.34 (15H, m), 7.96 (2H, d, <i>J</i> = 7.6 Hz), 8.06 (2H, d, <i>J</i> = 8.0 Hz), 8.75 (1H, s), 9.99 (1H, s), 10.14 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 22.8, 25.8, 28.0, 29.7, 30.7, 50.1, 93.2, 120.7, 125.7, 127.9, 128.8, 130.1, 135.4, 136.3, 140.8, 141.7, 146.1, 176.8 191.5.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>O</i>-Trityl-4-formylphenyltriazolyloctahydroxamate (<b>10d</b>)</h4><div class="NLM_p last">Reaction of 8-azido-<i>O</i>-trityloctahydroxamate <b>9d</b> (0.25 g, 0.57 mmol) and 4-ethynylbenzaldehyde <b>8</b> (0.07 g, 0.57 mmol) as described for the synthesis of <b>10a</b>, followed by purification using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–acetone, gradient 12:1, 10:1, 8:1) gave 0.19 g of <b>10d</b> (59%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.85–0.93 (2H, m), 1.08–1.17 (6H, m), 1.72–1.80 (4H, m), 4.38 (2H, t, <i>J</i> = 7.2), 7.24–7.28 (15H, m), 7.96 (2H, d, <i>J</i> = 7.6 Hz), 8.06 (2H, d, <i>J</i> = 8.0 Hz), 8.77 (1H, s), 9.99 (1H, s), 10.13 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 23.0, 26.0, 28.3, 28.5, 30.0, 30.8, 50.3, 93.1, 120.7, 125.8, 127.9, 128.8, 130.2, 135.4, 136.3, 140.8, 141.7, 146.1, 176.9, 191.5. HRMS (MALDI) calcd for C<sub>36</sub>H<sub>36</sub>N<sub>4</sub>O<sub>3</sub>Na [M + Na]<sup>+</sup> 595.2679; found 595.2609.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Daunorubicin-<i>N</i>-benzyl-4-triazolyl-<i>O</i>-tritylpentahydroxamate (<b>11a</b>)</h4><div class="NLM_p last">A solution of daunorubicin hydrochloride (0.08 g, 0.14 mmol) and <b>10a</b> (0.15 g, 0.28 mmol) in acetonitrile (9 mL) and water (3 mL) was stirred at room temperature for 30 min. A suspension of sodium cyanoborohydride in THF was added within 1 min, and stirring continued overnight at room temperature during which all of the starting material got consumed. The reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and water (30 mL), and the two layers were separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL), and the combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>. Solvent was removed under reduced pressure, and the crude was purified by preparative TLC, eluting with 12:1 CH<sub>2</sub>Cl<sub>2</sub>–MeOH to give 0.065 g of <b>11a</b> (44%) as red solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) 1.23–1.27 (5H, m), 1.36 (3H, d, <i>J</i> = 6.4 Hz), 1.60–1.68 (5H, m), 1.76–1.83 (2H, m), 2.10–2.15 (1H, m), 2.34–2.39 (1H, m), 2.88–2.93 (1H, m), 2.99–3.03 (1H, m), 3.21–3.26 (1H, m), 3.64 (1H, s), 3.67–3.70 (1H, m), 3.79–3.83 (1H, m), 3.97 (1H, q, <i>J</i> = 6.4 Hz), 4.06 (3H, s), 4.16–4.19 (2H, m), 4.73 (1H, s), 4.76 (1H, s), 5.30 (1H, s), 5.51 (1H, d, <i>J</i> = 3.2 Hz), 7.26–7.33 (15H, m), 7.36–7.42 (3H, m), 7.64 (1H, s), 7.71 (2H, d, <i>J</i> = 8.0 Hz), 7.76 (1H, t, <i>J</i> = 8.4 Hz), 8.01 (1H, d, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 17.4, 20.4, 29.7, 29.9, 30.4, 34.2, 35.7, 50.2, 50.3, 52.5, 56.9, 65.7, 67.0, 67.1, 69.5, 101.0, 111.6, 111.7, 118.6, 119.6, 120.0, 121.1, 126.0, 127.4, 128.1, 128.4, 128.7, 129.2, 129.9, 133.8, 134.0, 135.7, 136.0, 139.6, 141.1, 155.9, 156.4, 161.3, 186.9, 187.3, 213.9. HRMS (ESI) calcd for C<sub>60</sub>H<sub>60</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 1042.4233; found 1042.4189.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Daunorubicin-<i>N</i>-benzyl-4-triazolyl-<i>O</i>-tritylhexahydroxamate (<b>11b</b>)</h4><div class="NLM_p last">Reaction of daunorubicin hydrochloride (0.055 g, 0.097 mmol) with <b>10b</b> (0.159 g, 0.29 mmol) and sodium cyanoborohydride (0.018 g, 0.29 mmol) in acetonitrile–water solvent system, as described in the synthesis of <b>11a</b>, gave 0.05 g of <b>11b</b> (49%) as red solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) 1.23–1.28 (5H, m), 1.38 (3H, d, <i>J</i> = 6.4 Hz), 1.56–1.60 (3H, m), 1.66–1.85 (6H, m), 2.12–2.17 (1H, m), 2.35–2.41 (1H, m), 2.91–2.94 (1H, m), 2.99–3.04 (1H, m), 3.23–3.28 (1H, m), 3.66–3.72 (2H, m), 3.81–3.84 (1H, m), 3.99 (1H, q, <i>J</i> = 6.8 Hz), 4.07 (3H, s), 4.28 (2H, t, <i>J</i> = 7.6 Hz), 4.74 (1H, s), 4.78 (1H, s), 5.29–5.32 (1H, m), 5.53 (1H, d, <i>J</i> = 2.8 Hz), 7.30–7.35 (15H, m), 7.37–7.45 (3H, m), 7.67 (1H, s), 7.73–7.80 (3H, m), 8.02 (1H, d, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 17.1, 22.5, 25.7, 29.6, 29.8, 30.2, 30.7, 33.9, 35.4, 49.9, 50.0, 52.3, 56.6, 65.4, 66.7, 66.8, 69.3, 100.8, 111.3, 111.5, 118.4, 119.4, 119.8, 120.8, 125.8, 127.8, 128.1, 128.4, 128.9, 129.7, 133.5, 133.8, 135.4, 135.7, 139.5, 141.1, 147.3, 155.6, 156.2, 161.0, 186.7, 187.0, 213.7. HRMS (ESI) calcd for C<sub>61</sub>H<sub>62</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 1056.4389; found 1056.4440.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Daunorubicin-<i>N</i>-benzyl-4-triazolyl-<i>O</i>-tritylheptahydroxamate (<b>11c</b>)</h4><div class="NLM_p last">Reaction of daunorubicin hydrochloride (0.055 g, 0.097 mmol) with <b>10c</b> (0.162 g, 0.29 mmol) and sodium cyanoborohydride (0.018 g, 0.29 mmol) in acetonitrile–water solvent system, as described in the synthesis of <b>11a</b>, gave 0.05 g of <b>11c</b> (48%) as a red solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.99–1.07 (2H, m), 1.13–1.25 (6H, m), 1.36 (3H, d, <i>J</i> = 6.4 Hz), 1.52–1.57 (2H, m), 1.70–1.83 (5H, m), 2.02–2.10 (2H, m), 2.14 (1H, s), 2.33 (1H, s), 2.85–2.88 (1H, m), 2.93 (1H, s), 2.97–3.00 (1H, s), 3.14–3.19 (1H, m), 3.67–3.70 (2H, m), 3.80–3.83 (1H, m), 4.04 (3H, s), 4.28 (3H, t, <i>J</i> = 6.8 Hz), 4.66–4.69 (1H, m), 5.24 (1H, s), 5.50 (1H, d, <i>J</i> = 3.2 Hz), 7.26–7.30 (15H, m), 7.34–7.43 (3H, m), 7.63 (1H, s), 7.66–7.79 (3H, m), 7.97 (1H, d, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 17.1, 23.1, 24.8, 25.9, 28.2, 29.7, 30.0, 30.9, 30.9, 33.2, 34.9, 49.9, 50.2, 52.3, 56.6, 66.6, 66.7, 69.9, 100.6, 111.3, 111.5, 118.4, 119.4, 119.9, 120.9, 125.7, 127.8, 128.1, 128.4, 128.9, 129.9, 134.2, 134.2, 135.4, 135.7, 139.5, 141.1, 147.3, 155.6, 156.2, 161.0, 186.7, 187.1, 212.0. HRMS (ESI) calcd for C<sub>62</sub>H<sub>64</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 1070.4546; found 1070.4508.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Daunorubicin-<i>N</i>-benzyl-4-triazolyl-<i>O</i>-trityloctahydroxamate (<b>11d</b>)</h4><div class="NLM_p last">Reaction of daunorubicin hydrochloride (0.055 g, 0.097 mmol) with <b>10d</b> (0.166 g, 0.29 mmol) and sodium cyanoborohydride (0.018 g, 0.29 mmol) in acetonitrile–water solvent system, as described in the synthesis of <b>11a</b>, gave 0.048 g of <b>11d</b> (46%) as a red solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 0.98–1.06 (2H, m), 1.19–1.24 (8H, m), 1.37 (3H, d, <i>J</i> = 6.4 Hz), 1.53–1.58 (2H, m), 1.69–1.85 (5H, m), 2.07–2.10 (2H, m), 2.35 (1H, s), 2.88–2.92 (1H, m), 2.96–2.99 (1H, m), 3.15–3.20 (1H, m), 3.67–3.70 (2H, m), 3.79–3.83 (1H, m), 4.05 (3H, s), 4.31 (3H, t, <i>J</i> = 6.8 Hz), 4.68 (1H, s), 5.25 (1H, s), 5.50 (1H, s), 7.27–7.31 (15H, m), 7.35–7.47 (3H, m), 7.66 (1H, s), 7.69–7.77 (3H, m), 7.98 (1H, d, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz) δ 17.0, 23.1, 24.8, 26.1, 28.5, 29.6, 30.1, 30.2, 31.0, 33.2, 34.8, 50.0, 50.2, 52.5, 56.6, 66.5, 66.7, 69.8, 100.9, 111.1, 111.2, 118.3, 119.2, 119.7, 120.7, 125.7, 127.8, 128.0, 128.4, 128.9, 129.6, 134.2, 134.3, 135.4, 135.6, 139.5, 141.0, 147.3, 155.7, 156.3, 160.9, 186.5, 186.8, 211.8. HRMS (ESI) calcd for C<sub>63</sub>H<sub>66</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 1084.4702; found 1084.4657.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Daunorubicin-<i>N</i>-benzyl-4-triazolylpentahydroxamic Acid (<b>12a</b>)</h4><div class="NLM_p last">Reaction of <b>11a</b> (0.05 g, 0.048 mmol) and BF<sub>3</sub>·OEt<sub>2</sub> (0.1 mL in CH<sub>2</sub>Cl<sub>2</sub>–MeOH (4 mL/4 mL) within 2 h, as described for the synthesis of <b>7</b>, followed by preparative TLC (eluent, CH<sub>2</sub>Cl<sub>2</sub>–MeOH 7:1) to give 0.028 g of <b>12a</b> (73%) as red solid. Retention time 15.06 min (solvent gradient: 0–100% solvent B over 30 min). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.11–1.21 (7H, m), 1.42–1.50 (4H, m), 1.74–1.80 (2H, m), 1.96 (2H, t, <i>J</i> = 7.6 Hz), 2.06–2.22 (5H, m), 2.84–2.97 (3H, m), 3.63–3.80 (1H, m), 3.96 (3H, s), 4.07–4.09 (1H, m), 4.33 (2H, t, <i>J</i> = 6.8 Hz), 4.91 (1H, m), 5.22 (1H, s). 5.47 (1H, s), 7.37 (2H, d, <i>J</i> = 8.0 Hz), 7.61–7.63 (1H, m), 7.69–7.71 (2H, d, <i>J</i> = 8.0 Hz), 7.87–7.92 (2H, m), 8.46 (1H, s), 10.37 (1H, s). <sup>13</sup>C NMR (CDCl<sub>3</sub> with drops of CD<sub>3</sub>OD, 125 MHz) δ 15.1, 22.5, 24.1, 24.2, 27.3, 27.4, 28.3, 31.0, 31.3, 34.2, 35.4, 51.1, 52.2, 54.8, 65.4, 66.1, 68.9, 75.1 99.5, 109.7, 109.9, 113.1, 117.6, 118.2, 118.8, 119.0, 126.3, 127.9, 133.1, 133.2, 133.8, 134.7, 137.0, 153.7, 154.9, 159.8, 170.4, 172.0, 185.1, 185.5, 211.1. HRMS (ESI) calcd for C<sub>41</sub>H<sub>46</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 800.3137; found 800.3088.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Daunorubicin-<i>N</i>-benzyl-4-triazolylhexahydroxamic Acid (<b>12b</b>)</h4><div class="NLM_p last">Reaction of <b>11b</b> (0.05 g, 0.047 mmol) and BF<sub>3</sub>·OEt<sub>2</sub> (0.1 mL) in CH<sub>2</sub>Cl<sub>2</sub>–MeOH (4 mL/4 mL) within 2 h, as described for the synthesis of <b>7</b>, followed by preparative TLC (eluent, CH<sub>2</sub>Cl<sub>2</sub>–MeOH 7:1) gave 0.028 g of <b>12b</b> (76%) as red solid. Retention time 15.20 min (solvent gradient: 0–100% solvent B over 30 min). <sup>1</sup>H NMR (CDCl<sub>3</sub> +CD<sub>3</sub>OD, 400 MHz) δ 0.74–0.84 (2H, m), 1.25–1.31 (7H, m), 1.54–1.62 (3H, m), 1.72–1.73 (2H, m), 1.83–1.93 (2H, m), 1.99 (1H, t, <i>J</i> = 7.6 Hz), 2.03–2.08 (1H, m), 2.19–2.33 (2H, m), 3.57–3.60 (5H, m), 3.68–3.73 (2H, m), 4.00 (3H, s), 4.30 (2H, q, <i>J</i> = 7.2 Hz), 4.65–4.66 (1H, m), 5.22–5.23 (1H, m), 5.44 (1H, s), 7.24–7.25 (1H, m), 7.34 (2H, d, <i>J</i> = 8.4 Hz), 1.61–1.65 (2H, m), 7.70–7.72 (1H, m), 7.74–7.75 (1H, m), 7.95 (1H, d, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub> with drops of CD<sub>3</sub>OD, 100 MHz) δ 16.8, 22.5, 24.3, 25.4, 29.5, 30.7, 32.2, 33.6, 35.3, 50.0, 50.1, 51.9, 56.5, 65.0, 67.0, 67.2, 69.0, 100.6, 111.3, 111.4, 118.4, 119.7, 119.9, 125.7, 127.8, 128.6, 129.1, 133.7, 133.8, 135.3, 135.7, 147.3, 160.9, 170.2, 186.7, 187.1, 213.5. HRMS (ESI) calcd for C<sub>42</sub>H<sub>48</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 814.3294; found 814.3323.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Daunorubicin-<i>N</i>-benzyl-4-triazolylheptahydroxamic Acid (<b>12c</b>)</h4><div class="NLM_p last">Reaction of <b>11c</b> (0.05 g, 0.047 mmol) and BF<sub>3</sub>·OEt<sub>2</sub> (0.1 mL) in CH<sub>2</sub>Cl<sub>2</sub>–MeOH (4 mL/4 mL) within 2 h, as described for the synthesis of <b>7</b>, followed by preparative TLC (eluent, CH<sub>2</sub>Cl<sub>2</sub>–MeOH 7:1) gave 0.030 g of <b>12c</b> (78%) as red solid. Retention time 16.98 min (solvent gradient: 5–60% solvent B over 20 min). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.17–1.26 (8H, m), 1.37–1.49 (3H, m), 1.70–1.83 (5H, m), 1.89–1.92 (1H, m), 1.99 (1H, t, <i>J</i> = 7.2 Hz), 2.09–2.23 (5H, m), 2.83–2.99 (4H, m), 3.63–3.84 (2H, m), 3.92–3.96 (3H, m), 4.08 (1H, t, <i>J</i> = 6.8 Hz), 4.31 (2H, t, <i>J</i> = 6.8 Hz), 4.93–4.96 (1H, m), 5.25 (1H, s). 5.34 (1H, s), 7.36 (2H, d, <i>J</i> = 8.0 Hz), 7.53–7.60 (1H, m), 7.70 (2H, d, <i>J</i> = 8.0 Hz), 7.79–7.80 (1H, m), 7.85–7.86 (1H, m), 8.41 (1H, s), 10.21 (1H, s). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz) δ 17.7, 24.6, 25.5, 25.8, 26.1, 26.2, 27.2, 28.4, 28.6, 28.6, 30.1, 32.4, 32.8, 37.0, 50.1, 57.3, 67.4, 70.7, 76.1, 101.2, 111.5, 119.8, 120.6, 120.9, 121.8, 125.6, 128.6, 129.0, 129.5, 135.6, 136.4, 136.9, 146.8, 155.2, 155.9, 161.7, 186.8, 212.0. HRMS (ESI) calcd for C<sub>43</sub>H<sub>50</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 828.3450; found 828.3407.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Daunorubicin-<i>N</i>-benzyl-4-triazolyloctahydroxamic Acid (<b>12d</b>)</h4><div class="NLM_p last">Reaction of <b>11d</b> (0.05 g, 0.046 mmol) and BF<sub>3</sub>·OEt<sub>2</sub> (0.1 mL) in CH<sub>2</sub>Cl<sub>2</sub>–MeOH (4 mL/4 mL) within 2 h, as described for the synthesis of <b>7</b>, followed by preparative TLC (eluent, CH<sub>2</sub>Cl<sub>2</sub>–MeOH 7:1), gave 0.028 g of <b>12d</b> (73%) as red solid. Retention time 16.93 min (solvent gradient: 5–60% solvent B over 20 min). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ 1.15–1.20 (8H, m), 1.41–1.44 (2H, m), 1.64–1.67 (2H, m), 1.77–1.80 (2H, m), 1.88 (2H, t, <i>J</i> = 7.6), 1.95–1.20 (2H, m), 2.23–2.24 (3H, m), 2.80–2.94 (3H, m), 3.60–3.67 (2H, m), 3.76–3.79 (1H, m), 3.89–3.94 (3H, m), 4.05–4.10 (1H, m), 4.30 (2H, t, <i>J =</i> 7.2), 4.88–4.91 (1H, m), 5.21 (1H, m), 5.42 (1H, s), 7.33–7.35 (2H, m), 7.57–7.59 (1H, m), 7.65–7.73 (2H, m), 7.83–7.86 (2H, m), 8.44 (1H, s), 10.29 (1H, m). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz) δ 17.2, 24.0, 24.8, 25.5, 27.9, 29.4, 30.8, 31.5, 32.1, 36.2, 48.4, 49.3, 51.8, 54.8, 56.5, 66.8, 70.0, 75.1, 75.2, 100.6, 110.5, 110.6, 118.8, 119.5, 119.9, 120.8, 124.9, 128.3, 129.1, 134.4, 134.6, 135.5, 136.1, 146.2, 154.1, 155.8, 160.6, 169.0, 186.3, 211.5. HRMS (ESI) calcd for C<sub>44</sub>H<sub>50</sub>N<sub>5</sub>O<sub>12</sub> [M + H]<sup>+</sup> 842.3607; found 842.3626.</div></div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> In Vitro HDAC Inhibition</h3><div class="NLM_p last">In vitro HDAC inhibition was assayed using the HDAC Fluorimetric Assay/Drug Discovery Kit as previously described.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Briefly, 15 μL of HeLa nuclear extract was mixed with 5 μL of 10× compound and 5 μL of assay buffer. Fluorogenic substrate (25 μL) was added, and reaction was allowed to proceed for 15 min at room temperature and then stopped by addition of a developer containing TSA. Fluorescence was monitored after 15 min at excitation and emission wavelengths of 360 and 460 nm, respectively. IC<sub>50</sub> values were determined using logit plots.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> KDNA Decatenation Assay</h3><div class="NLM_p last">The decatenation of KDNA was assayed according to TopoGen protocol in order to determine topoisomerase II activity. The substrate KDNA (200 ng) and 50 μM drug were combined in assay buffer (50 mM Tris–HCl, pH 8, 120 mM KCl, 10 mM MgCl<sub>2</sub>, 0.5 mM ATP, 0.5 mM dithiothreitol, 300ug/mL bovine serum albumin (BSA)) and incubated for 10 min on ice. Next, 1 U of topoisomerase II was added and the reaction was allowed to proceed for 10 min at 37 °C. The reaction was quenched via the addition of loading buffer (1% sarkosyl, 0.025% bromophenol blue, and 5% glycerol) and was then analyzed by electrophoresis on a 1% agarose gel in TBE buffer (89 mM Tris, 89 mM borate, and 2 mM Na–EDTA, pH 8.3) for 3.5 h at 40 V. The gel was stained with SYBR Green I (Molecular Probes) for 30 min and was visualized under UV illumination and photographed on an AlphaImager.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Cellular Topo II Inhibition</h3><div class="NLM_p last">DU-145 cells were probed for Topo II inhibition with an in vitro blotting kit designed to show relative amounts of stabilized Topo II–DNA cleavage complexes (Topoisomerase II In Vivo Link Kit, Topogen). Briefly, cells were dosed with Topo II–HDACi’s at concentrations pertaining to their respective IC<sub>50</sub> values for cell viability inhibition. Control cells were dosed with 0.1% DMSO to take into account DMSO from stock solutions of drug. As recommended in the protocol instructions, cells were dosed for 30 min, counted, and lysed with 1% sarkosyl. Alternately, DU-145 cells were dosed for 72 h, counted, and equalized with the cell count from the 30 min incubation before subsequent lysis. Lysate was collected, loaded on a CsCl gradient, and subjected to centrifugation at 31000 rpm at room temperature for 12 h. Aliquots of the gradient separations were then taken and the Topo II–DNA cleavage complexes were identified via absorbance at 260 nm. Aliquots were then loaded into a slot blotting device and subjected to vacuum to load proteins onto a nitrocellulose membrane. Immunoblotting using the Odyssey Imaging System (LiCor Biosciences) revealed Topo II levels associated with the stabilized DNA complexes.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Cell Culture and Viability</h3><div class="NLM_p last">DU-145 prostate carcinoma and SK-MES-1 nonsmall cell lung carcinoma was obtained from ATCC (Manassass, VA) and maintained in the recommended growth mediums. MCF-7 breast cancer cells were a generous gift from Dr. Donald Doyle. All cell lines were maintained in a 37 °C incubator with a 5% CO<sub>2</sub> environment. All compounds to be tested were dissolved to a concentration of 10 mM in DMSO and stored at −80 °C. Cells were passaged 24 h prior to cell viability experiments. For cancer cell viability experiments, cells were dosed for 72 h and viability was determined through the use of the MTS assay (Promega) according to manufacturer’s instructions. Control wells were dosed with fresh media containing 0.1% DMSO.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Western Blot of p21<sup>waf1</sup> Expression and Histone Hyperacetylation</h3><div class="NLM_p last">DU-145 prostate cancer cells were passaged 24 h prior to the experiment. Compounds to be tested were diluted in the growth medium so that the final concentration of DMSO was 0.1% and control cells were dosed with fresh media containing 0.1% DMSO. Cells were dosed for 24 h then washed twice with ice-cold PBS and lysed on the culture plate at 4 °C for 5 min with RIPA buffer containing protease inhibitors. Lysates were mixed repeatedly by pipetting and centrifuged at 14000<i>g</i> for 15 min at 4 °C. Supernatant was saved and protein concentration was quantified using the Bio-Rad Protein Assay (Bio-Rad) with BSA as the standard. Loading buffer was added, and protein samples were incubated at 100 °C for 10 min before electrophoresis. Proteins were then transferred to a nitrocellulose membrane for 1 h, followed by blocking overnight in a 1:1 mixture of Odyssey Blocking Buffer (LiCor Biosciences) and PBS. Membranes were incubated with primary and secondary antibodies, both diluted in 1:1 Odyssey Blocking Buffer/PBS. Membranes were scanned on the Odyssey infrared imaging system (LiCor Biosciences) using both 700 and 800 nm channels simultaneously at 169 μm resolution and analyzed on the imaging software.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Western Blot of Tubulin Acetylation</h3><div class="NLM_p last">DU-145 cells were passaged 24 h prior to dosing. Compounds were diluted such that cells, including controls, were exposed to no more than 0.1% DMSO. Cells were dosed for 4 h before lysis in RIPA buffer with protease inhibitors. Lysates were vortexed and centrifuged at 14000 rpm at 4 °C for 15 min. Supernatants were removed, and protein concentration was assayed using the Bio Rad Protein Assay with BSA as a standard. Electrophoresis and immunoblotting were performed as described above. Rabbit antitubulin (Sigma) and mouse antiacetyl tubulin (Invitrogen) were used to probe the membrane after blocking with Odyssey blocking buffer (Li Cor). Li Cor near-infrared secondary antibodies were used to image the blot with the Odyssey infrared imaging system at 700 and 800 nm.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Confocal Microscopy</h3><div class="NLM_p last">Cells were plated on glass coverslips in 35 mm dishes 24 h before the experiment. They were then incubated with fresh media containing the indicated compounds at concentration of 1 μM. After 4 h, cells were washed with PBS. Coverslips were then mounted and viewed under a confocal microscope (DAU λ<sub>ex</sub> = 488 nm; Zeiss LSM 510 UV confocal microscope).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/jm200799p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectral information, HPLC traces, and molecular modeling outputs.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200799p/suppl_file/jm200799p_si_001.pdf">jm200799p_si_001.pdf (7.52 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200799p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adegboyega K. Oyelere</span> - <span class="hlFld-Affiliation affiliation">†School of Chemistry
and Biochemistry, ‡Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta,
Georgia 30332-0400, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a2c3cddbc7cec7d0c7e2c5c3d6c7c1ca8cc7c6d7"><span class="__cf_email__" data-cfemail="5d3c32243831382f381d3a3c29383e3573383928">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Guerrant</span> - <span class="hlFld-Affiliation affiliation">†School of Chemistry
and Biochemistry, ‡Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta,
Georgia 30332-0400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal Patil</span> - <span class="hlFld-Affiliation affiliation">†School of Chemistry
and Biochemistry, ‡Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta,
Georgia 30332-0400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua C. Canzoneri</span> - <span class="hlFld-Affiliation affiliation">†School of Chemistry
and Biochemistry, ‡Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta,
Georgia 30332-0400, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d1549e2972-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Professor Olaf Wiest for providing us with the HDAC 1 homology model. This work was financially supported by NIH grant R01CA131217.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> Abbreviations Used</h2><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">histone acetyltransferase</p></td></tr><tr><td class="NLM_term">HDACi</td><td class="NLM_def"><p class="first last">histone deacetylase inhibitors</p></td></tr><tr><td class="NLM_term">HDLP</td><td class="NLM_def"><p class="first last">histone deacetylase-like protein</p></td></tr><tr><td class="NLM_term">SAHA</td><td class="NLM_def"><p class="first last">suberoylanilide hydroxamic acid</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">trichostatin A</p></td></tr><tr><td class="NLM_term">DOX</td><td class="NLM_def"><p class="first last">doxorubicin</p></td></tr><tr><td class="NLM_term">DAU</td><td class="NLM_def"><p class="first last">daunomycin</p></td></tr><tr><td class="NLM_term">Topo II</td><td class="NLM_def"><p class="first last">topoisomerase II class of enzymes</p></td></tr><tr><td class="NLM_term">KDNA</td><td class="NLM_def"><p class="first last">kinetoplast DNA</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0lhATHRm1NuSjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed Multiple Ligands. An Emerging Drug Discovery Paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+Multiple+Ligands.+An+Emerging+Drug+Discovery+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0ljZICGP2sFkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520Multiple%2520Ligands.%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0ljqoGYMlq7GXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cmeserly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: The network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Cmeserlyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+The+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCmeserly%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520The%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fray, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stobie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-(1,2-Diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4345</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4345-4348&author=M.+J.+Frayauthor=G.+Bishauthor=A.+D.+Brownauthor=P.+V.+Fishauthor=A.+Stobieauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=N-%281%2C2-Diphenylethyl%29piperazines%3A+a+new+class+of+dual+serotonin%2Fnoradrenaline+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFray%26aufirst%3DM.%2BJ.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DStobie%26aufirst%3DA.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DN-%25281%252C2-Diphenylethyl%2529piperazines%253A%2520a%2520new%2520class%2520of%2520dual%2520serotonin%252Fnoradrenaline%2520reuptake%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4345%26epage%3D4348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidlack, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span> </span><span class="NLM_article-title">New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5640</span><span class="NLM_x">–</span> <span class="NLM_lpage">5643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605785" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5640-5643&author=J.+L.+Neumeyerauthor=X.+Pengauthor=B.+I.+Knappauthor=J.+M.+Bidlackauthor=L.+H.+Lazarusauthor=S.+Salvadoriauthor=C.+Trapellaauthor=G.+Balboni&title=New+opioid+designed+multiple+ligand+from+Dmt-Tic+and+morphinan+pharmacophores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0605785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605785%26sid%3Dliteratum%253Aachs%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DB.%2BI.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DBalboni%26aufirst%3DG.%26atitle%3DNew%2520opioid%2520designed%2520multiple%2520ligand%2520from%2520Dmt-Tic%2520and%2520morphinan%2520pharmacophores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5640%26epage%3D5643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jones, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baylin, S. B.</span><span> </span><span class="NLM_article-title">The epigenomics of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.cell.2007.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17320506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=683-692&author=P.+A.+Jonesauthor=S.+B.+Baylin&title=The+epigenomics+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The epigenomics of cancer</span></div><div class="casAuthors">Jones, Peter A.; Baylin, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Aberrant gene function and altered patterns of gene expression are key features of cancer.  Growing evidence shows that acquired epigenetic abnormalities participate with genetic alterations to cause this dysregulation.  Here, we review recent advances in understanding how epigenetic alterations participate in the earliest stages of neoplasia, including stem/precursor cell contributions, and discuss the growing implications of these advances for strategies to control cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBpHNAkcSPbVg90H21EOLACvtfcHk0liT1Iqj6gNcDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7k%253D&md5=78eac8ecc093f1aed0acbfd578f34717</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BA.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26atitle%3DThe%2520epigenomics%2520of%2520cancer%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D683%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Chromatin modifications and their function</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.cell.2007.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17320507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=693-705&author=T.+Kouzarides&title=Chromatin+modifications+and+their+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications and their function</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The surface of nucleosomes is studded with a multiplicity of modifications.  At least eight different classes have been characterized to date and many different sites have been identified for each class.  Operationally, modifications function either by disrupting chromatin contacts or by affecting the recruitment of nonhistone proteins to chromatin.  Their presence on histones can dictate the higher-order chromatin structure in which DNA is packaged and can orchestrate the ordered recruitment of enzyme complexes to manipulate DNA.  In this way, histone modifications have the potential to influence many fundamental biol. processes, some of which may be epigenetically inherited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAH9AX2dGicbVg90H21EOLACvtfcHk0liT1Iqj6gNcDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D&md5=c5995fe68fd9473f4268d59c01d3b9de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DChromatin%2520modifications%2520and%2520their%2520function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D693%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Shilatifard, A.</span><span> </span><span class="NLM_article-title">Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1146%2Fannurev.biochem.75.103004.142422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16756492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=243-269&author=A.+Shilatifard&title=Chromatin+modifications+by+methylation+and+ubiquitination%3A+implications+in+the+regulation+of+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression</span></div><div class="casAuthors">Shilatifard, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">243-269</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  It is more evident now than ever that nucleosomes can transmit epigenetic information from one cell generation to the next.  It has been demonstrated during the past decade that the posttranslational modifications of histone proteins within the chromosome impact chromatin structure, gene transcription, and epigenetic information.  Multiple modifications decorate each histone tail within the nucleosome, including some amino acids that can be modified in several different ways.  Covalent modifications of histone tails known thus far include acetylation, phosphorylation, sumoylation, ubiquitination, and methylation.  A large body of exptl. evidence compiled during the past several years has demonstrated the impact of histone acetylation on transcriptional control.  Although histone modification by methylation and ubiquitination was discovered long ago, it was only recently that functional roles for these modifications in transcriptional regulation began to surface.  Highlighted in this review are the recent biochem., mol., cellular, and physiol. functions of histone methylation and ubiquitination involved in the regulation of gene expression as detd. by a combination of enzymol., structural, and genetic methodologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSKFyMGk_4zrVg90H21EOLACvtfcHk0ljJRTnUIhA_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs74%253D&md5=5175ea223985f921afac8353634e8a5c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142422%26sid%3Dliteratum%253Aachs%26aulast%3DShilatifard%26aufirst%3DA.%26atitle%3DChromatin%2520modifications%2520by%2520methylation%2520and%2520ubiquitination%253A%2520implications%2520in%2520the%2520regulation%2520of%2520gene%2520expression%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D243%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ropero, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteller, M.</span><span> </span><span class="NLM_article-title">The role of histone deacetylases (HDACs) in human cancer</span> <span class="citation_source-journal">Mol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.molonc.2007.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=19383284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOitbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=19-25&author=S+Roperoauthor=M.+Esteller&title=The+role+of+histone+deacetylases+%28HDACs%29+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of histone deacetylases (HDACs) in human cancer</span></div><div class="casAuthors">Ropero, Santiago; Esteller, Manel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The balance of histone acetylation and deacetylation is an epigenetic layer with a crit. role in the regulation of gene expression.  Histone acetylation induced by histone acetyl transferases (HATs) is assocd. with gene transcription, while histone hypoacetylation induced by histone deacetylase (HDAC) activity is assocd. with gene silencing.  Altered expression and mutations of genes that encode HDACs have been linked to tumor development since they both induce the aberrant transcription of key genes regulating important cellular functions such as cell proliferation, cell-cycle regulation and apoptosis.  Thus, HDACs are among the most promising therapeutic targets for cancer treatment, and they have inspired researchers to study and develop HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvbJD8bqroSLVg90H21EOLACvtfcHk0ljJRTnUIhA_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOitbnI&md5=d925bcde258dce7d53cbb98563e1f2ae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2007.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2007.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DRopero%26aufirst%3DS%26aulast%3DEsteller%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520histone%2520deacetylases%2520%2528HDACs%2529%2520in%2520human%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2007%26volume%3D1%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1210</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1093%2Fjnci%2F92.15.1210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=10922406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFyhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1210-1216&author=P.+A.+Marksauthor=V.+M.+Richonauthor=R.+A.+Rifkind&title=Histone+deacetylase+inhibitors%3A+inducers+of+differentiation+or+apoptosis+of+transformed+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells</span></div><div class="casAuthors">Marks, Paul A.; Richon, Victoria M.; Rifkind, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1210-1216</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 84 refs.  Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death of transformed cells in vitro and in vivo.  One class of HDAC inhibitors, hydroxamic acid-based hybrid polar compds. (HPCs), induce differentiation at micromolar or lower concns.  Studies (x-ray crystallog.) showed that the catalytic site of HDAC has a tubular structure with a zinc atom at its base and that these HDAC inhibitors, such as suberoylanilide hydroxamic acid and trichostatin A, fit into this structure with the hydroxamic moiety of the inhibitor binding to the zinc.  HDAC inhibitors cause acetylated histones to accumulate in both tumor and normal tissues, and this accumulation can be used as a marker of the biol. activity of the HDAC inhibitors.  Hydroxamic acid-based HPCs act selectively to inhibit tumor cell growth at levels that have little or no toxicity for normal cells.  These compds. also act selectively on gene expression, altering the expression of only about 2% of the genes expressed in cultured tumor cells.  In general, chromatin fractions enriched in actively transcribed genes are also enriched in highly acetylated core histones, whereas silent genes are assocd. with nucleosomes with a low level of acetylation.  However, HDACs can also acetylate proteins other than histones in nucleosomes.  The role that these other targets play in the induction of cell growth arrest, differentiation, and/or apoptotic cell death has not been detd.  Our working hypothesis is that inhibition of HDAC activity leads to the modulation of expression of a specific set of genes that, in turn, result in growth arrest, differentiation, and/or apoptotic cell death.  The hydroxamic acid-based HPCs are potentially effective agents for cancer therapy and, possibly, cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa7JHGYu0fJLVg90H21EOLACvtfcHk0lgyPlZhoT3qvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFyhsb8%253D&md5=413775f266f555bfc6539d052b4d2b15</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.15.1210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.15.1210%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520inducers%2520of%2520differentiation%2520or%2520apoptosis%2520of%2520transformed%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1210%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamashitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Glick, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swindemen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Quaglia, M. P.</span><span> </span><span class="NLM_article-title">Hybrid polar histone deacetylase induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4392-4399&author=R.+D.+Glickauthor=S.+L.+Swindemenauthor=D.+C.+Coffeyauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=V.+M.+Richonauthor=M.+P.+La+Quaglia&title=Hybrid+polar+histone+deacetylase+induces+apoptosis+and+CD95%2FCD95+ligand+expression+in+human+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlick%26aufirst%3DR.%2BD.%26aulast%3DSwindemen%26aufirst%3DS.%2BL.%26aulast%3DCoffey%26aufirst%3DD.%2BC.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DLa%2BQuaglia%26aufirst%3DM.%2BP.%26atitle%3DHybrid%2520polar%2520histone%2520deacetylase%2520induces%2520apoptosis%2520and%2520CD95%252FCD95%2520ligand%2520expression%2520in%2520human%2520neuroblastoma%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4392%26epage%3D4399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Butler, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=11016644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5165-5170&author=L.+M.+Butlerauthor=D.+B.+Agusauthor=H.+I.+Scherauthor=B.+Higginsauthor=A.+Roseauthor=C.+Cordon-Cardoauthor=H.+T.+Thalerauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=V.+M.+Richon&title=Suberoylanilide+hydroxamic+acid%2C+an+inhibitor+of+histone+deacetylase%2C+suppresses+the+growth+of+prostate+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo</span></div><div class="casAuthors">Butler, Lisa M.; Agus, David B.; Scher, Howard I.; Higgins, Brian; Rose, Adam; Cordon-Cardo, Carlos; Thaler, Howard T.; Rifkind, Richard A.; Marks, Paul A.; Richon, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5165-5170</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA) is the prototype of a family of hybrid polar compds. that induce growth arrest in transformed cells and show promise for the treatment of cancer.  SAHA induces differentiation and/or apoptosis in certain transformed cells in culture and is a potent inhibitor of histone deacetylases.  In this study, we examd. the effects of SAHA on the growth of human prostate cancer cells in culture and on the growth of the CWR22 human prostate xenograft in nude mice.  SAHA suppressed the growth of the LNCaP, PC-3, and TSU-Pr1 cell lines at micromolar concns. (2.5-7.5 μM).  SAHA induced dose-dependent cell death in the LNCaP cells.  In mice with transplanted CWR22 human prostate tumors, SAHA (25, 50, and 100 mg/kg/day) caused significant suppression of tumor growth compared with mice receiving vehicle alone; treatment with 50 mg/kg/day resulted in a 97% redn. in the mean final tumor vol. compared with controls.  At this dose, there was no detectable toxicity as evaluated by wt. gain and necropsy examn.  Increased accumulation of acetylated core histones was detected in the CWR22 tumors within 6 h of SAHA administration.  SAHA induced prostate-specific antigen mRNA expression in CWR22 prostate cancer cells, resulting in higher levels of serum prostate-specific antigen than predicted from tumor vol. alone.  The results suggest that hydroxamic acid-based hybrid polar compds. inhibit prostate cancer cell growth and may be useful, relatively nontoxic agents for the treatment of prostate carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2lQ8o4-KsH7Vg90H21EOLACvtfcHk0ljrN3RZKi3qfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVamur0%253D&md5=6aa59edaa70517a0269aee0540e08dbf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DL.%2BM.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DRose%26aufirst%3DA.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DThaler%26aufirst%3DH.%2BT.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%252C%2520an%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520suppresses%2520the%2520growth%2520of%2520prostate%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5165%26epage%3D5170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span> </span><span class="NLM_article-title">Non-peptide macrocyclic histone deacetylases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801128g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=456-468&author=A.+K.+Oyelereauthor=P.+C.+Chenauthor=W.+Guerrantauthor=S.+C.+Mwakwariauthor=R.+Hoodauthor=Y.+Zhangauthor=Y.+Fan&title=Non-peptide+macrocyclic+histone+deacetylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm801128g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801128g%26sid%3Dliteratum%253Aachs%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DHood%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26atitle%3DNon-peptide%2520macrocyclic%2520histone%2520deacetylases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D456%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gu, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R. G.</span><span> </span><span class="NLM_article-title">Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS0092-8674%2800%2980521-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=9288740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFKmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=595-606&author=W+Guauthor=R.+G.+Roeder&title=Activation+of+p53+sequence-specific+DNA+binding+by+acetylation+of+the+p53+C-terminal+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain</span></div><div class="casAuthors">Gu, Wei; Roeder, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-606</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The tumor suppressor p53 exerts antiproliferation effects through its ability to function as a sequence-specific DNA-binding transcription factor.  Here, we demonstrate that p53 can be modified by acetylation both in vivo and in vitro.  Remarkably, the site of p53 that is acetylated by its coactivator, p300, resides in a C-terminal domain known to be crit. for the regulation of p53 DNA binding.  Furthermore, the acetylation of p53 can dramatically stimulate its sequence-specific DNA-binding activity, possibly as a result of an acetylation-induced conformational change.  These observations clearly indicate a novel pathway for p53 activation and, importantly, provide an example of an acetylation-mediated change in the function of a nonhistone regulatory protein.  These results have significant implications regarding the mol. mechanisms of various acetyltransferase-contg. transcriptional coactivators, whose primary targets have been presumed to be histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB5s91q-kuJ7Vg90H21EOLACvtfcHk0ljrN3RZKi3qfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFKmtLc%253D&md5=79ca277f5512ced39149f79b27b0b700</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980521-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980521-8%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DW%26aulast%3DRoeder%26aufirst%3DR.%2BG.%26atitle%3DActivation%2520of%2520p53%2520sequence-specific%2520DNA%2520binding%2520by%2520acetylation%2520of%2520the%2520p53%2520C-terminal%2520domain%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D595%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Martinez-Balbás, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brehm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Regulation of E2F1 activity by acetylation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=662-671&author=M.+A.+Martinez-Balb%C3%A1sauthor=U.+M.+Bauerauthor=S.+J.+Nielsenauthor=A.+Brehmauthor=T.+Kouzarides&title=Regulation+of+E2F1+activity+by+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Balb%25C3%25A1s%26aufirst%3DM.%2BA.%26aulast%3DBauer%26aufirst%3DU.%2BM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26aulast%3DBrehm%26aufirst%3DA.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520E2F1%2520activity%2520by%2520acetylation%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26spage%3D662%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Marzio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacca, M.</span><span> </span><span class="NLM_article-title">E2F family members are differentially regulated by reversible acetylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">10887</span><span class="NLM_x">–</span> <span class="NLM_lpage">10892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=10887-10892&author=G.+Marzioauthor=C.+Wagenerauthor=M.+I.+Gutierrezauthor=P.+Cartwrightauthor=K.+Helinauthor=M.+Giacca&title=E2F+family+members+are+differentially+regulated+by+reversible+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzio%26aufirst%3DG.%26aulast%3DWagener%26aufirst%3DC.%26aulast%3DGutierrez%26aufirst%3DM.%2BI.%26aulast%3DCartwright%26aufirst%3DP.%26aulast%3DHelin%26aufirst%3DK.%26aulast%3DGiacca%26aufirst%3DM.%26atitle%3DE2F%2520family%2520members%2520are%2520differentially%2520regulated%2520by%2520reversible%2520acetylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D10887%26epage%3D10892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hubbert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardiola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455-458&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.+F.+Wangauthor=T.+P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kovacs, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.+T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.+P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mann, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padzur, R.</span><span> </span><span class="NLM_article-title">FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1247-1252&author=B.+S.+Mannauthor=J.+R.+Johnsonauthor=M.+H.+Cohenauthor=R.+Justiceauthor=R.+Padzur&title=FDA+approval+summary%3A+vorinostat+for+treatment+of+advanced+primary+cutaneous+T-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DB.%2BS.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPadzur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520vorinostat%2520for%2520treatment%2520of%2520advanced%2520primary%2520cutaneous%2520T-cell%2520lymphoma%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D1247%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piekarz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Romidepsin; a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1586%2Fera.10.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=20645688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=997-1008&author=C.+Grantauthor=F.+Rahmanauthor=R.+Piekarzauthor=C.+Peerauthor=R.+Fryeauthor=R.+W.+Robeyauthor=E.+R.+Gardnerauthor=W.+D.+Figgauthor=S.+E.+Bates&title=Romidepsin%3B+a+new+therapy+for+cutaneous+T-cell+lymphoma+and+a+potential+therapy+for+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span></div><div class="casAuthors">Grant, Cliona; Rahman, Fahd; Piekarz, Richard; Peer, Cody; Frye, Robin; Robey, Robert W.; Gardner, Erin R.; Figg, William D.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">997-1008</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Romidepsin is a histone deacetylase inhibitor (HDI), approved by the US FDA for the treatment of cutaneous T-cell lymphoma (CTCL).  Although various mechanisms have been proposed for the activity of HDIs, including induction of genes controlling cell cycle, acetylation of cytoplasmic proteins and direct induction of apoptosis, the mechanism underlying activity of romidepsin and other HDIs in CTCL is not known.  Romidepsin induces long-lasting responses.  The side-effect profile is similar to that of other HDIs, causing fatigue, nausea and thrombocytopenia.  Management of the CTCL population requires vigilence to prevent infection with skin contaminants, and monitoring of potassium and magnesium, electrolytes found to be low in a large proportion of patients.  Electrocardiog. (ECG) changes are common but are not assocd. with myocardial damage.  When mol. end points were evaluated in 61 patients enrolled on a Phase II trial with romidepsin, response was assocd. with persistence of acetylated histone H3, suggesting that drug exposure is important in effective therapy with romidepsin.  Future studies will endeavor to identify combination strategies to increase the efficacy both in resistant CTCL and in solid tumors and to identify biomarkers of response that will allow selection of patients most likely to benefit from the therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhGXcIbdqpk7Vg90H21EOLACvtfcHk0li5GcIEKlvO2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D&md5=b28fd17c77991e4662f7c0e08d6d7297</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1586%2Fera.10.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.88%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DF.%26aulast%3DPiekarz%26aufirst%3DR.%26aulast%3DPeer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DRomidepsin%253B%2520a%2520new%2520therapy%2520for%2520cutaneous%2520T-cell%2520lymphoma%2520and%2520a%2520potential%2520therapy%2520for%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D997%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Macrocyclic histone deacetylases inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.2174%2F156802610792232079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=20536416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1423-1440&author=S.+C.+Mwakwariauthor=V.+Patilauthor=W.+Guerrantauthor=A.+K.+Oyelere&title=Macrocyclic+histone+deacetylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic histone deacetylase inhibitors</span></div><div class="casAuthors">Mwakwari, Sandra C.; Patil, Vishal; Guerrant, William; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1423-1440</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACi) are an emerging class of novel anti-cancer drugs that cause growth arrest, differentiation, and apoptosis of tumor cells.  In addn., they have shown promise as anti-parasitic, anti-neurodegenerative, anti-rheumatol. and immunosuppressant agents.  To date, several structurally distinct small mol. HDACi have been reported including aryl hydroxamates, benzamides, short-chain fatty acids, electrophilic ketones, and macrocyclic peptides.  Macrocyclic HDACi possess the most complex cap-groups which interact with HDAC enzyme's outer rim and have demonstrated excellent HDAC inhibition potency and isoform selectivity.  This review focuses on the recent progress and current state of macrocyclic HDACi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXzgRmfQBx27Vg90H21EOLACvtfcHk0li5GcIEKlvO2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajurrF&md5=d027b0380e04f364fb0985a350e99c60</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F156802610792232079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610792232079%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DMacrocyclic%2520histone%2520deacetylases%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1423%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kelly, W. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: from target to clinical trials</span> <span class="citation_source-journal">Expert. Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1517%2F13543784.11.12.1695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12457432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1695-1713&author=W.+K+Kellyauthor=O.+A.+O%E2%80%99Connorauthor=P.+A.+Marks&title=Histone+deacetylase+inhibitors%3A+from+target+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: from target to clinical trials</span></div><div class="casAuthors">Kelly, William K.; O'Connor, Owen A.; Marks, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1695-1713</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Transformed cells, characterized by inappropriate cell proliferation, do not necessarily lose the capacity to undergo growth arrest under certain stimuli.  DNA, genetic information, is packaged in chromatin proteins, for example, histones.  The structure of chromatin may be altered by post-translational modifications (e.g., acetylation, phosphorylation, methylation and ubiquitylation) which play a role in regulating gene expression.  Two groups of enzymes, histone deacetylases (HDACs) and acetyl transferases, det. the acetylation status of histones.  This review focuses on compds. that inhibit HDAC activity.  These agents have been shown to be active in vitro and in vivo in causing cancer cell growth arrest, differentiation and/or apoptosis.  Several HDAC inhibitors are currently in clin. trials as anticancer agents and, in particular, hydroxamic acid-based HDAC inhibitors have shown activity against cancers at well-tolerated doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1tCC-H5caxbVg90H21EOLACvtfcHk0li5GcIEKlvO2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFCjs7s%253D&md5=713b9afb7d101869e8c203d0d0c0ee60</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F13543784.11.12.1695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.11.12.1695%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520from%2520target%2520to%2520clinical%2520trials%26jtitle%3DExpert.%2520Opin.%2520Invest.%2520Drugs.%26date%3D2002%26volume%3D11%26spage%3D1695%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Rosato, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1517%2F13543784.13.1.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14680450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=21-38&author=R.+R.+Rosatoauthor=S.+Grant&title=Histone+deacetylase+inhibitors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors in clinical development</span></div><div class="casAuthors">Rosato, Roberto R.; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to a variety of other novel agents, interest in histone deacetylase inhibitors (HDACIs) as antineoplastic drugs has recently accelerated and increasing nos. of these compds. have entered clin. trials in humans.  HDACIs represent a prototype of molecularly targeted agents that perturb signal transduction, cell cycle-regulatory and survival-related pathways.  Newer generation HDACIs have been introduced into the clin. arena that are considerably more potent on a molar basis than their predecessors and are beginning to show early evidence of activity, particularly in hematopoietic malignancies.  In addn., there is an increasing appreciation of the fact that HDACIs may act through mechanisms other than induction of histone acetylation and, as in the case of other molecularly-targeted agents, it is conceivable that the ultimate role of HDACIs in cancer therapy will be as modulators of apoptosis induced by other cytotoxic agents.  One particularly promising strategy involves attempts to combine HDACIs with other novel agents to promote tumor cell differentiation or apoptosis.  The present review focuses on recent insights into the mechanisms by which HDACIs exert their anticancer effects, either alone or in combination with other compds., as well as attempts to translate these findings into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tg9iWnHF3bVg90H21EOLACvtfcHk0lg1UIKk1_Npkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7s%253D&md5=3e8dcec235cc2ebc828265dce839733a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.1.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.1.21%26sid%3Dliteratum%253Aachs%26aulast%3DRosato%26aufirst%3DR.%2BR.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D21%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yoo, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. A.</span><span> </span><span class="NLM_article-title">Epigenetic therapy of cancer: past, present and future</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=37-50&author=C.+B.+Yooauthor=P.+A.+Jones&title=Epigenetic+therapy+of+cancer%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DC.%2BB.%26aulast%3DJones%26aufirst%3DP.%2BA.%26atitle%3DEpigenetic%2520therapy%2520of%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1038%2F43710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=10490031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=188-193&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=A.+Cohenauthor=V.+M.+Richonauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=R.+Breslowauthor=N.+P.+Pavletich&title=Structures+of+a+histone+deacetylase+homologue+bound+to+the+TSA+and+SAHA+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Cohen, Alona; Richon, Victoria M.; Rifkind, Richard A.; Marks, Paul A.; Breslow, Ronald; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6749</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression.  HDACs are involved in cell-cycle progression and differentiation, and their deregulation is assocd. with several cancers.  HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumor effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumors in mice models, and they are effective in the treatment of promyelocytic leukemia.  Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homolog from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA.  The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition.  The residues that make up the active site and contact the inhibitors are conserved across the HDAC family.  These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrG0lsZMMo37Vg90H21EOLACvtfcHk0lg1UIKk1_Npkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D&md5=29bbc6d3ba9a9d2a8c330349ae8199a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F43710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43710%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructures%2520of%2520a%2520histone%2520deacetylase%2520homologue%2520bound%2520to%2520the%2520TSA%2520and%2520SAHA%2520inhibitors%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wang, D.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan-Hargest, H-Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiech, N. L.</span><span> </span><span class="NLM_article-title">On the function of the 14 Å long internal cavity of histone deacetylase-like protein: implication for the design of histone deacetylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3409</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498497" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3409-3417&author=D.-F.+Wangauthor=O.+Wiestauthor=P.+Helquistauthor=H-Y+Lan-Hargestauthor=N.+L.+Wiech&title=On+the+function+of+the+14+%C3%85+long+internal+cavity+of+histone+deacetylase-like+protein%3A+implication+for+the+design+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0498497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498497%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.-F.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DLan-Hargest%26aufirst%3DH-Y%26aulast%3DWiech%26aufirst%3DN.%2BL.%26atitle%3DOn%2520the%2520function%2520of%2520the%252014%2520%25C3%2585%2520long%2520internal%2520cavity%2520of%2520histone%2520deacetylase-like%2520protein%253A%2520implication%2520for%2520the%2520design%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3409%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070864w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6685-6691&issue=26&author=L.+Chenauthor=D.+Wilsonauthor=H.+N.+Jayaramauthor=K.+W.+Pankiewicz&title=Dual+inhibitors+of+inosine+monophosphate+dehydrogenase+and+histone+deacetylases+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm070864w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070864w%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DD.%26aulast%3DJayaram%26aufirst%3DH.%2BN.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDual%2520inhibitors%2520of%2520inosine%2520monophosphate%2520dehydrogenase%2520and%2520histone%2520deacetylases%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D26%26spage%3D6685%26epage%3D6691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of iminatib hybrids as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rβ, and histone deacetylases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2265</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800988r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2265-2279&issue=8&author=S.+Mahboobiauthor=S.+Doveauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=T.+Maierauthor=T.+Beckers&title=Design+of+chimeric+histone+deacetylase-+and+tyrosine+kinase-inhibitors%3A+a+series+of+iminatib+hybrids+as+potent+inhibitors+of+wild-type+and+mutant+BCR-ABL%2C+PDGF-R%CE%B2%2C+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800988r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800988r%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DDesign%2520of%2520chimeric%2520histone%2520deacetylase-%2520and%2520tyrosine%2520kinase-inhibitors%253A%2520a%2520series%2520of%2520iminatib%2520hybrids%2520as%2520potent%2520inhibitors%2520of%2520wild-type%2520and%2520mutant%2520BCR-ABL%252C%2520PDGF-R%25CE%25B2%252C%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2265%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng-Jung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&issue=5&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=L.+Cheng-Jungauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+potent+multi-acting+HDAC%2C+EGFR%2C+and+HER2+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DCheng-Jung%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520potent%2520multi-acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D5%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Piccart-Gebhart, M. J.</span><span> </span><span class="NLM_article-title">Anthracyclines and the tailoring of treatment for early breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1056%2FNEJMe068065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16707755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2177-2179&author=M.+J.+Piccart-Gebhart&title=Anthracyclines+and+the+tailoring+of+treatment+for+early+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracyclines and the tailoring of treatment for early breast cancer</span></div><div class="casAuthors">Piccart-Gebhart, Martine J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXtDD4dhRJ-7Vg90H21EOLACvtfcHk0lhK65bXaOfhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCrtr4%253D&md5=d6b3aee4890c808e8311a8e23630bb68</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMe068065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe068065%26sid%3Dliteratum%253Aachs%26aulast%3DPiccart-Gebhart%26aufirst%3DM.%2BJ.%26atitle%3DAnthracyclines%2520and%2520the%2520tailoring%2520of%2520treatment%2520for%2520early%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, F.</span><span> </span><span class="NLM_article-title">Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7291</span><span class="NLM_x">–</span> <span class="NLM_lpage">7300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14612526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7291-7300&author=M.+S.+Kimauthor=M.+Blakeauthor=J.+H.+Baekauthor=G.+Kohlhagenauthor=Y.+Pommierauthor=F.+Carrier&title=Inhibition+of+histone+deacetylase+increases+cytotoxicity+to+anticancer+drugs+targeting+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylase Increases Cytotoxicity to Anticancer Drugs Targeting DNA</span></div><div class="casAuthors">Kim, Myoung Sook; Blake, Mellissa; Baek, Jin Hyen; Kohlhagen, Glenda; Pommier, Yves; Carrier, France</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7291-7300</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Several anticancer drugs target DNA or enzymes acting on the DNA.  Because chromatin DNA is tightly compacted, accessibility to the drug target may reduce the efficiency of these anticancer drugs.  We thus treated four human cancer cell lines and two normal epithelial cell lines with either trichostatin A (TSA) or SAHA, two histone deacetylase inhibitors, before exposing the cells to VP-16, ellipticine, camptothecin, doxorubicin, cisplatin, 5-fluorouracil, or cyclophosphamide.  Pretreatment with TSA or SAHA increased the killing efficiency of VP-16, ellipticine, doxorubicin, and cisplatin.  The magnitude of sensitization is cell type specific and is >10-fold for VP-16 in D54, a brain tumor cell line intrinsically resistant to topoisomerase II inhibitors.  Topoisomerase II levels and activity were not affected by this treatment, but p53, p21, and Gadd45 protein levels were markedly induced.  Moreover, pretreatment with TSA also increased VP-16-induced apoptosis in a p53-dependent and -independent manner.  Treating the cells in the reverse order (anticancer drug first, followed by TSA or SAHA) had no more cytotoxic effect than the drug alone.  These data suggest that loosening-up the chromatin structure by histone acetylation can increase the efficiency of several anticancer drugs targeting DNA.  This may be advantageous for treating tumors intrinsically resistant to these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24HjggpPirLVg90H21EOLACvtfcHk0lhK65bXaOfhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGlt70%253D&md5=6fe3bc8b32550917fc8f80ac648e680b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DBlake%26aufirst%3DM.%26aulast%3DBaek%26aufirst%3DJ.%2BH.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCarrier%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%2520increases%2520cytotoxicity%2520to%2520anticancer%2520drugs%2520targeting%2520DNA%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7291%26epage%3D7300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Catalano, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosco, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrocola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aragno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocuzzi, G.</span><span> </span><span class="NLM_article-title">Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1677%2Fjoe.1.06970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17088416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlejsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2006&pages=465-472&issue=2&author=M.+G.+Catalanoauthor=N.+Fortunatiauthor=M.+Puglieseauthor=R.+Poliauthor=O.+Boscoauthor=R.+Mastrocolaauthor=M.+Aragnoauthor=G.+Bocuzzi&title=Valproic+acid%2C+a+histone+deacetylase+inhibitor%2C+enhances+sensitivity+to+doxorubicin+in+anaplastic+thyroid+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells</span></div><div class="casAuthors">Catalano, Maria G.; Fortunati, Nicoletta; Pugliese, Mariateresa; Poli, Roberta; Bosco, Ornella; Mastrocola, Raffaella; Aragno, Manuela; Boccuzzi, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-472</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">Multimodality treatments (i.e. surgery, chemotherapy, and radiotherapy) are recommended for anaplastic thyroid carcinoma (ATC), an extremely lethal human cancer, but to date there is little evidence that such approaches improve survival rates.  It is thus necessary to seek new therapeutic tools.  Histone deacetylase (HDAC) inhibitors are a promising class of antineoplastic agents that induce differentiation and apoptosis.  Moreover, they may enhance the cytotoxicity of drugs targeting DNA through acetylation of histones.  Using two ATC cell lines (CAL-62 and ARO), we show here that valproic acid (VPA), a clin. available HDAC inhibitor, enhances the activity of doxorubicin, whose antitumor properties involve binding to DNA and inhibiting topoisomerase II.  A meager 0·7 mM VPA, which corresponds to serum concns. in patients treated for epilepsy, is able to increase the cytotoxicity of doxorubicin about threefold in CAL-62 cells and twofold in ARO cells.  The sensitizing effect, which is through histone acetylation, involves increased apoptosis, which is also shown by the increased caspase 3 activation and the enhancement of doxorubicin-induced G2 cell cycle arrest.  These results might offer a rationale for clin. studies of a new combined therapy in an effort to improve the outcome of patients with anaplastic thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmTtQReyIxnrVg90H21EOLACvtfcHk0lg8_mgZ6NewHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlejsLrM&md5=c5f3780cd38d2ca4b53c7812f9e49836</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1677%2Fjoe.1.06970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.1.06970%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DM.%2BG.%26aulast%3DFortunati%26aufirst%3DN.%26aulast%3DPugliese%26aufirst%3DM.%26aulast%3DPoli%26aufirst%3DR.%26aulast%3DBosco%26aufirst%3DO.%26aulast%3DMastrocola%26aufirst%3DR.%26aulast%3DAragno%26aufirst%3DM.%26aulast%3DBocuzzi%26aufirst%3DG.%26atitle%3DValproic%2520acid%252C%2520a%2520histone%2520deacetylase%2520inhibitor%252C%2520enhances%2520sensitivity%2520to%2520doxorubicin%2520in%2520anaplastic%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Endocrinol.%26date%3D2006%26volume%3D191%26issue%3D2%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Johnson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padget, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. M.</span><span> </span><span class="NLM_article-title">Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4539</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=4539-4542&issue=7&author=C.+A.+Johnsonauthor=K.+Padgetauthor=C.+A.+Austinauthor=B.+M.+Turner&title=Deacetylase+activity+associates+with+topoisomerase+II+and+is+necessary+for+etoposide-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BA.%26aulast%3DPadget%26aufirst%3DK.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DTurner%26aufirst%3DB.%2BM.%26atitle%3DDeacetylase%2520activity%2520associates%2520with%2520topoisomerase%2520II%2520and%2520is%2520necessary%2520for%2520etoposide-induced%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D7%26spage%3D4539%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Marchion, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicaku, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span> </span><span class="NLM_article-title">Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=223-237&issue=2&author=D.+C.+Marchionauthor=E.+Bicakuauthor=A.+I.+Daudauthor=V.+Richonauthor=D.+M.+Sullivanauthor=P.+N.+Munster&title=Sequence-specific+potentiation+of+topoisomerase+II+inhibitors+by+the+histone+deacetylase+inhibitor+suberoylanilide+hydroxamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchion%26aufirst%3DD.%2BC.%26aulast%3DBicaku%26aufirst%3DE.%26aulast%3DDaud%26aufirst%3DA.%2BI.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DSullivan%26aufirst%3DD.%2BM.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26atitle%3DSequence-specific%2520potentiation%2520of%2520topoisomerase%2520II%2520inhibitors%2520by%2520the%2520histone%2520deacetylase%2520inhibitor%2520suberoylanilide%2520hydroxamic%2520acid%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2004%26volume%3D92%26issue%3D2%26spage%3D223%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Tewey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1126%2Fscience.6093249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=6093249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaL2cXmt1ahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=466-468&author=K.+M.+Teweyauthor=T.+C.+Roweauthor=L.+Yangauthor=B.+D.+Halliganauthor=L.+F.+Liu&title=Adriamycin-induced+DNA+damage+mediated+by+mammalian+DNA+topoisomerase+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II</span></div><div class="casAuthors">Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4673</span>),
    <span class="NLM_cas:pages">466-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Results from in vitro studies with purified calf thymus DNA topoisomerase  [80449-01-0] II showed that mammalian DNA topoisomerase II mediates DNA damage by adriamycin  [23214-92-8] and other related antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMQQc-o8E-1rVg90H21EOLACvtfcHk0lg8_mgZ6NewHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmt1ahs7g%253D&md5=3ad5aebab04c9a92535d1717033373f4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093249%26sid%3Dliteratum%253Aachs%26aulast%3DTewey%26aufirst%3DK.%2BM.%26aulast%3DRowe%26aufirst%3DT.%2BC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHalligan%26aufirst%3DB.%2BD.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DAdriamycin-induced%2520DNA%2520damage%2520mediated%2520by%2520mammalian%2520DNA%2520topoisomerase%2520II%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D466%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Binaschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capranico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Animati, F.</span><span> </span><span class="NLM_article-title">Anthracyclines: selected new developments</span> <span class="citation_source-journal">Curr. Med. Chem. Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=113-130&issue=2&author=M.+Binaschiauthor=M.+Bigioniauthor=A.+Cipolloneauthor=C.+Rossiauthor=C.+Gosoauthor=C.+A.+Maggiauthor=G.+Capranicoauthor=F.+Animati&title=Anthracyclines%3A+selected+new+developments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinaschi%26aufirst%3DM.%26aulast%3DBigioni%26aufirst%3DM.%26aulast%3DCipollone%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DGoso%26aufirst%3DC.%26aulast%3DMaggi%26aufirst%3DC.%2BA.%26aulast%3DCapranico%26aufirst%3DG.%26aulast%3DAnimati%26aufirst%3DF.%26atitle%3DAnthracyclines%253A%2520selected%2520new%2520developments%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anti-Cancer%2520Agents%26date%3D2001%26volume%3D1%26issue%3D2%26spage%3D113%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwelling, L. A.</span><span> </span><span class="NLM_article-title">Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated nuclei by antineoplastic intercalating agents</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3194</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00309a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=3194-3201&author=Y.+Pommierauthor=R.+E.+Schwartzauthor=K.+W.+Kohnauthor=L.+A.+Zwelling&title=Formation+and+rejoining+of+deoxyribonucleic+acid+double-strand+breaks+induced+in+isolated+nuclei+by+antineoplastic+intercalating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi00309a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00309a013%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSchwartz%26aufirst%3DR.%2BE.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DZwelling%26aufirst%3DL.%2BA.%26atitle%3DFormation%2520and%2520rejoining%2520of%2520deoxyribonucleic%2520acid%2520double-strand%2520breaks%2520induced%2520in%2520isolated%2520nuclei%2520by%2520antineoplastic%2520intercalating%2520agents%26jtitle%3DBiochemistry%26date%3D1984%26volume%3D23%26spage%3D3194%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span> </span><span class="NLM_article-title">Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1853</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1853-1860&issue=20&author=K.+Kiyomiyaauthor=S.+Matsuoauthor=M.+Kurebe&title=Proteasome+is+a+carrier+to+translocate+doxorubicin+from+cytoplasm+into+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DS.%26aulast%3DKurebe%26aufirst%3DM.%26atitle%3DProteasome%2520is%2520a%2520carrier%2520to%2520translocate%2520doxorubicin%2520from%2520cytoplasm%2520into%2520nucleus%26jtitle%3DLife%2520Sci.%26date%3D1998%26volume%3D62%26issue%3D20%26spage%3D1853%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span> </span><span class="NLM_article-title">Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin–proteasome complex</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2467-2471&author=K.+Kiyomiyaauthor=S.+Matsuoauthor=M.+Kurebe&title=Mechanism+of+specific+nuclear+transport+of+adriamycin%3A+the+mode+of+nuclear+translocation+of+adriamycin%E2%80%93proteasome+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DS.%26aulast%3DKurebe%26aufirst%3DM.%26atitle%3DMechanism%2520of%2520specific%2520nuclear%2520transport%2520of%2520adriamycin%253A%2520the%2520mode%2520of%2520nuclear%2520translocation%2520of%2520adriamycin%25E2%2580%2593proteasome%2520complex%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2467%26epage%3D2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Tong, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. W.</span><span> </span><span class="NLM_article-title">Adriamycin analogs. 3. Synthesis of <i>N</i>-alkylated anthracyclines with enhanced efficacy and reduced toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00194a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=912-918&author=G.+L.+Tongauthor=H.+Y.+Wuauthor=T.+H.+Smithauthor=D.+W.+Henry&title=Adriamycin+analogs.+3.+Synthesis+of+N-alkylated+anthracyclines+with+enhanced+efficacy+and+reduced+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00194a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00194a005%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DG.%2BL.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DT.%2BH.%26aulast%3DHenry%26aufirst%3DD.%2BW.%26atitle%3DAdriamycin%2520analogs.%25203.%2520Synthesis%2520of%2520N-alkylated%2520anthracyclines%2520with%2520enhanced%2520efficacy%2520and%2520reduced%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D912%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Martín, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiated in vitro</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3402</span><span class="NLM_x">–</span> <span class="NLM_lpage">3409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=3402-3409&author=B.+Mart%C3%ADnauthor=A.+Vaqueroauthor=W.+Priebeauthor=J.+Portugal&title=Bisanthracycline+WP631+inhibits+basal+and+Sp1-activated+transcription+initiated+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADn%26aufirst%3DB.%26aulast%3DVaquero%26aufirst%3DA.%26aulast%3DPriebe%26aufirst%3DW.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DBisanthracycline%2520WP631%2520inhibits%2520basal%2520and%2520Sp1-activated%2520transcription%2520initiated%2520in%2520vitro%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1999%26volume%3D27%26spage%3D3402%26epage%3D3409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lothstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatman, T. W.</span><span> </span><span class="NLM_article-title">Anthracycline drug targeting: cytoplasmic versus nuclear—a fork in the road</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1054%2Fdrup.2001.0201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=11768330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=169-177&author=L.+Lothsteinauthor=M.+Israelauthor=T.+W.+Sweatman&title=Anthracycline+drug+targeting%3A+cytoplasmic+versus+nuclear%E2%80%94a+fork+in+the+road"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracycline drug targeting: Cytoplasmic versus nuclear - a fork in the road</span></div><div class="casAuthors">Lothstein, Leonard; Israel, Mervyn; Sweatman, Trevor W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The anthracycline antibiotics doxorubicin (Adriamycin; DOX) and daunorubicin (DNR) continue to be essential components of first-line chemotherapy in the treatment of a variety of solid and hematopoietic tumors.  The overall efficacies of DOX and DNR are, however, impeded by serious dose-limiting toxicities, including cardiotoxicity, and the selection of multiple mechanisms of cellular drug resistance.  These limitations have necessitated the development of newer anthracyclines whose structural and functional modifications circumvent these impediments.  In this review, we will present recent strategies in anthracycline design and assess their potential therapeutic merits.  Current anthracycline design has diverged to target either cytoplasmic or nuclear sites.  Nuclear targets have been broadened to include not only topoisomerase II (topo II) inhibition through ternary complex stabilization and catalytic inhibition, but also topoisomerase I (topo I) inhibition and transcriptional inhibition.  In contrast, cytoplasmic targeting focuses on anthracycline binding to protein kinase C (PKC) regulatory domain with consequent modulation of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-lYuQBgFf2rVg90H21EOLACvtfcHk0lgCqxC-LANIyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wlt7w%253D&md5=9af6a048b82b46c3119d6d97c91d2571</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1054%2Fdrup.2001.0201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fdrup.2001.0201%26sid%3Dliteratum%253Aachs%26aulast%3DLothstein%26aufirst%3DL.%26aulast%3DIsrael%26aufirst%3DM.%26aulast%3DSweatman%26aufirst%3DT.%2BW.%26atitle%3DAnthracycline%2520drug%2520targeting%253A%2520cytoplasmic%2520versus%2520nuclear%25E2%2580%2594a%2520fork%2520in%2520the%2520road%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2001%26volume%3D4%26spage%3D169%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gate, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen-Ba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapiero, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methylation of anthracyclines modulates their cytotoxicity and pharmacokinetics in wild type and multidrug resistant cells</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS0753-3322%2803%2900037-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14499178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=301-308&author=L.+Gateauthor=P.+Couvreurauthor=G.+Nguyen-Baauthor=H.+Tapiero&title=N-Methylation+of+anthracyclines+modulates+their+cytotoxicity+and+pharmacokinetics+in+wild+type+and+multidrug+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells</span></div><div class="casAuthors">Gate, L.; Couvreur, P.; Nguyen-Ba, G.; Tapiero, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Anthracyclines are the most commonly used classes of anticancer agents in chemotherapy.  Development of resistance to these mols. is one of the major reasons for treatment failure.  The overexpression of the membrane transporter P-glycoprotein (P-gp) is among the principal mechanisms involved in this phenomenon.  This pump, which is responsible for the multidrug resistance (MDR) phenotype, decreases the toxicity of a wide range of unrelated anticancer drugs by increasing their cellular efflux.  Structure-activity relationship expts. have shown that the pos. charged amino group of the anthracyclines could be responsible for their transport by P-gp.  Here, we used three new anthracyclines that shared the same chromophore but differed by the degree of N-methylation of their sugar moiety.  Oxaunomycin (OXN) possessed a non-methylated amino group, while LB-1 was monomethylated and β-clamycin T (BCT) was dimethylated.  In sensitive cells (FLC), reduced cytotoxicity was related to the level of N-methylation; whereas in resistant cells (DOX-RFLC1 and DOX-RFLC2) overexpressing different levels of P-gp, increased N-methylation enhanced anthracycline cytotoxicity.  Decreased resistance in DOX-RFLCs was assocd. with an increased drug accumulation due to a reduced cellular efflux.  As expected, the MDR modulator verapamil decreased resistance to these anthracyclines by increasing the cellular accumulation.  These results suggest that N-methylation of anthracyclines circumvents resistance by diminishing drug transport by P-gp in MDR-pos. cells.  These observations could be the consequence of the steric hindrance created by the Me group(s) which may impair the interaction between the pos. charged amino group and the active site of P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9VHSQL3ZU7Vg90H21EOLACvtfcHk0lg9bmVda4s2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gntb8%253D&md5=e529327a6bf43cb830f914afffb0e6c9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0753-3322%2803%2900037-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0753-3322%252803%252900037-4%26sid%3Dliteratum%253Aachs%26aulast%3DGate%26aufirst%3DL.%26aulast%3DCouvreur%26aufirst%3DP.%26aulast%3DNguyen-Ba%26aufirst%3DG.%26aulast%3DTapiero%26aufirst%3DH.%26atitle%3DN-Methylation%2520of%2520anthracyclines%2520modulates%2520their%2520cytotoxicity%2520and%2520pharmacokinetics%2520in%2520wild%2520type%2520and%2520multidrug%2520resistant%2520cells%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurard-Levin, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrksich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Non-peptide histone deacetylases inhibitors derived from tricyclic ketolide skeleton</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-peptide+histone+deacetylases+inhibitors+derived+from+tricyclic+ketolide+skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-peptide%2520histone%2520deacetylases%2520inhibitors%2520derived%2520from%2520tricyclic%2520ketolide%2520skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6100%26epage%3D6111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4839-4853&author=P.+C.+Chenauthor=V.+Patilauthor=W.+Guerrantauthor=P.+Greenauthor=A.+K.+Oyelere&title=Synthesis+and+structure%E2%80%93activity+relationship+of+histone+deacetylase+%28HDAC%29+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4839%26epage%3D4853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, O</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimoto, H.</span><span> </span><span class="NLM_article-title">Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=251-253&author=J.+Luauthor=O+Yoshidaauthor=S.+Hayashiauthor=H.+Arimoto&title=Synthesis+of+rigidly-linked+vancomycin+dimers+and+their+in+vivo+efficacy+against+resistant+bacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DO%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DArimoto%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520rigidly-linked%2520vancomycin%2520dimers%2520and%2520their%2520in%2520vivo%2520efficacy%2520against%2520resistant%2520bacteria%26jtitle%3DChem.%2520Commun.%26date%3D2007%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Preobrazhenskaya, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsufyeva, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solovieva, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tevyashova, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznikova, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzikov, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terekhova, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trenin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treshalin, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirchink, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhman, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sletta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotchev, S. B.</span><span> </span><span class="NLM_article-title">Chemical modification and biological evaluation of new semi-synthetic derivatives of 28, 29-didehydronystatin A<sub>1</sub> (S44HP), a genetically engineered anti-fungal polyene macrolide antibiotic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800695k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=189-196&author=M.+N.+Preobrazhenskayaauthor=E.+N.+Olsufyevaauthor=S.+E.+Solovievaauthor=A.+N.+Tevyashovaauthor=M.+I.+Reznikovaauthor=Y.+N.+Luzikovauthor=L.+P.+Terekhovaauthor=A.+S.+Treninauthor=O.+A.+Galatenkoauthor=I.+D.+Treshalinauthor=E.+P.+Mirchinkauthor=V.+M.+Bukhmanauthor=H.+Slettaauthor=S.+B.+Zotchev&title=Chemical+modification+and+biological+evaluation+of+new+semi-synthetic+derivatives+of+28%2C+29-didehydronystatin+A1+%28S44HP%29%2C+a+genetically+engineered+anti-fungal+polyene+macrolide+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm800695k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800695k%26sid%3Dliteratum%253Aachs%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26aulast%3DOlsufyeva%26aufirst%3DE.%2BN.%26aulast%3DSolovieva%26aufirst%3DS.%2BE.%26aulast%3DTevyashova%26aufirst%3DA.%2BN.%26aulast%3DReznikova%26aufirst%3DM.%2BI.%26aulast%3DLuzikov%26aufirst%3DY.%2BN.%26aulast%3DTerekhova%26aufirst%3DL.%2BP.%26aulast%3DTrenin%26aufirst%3DA.%2BS.%26aulast%3DGalatenko%26aufirst%3DO.%2BA.%26aulast%3DTreshalin%26aufirst%3DI.%2BD.%26aulast%3DMirchink%26aufirst%3DE.%2BP.%26aulast%3DBukhman%26aufirst%3DV.%2BM.%26aulast%3DSletta%26aufirst%3DH.%26aulast%3DZotchev%26aufirst%3DS.%2BB.%26atitle%3DChemical%2520modification%2520and%2520biological%2520evaluation%2520of%2520new%2520semi-synthetic%2520derivatives%2520of%252028%252C%252029-didehydronystatin%2520A1%2520%2528S44HP%2529%252C%2520a%2520genetically%2520engineered%2520anti-fungal%2520polyene%2520macrolide%2520antibiotic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D189%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Mild and efficient lewis acid-promoted detritylation in the synthesis of <i>N</i>-hydroxy amides: a concise synthesis of (−)-cobactin T</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">8123</span><span class="NLM_x">–</span> <span class="NLM_lpage">8126</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo701411d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=8123-8126&issue=21&author=S.+Yangauthor=B.+Laguauthor=L.+Wilson&title=Mild+and+efficient+lewis+acid-promoted+detritylation+in+the+synthesis+of+N-hydroxy+amides%3A+a+concise+synthesis+of+%28%E2%88%92%29-cobactin+T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo701411d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701411d%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMild%2520and%2520efficient%2520lewis%2520acid-promoted%2520detritylation%2520in%2520the%2520synthesis%2520of%2520N-hydroxy%2520amides%253A%2520a%2520concise%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-cobactin%2520T%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D21%26spage%3D8123%26epage%3D8126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+empirical+binding+free+energy+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0ljnVIDHZyuLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Estiu, G.; Wiest, O.</span><span> </span><span class="NLM_article-title">HDAC1 homology model</span>. <div class="note"><p class="first last">Personal Communication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Estiu%2C+G.%3B+Wiest%2C+O.+HDAC1+homology+model.+Personal+Communication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEstiu%26aufirst%3DG.%26atitle%3DHDAC1%2520homology%2520model" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Marini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, P. T.</span><span> </span><span class="NLM_article-title">Decatenation of kinetoplast DNA by topoisomerases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4976</span><span class="NLM_x">–</span> <span class="NLM_lpage">4979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=4976-4979&issue=11&author=J.+C.+Mariniauthor=K.+G.+Millerauthor=P.+T.+Englund&title=Decatenation+of+kinetoplast+DNA+by+topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarini%26aufirst%3DJ.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BG.%26aulast%3DEnglund%26aufirst%3DP.%2BT.%26atitle%3DDecatenation%2520of%2520kinetoplast%2520DNA%2520by%2520topoisomerases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26issue%3D11%26spage%3D4976%26epage%3D4979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Sahai, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span> </span><span class="NLM_article-title">A quantitative decatenation assay for type II topoisomerases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1986&pages=364-379&issue=2&author=B+Sahaiauthor=J.+Kaplan&title=A+quantitative+decatenation+assay+for+type+II+topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DB%26aulast%3DKaplan%26aufirst%3DJ.%26atitle%3DA%2520quantitative%2520decatenation%2520assay%2520for%2520type%2520II%2520topoisomerases%26jtitle%3DAnal.%2520Biochem.%26date%3D1986%26volume%3D156%26issue%3D2%26spage%3D364%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewail, A. H.</span><span> </span><span class="NLM_article-title">The anticancer drug–DNA complex: femtosecond primary dynamics for anthracycline antibiotics function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">14212</span><span class="NLM_x">–</span> <span class="NLM_lpage">14217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=14212-14217&issue=25&author=X.+Quauthor=C.+Wanauthor=H.+C.+Beckerauthor=D.+Zhongauthor=A.+H.+Zewail&title=The+anticancer+drug%E2%80%93DNA+complex%3A+femtosecond+primary+dynamics+for+anthracycline+antibiotics+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DH.%2BC.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DZewail%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anticancer%2520drug%25E2%2580%2593DNA%2520complex%253A%2520femtosecond%2520primary%2520dynamics%2520for%2520anthracycline%2520antibiotics%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26issue%3D25%26spage%3D14212%26epage%3D14217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Kulp, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span> </span><span class="NLM_article-title">Antitumor effects of a novel phenylbutyrate-based histone deacetylases inhibitor, (<i>S</i>)-HDAC-42, in prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5199</span><span class="NLM_x">–</span> <span class="NLM_lpage">5206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1158%2F1078-0432.CCR-06-0429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16951239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XovF2gsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5199-5206&author=S.+K.+Kulpauthor=C.+S.+Chenauthor=D.+S.+Wangauthor=C.+Y.+Chenauthor=C.+S.+Chen&title=Antitumor+effects+of+a+novel+phenylbutyrate-based+histone+deacetylases+inhibitor%2C+%28S%29-HDAC-42%2C+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer</span></div><div class="casAuthors">Kulp, Samuel K.; Chen, Chang-Shi; Wang, Da-Sheng; Chen, Ching-Yu; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5199-5206</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To assess the antitumor effects of a novel phenylbutyrate-derived histone deacetylase (HDAC) inhibitor, (S)-HDAC-42, vis-a-vis suberoylanilide hydroxamic acid (SAHA) in in vitro and in vivo models of human prostate cancer.  The in vitro effects of (S)-HDAC-42 and SAHA were evaluated in PC-3, DU-145, or LNCaP human prostate cancer cell lines.  Cell viability, apoptosis, and indicators of HDAC inhibition were assessed.  Effects on Akt and members of the Bcl-2 and inhibitor of apoptosis protein families were detd. by immunoblotting.  Immunocompromised mice bearing established s.c.  PC-3 xenograft tumors were treated orally with (S)-HDAC-42 (50 mg/kg q.o.d. or 25 mg/kg q.d.) or SAHA (50 mg/kg q.d.) for 28 days.  In vivo end points included tumor vols. and intratumoral changes in histone acetylation, phospho-Akt status, and protein levels of Bcl-xL and survivin.  (S)-HDAC-42 was more potent than SAHA in suppressing the viability of all cell lines evaluated with submicromolar IC50 values.  Relative to SAHA, (S)-HDAC-42 exhibited distinctly superior apoptogenic potency, and caused markedly greater decreases in phospho-Akt, Bcl-xL, and survivin in PC-3 cells.  The growth of PC-3 tumor xenografts was suppressed by 52% and 67% after treatment with (S)-HDAC-42 at 25 and 50 mg/kg, resp., whereas SAHA at 50 mg/kg suppressed growth by 31%.  Intratumoral levels of phospho-Akt and Bcl-xL were markedly reduced in (S)-HDAC-42-treated mice, in contrast to mice treated with SAHA.  (S)-HDAC-42 is a potent orally bioavailable inhibitor of HDAC, as well as targets regulating multiple aspects of cancer cell survival, which might have clin. value in prostate cancer chemotherapy and warrants further investigation in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyU7zubYRr_rVg90H21EOLACvtfcHk0liRfnDpPzKrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovF2gsbY%253D&md5=284eba293f0d70487427dba52123d6f4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0429%26sid%3Dliteratum%253Aachs%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BS.%26aulast%3DWang%26aufirst%3DD.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BS.%26atitle%3DAntitumor%2520effects%2520of%2520a%2520novel%2520phenylbutyrate-based%2520histone%2520deacetylases%2520inhibitor%252C%2520%2528S%2529-HDAC-42%252C%2520in%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5199%26epage%3D5206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongming, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=Y.+W.+Abruzzoauthor=T.+Krogmannauthor=G.+Yongmingauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0liRfnDpPzKrZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DAbruzzo%26aufirst%3DY.%2BW.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DYongming%26aufirst%3DG.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhoff, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor selectively induces p21<sup>WAF1</sup> expression and gene-associated histone acetylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">10014</span><span class="NLM_x">–</span> <span class="NLM_lpage">10019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10014-10019&issue=18&author=V.+M.+Richonauthor=T.+W.+Sandhoffauthor=R.+A.+Rifkindauthor=P.+A.+Marks&title=Histone+deacetylase+inhibitor+selectively+induces+p21WAF1+expression+and+gene-associated+histone+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSandhoff%26aufirst%3DT.%2BW.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520selectively%2520induces%2520p21WAF1%2520expression%2520and%2520gene-associated%2520histone%2520acetylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26issue%3D18%26spage%3D10014%26epage%3D10019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Gartenhaus, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P.</span><span> </span><span class="NLM_article-title">Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using the p53-dndependent pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=265-268&author=R.+B.+Gartenhausauthor=P.+Wangauthor=P.+Hoffmann&title=Induction+of+the+WAF1%2FCIP1+protein+and+apoptosis+in+human+T-cell+leukemia+virus+type+I-transformed+lymphocytes+after+treatment+with+adriamycin+by+using+the+p53-dndependent+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DP.%26atitle%3DInduction%2520of%2520the%2520WAF1%252FCIP1%2520protein%2520and%2520apoptosis%2520in%2520human%2520T-cell%2520leukemia%2520virus%2520type%2520I-transformed%2520lymphocytes%2520after%2520treatment%2520with%2520adriamycin%2520by%2520using%2520the%2520p53-dndependent%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D265%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borra, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">The human Sir2 ortholog, SIRT2, is an NAD<sup>+</sup>-dependent tubulin deacetylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS1097-2765%2803%2900038-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12620231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=437-444&author=B.+J.+Northauthor=B.+L.+Marshallauthor=M.+T.+Borraauthor=J.+M.+Denuauthor=E.+Verdin&title=The+human+Sir2+ortholog%2C+SIRT2%2C+is+an+NAD%2B-dependent+tubulin+deacetylase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span></div><div class="casAuthors">North, Brian J.; Marshall, Brett L.; Borra, Margie T.; Denu, John M.; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The silent information regulator 2 protein (Sir2p) of Saccharomyces cerevisiae is an NAD-dependent histone deacetylase that plays a crit. role in transcriptional silencing.  Here, we report that a human ortholog of Sir2p, sirtuin type 2 (SIRT2), is a predominantly cytoplasmic protein that colocalizes with microtubules.  SIRT2 deacetylates lysine-40 of α-tubulin both in vitro and in vivo.  Knockdown of SIRT2 via siRNA results in tubulin hyperacetylation.  SIRT2 colocalizes and interacts in vivo with HDAC6, another tubulin deacetylase.  Enzymic anal. of recombinant SIRT2 in comparison to a yeast homolog of Sir2 protein (Hst2p) shows a striking preference of SIRT2 for acetylated tubulin peptide as a substrate relative to acetylated histone H3 peptide.  These observations establish SIRT2 as a bona fide tubulin deacetylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrA4k4bpBlrVg90H21EOLACvtfcHk0lj0gbCCCr3ucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D&md5=622e6bf7b48be1ec6afedf403c56350c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900038-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900038-8%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DBorra%26aufirst%3DM.%2BT.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DThe%2520human%2520Sir2%2520ortholog%252C%2520SIRT2%252C%2520is%2520an%2520NAD%252B-dependent%2520tubulin%2520deacetylase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D437%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Schäfer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickmanns, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2011</span><span class="NLM_x">–</span> <span class="NLM_lpage">2033</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2011-2033&author=S.+Sch%C3%A4ferauthor=L.+Saundersauthor=E.+Eliseevaauthor=A.+Velenaauthor=M.+Jungauthor=A.+Schwienhorstauthor=A.+Strasserauthor=A.+Dickmannsauthor=R.+Ficnerauthor=S.+Schlimmeauthor=W.+Sipplauthor=E.+Verdinauthor=M.+Jung&title=Phenylalanine-containing+hydroxamic+acids+as+selective+inhibitors+of+class+IIb+histone+deacetylases+%28HDACs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DEliseeva%26aufirst%3DE.%26aulast%3DVelena%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSchwienhorst%26aufirst%3DA.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDickmanns%26aufirst%3DA.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchlimme%26aufirst%3DS.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DPhenylalanine-containing%2520hydroxamic%2520acids%2520as%2520selective%2520inhibitors%2520of%2520class%2520IIb%2520histone%2520deacetylases%2520%2528HDACs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2011%26epage%3D2033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Namdar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of histone deacetylases 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">20003</span><span class="NLM_x">–</span> <span class="NLM_lpage">20008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20003-20008&author=M.+Namdarauthor=G.+Perezauthor=L.+Ngoauthor=P.+A.+Marks&title=Selective+inhibition+of+histone+deacetylases+6+%28HDAC6%29+induces+DNA+damage+and+sensitizes+transformed+cells+to+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNamdar%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520histone%2520deacetylases%25206%2520%2528HDAC6%2529%2520induces%2520DNA%2520damage%2520and%2520sensitizes%2520transformed%2520cells%2520to%2520anticancer%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D20003%26epage%3D20008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Blagosklonny, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traganos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darzynkiewicz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Histone deacetylases inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity</span> <span class="citation_source-journal">Mol. Cell Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=937-941&author=M.+V.+Blagosklonnyauthor=R.+Robeyauthor=D.+L.+Sackettauthor=L.+Duauthor=F.+Traganosauthor=Z.+Darzynkiewiczauthor=T.+Fojoauthor=S.+E.+Bates&title=Histone+deacetylases+inhibitors+all+induce+p21+but+differentially+cause+tubulin+acetylation%2C+mitotic+arrest%2C+and+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity</span></div><div class="casAuthors">Blagosklonny, Mikhail V.; Robey, Robert; Sackett, Dan L.; Du, Litong; Traganos, Frank; Darzynkiewicz, Zbigniew; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">937-941</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">By preventing deacetylation of histones, histone deacetylase inhibitors (HDIs) transcriptionally induce p21.  Here we show that the HDIs sodium butyrate (Bu), trichostatin A (TSA) and depsipeptide (FR901228) all induced p21, but only TSA and FR901228 caused mitotic arrest (in addn. to arrest in G1 and G2).  The ability to cause mitotic arrest correlated with the higher cytotoxicity of these compds.  Although causing mitotic arrest, TSA and FR901228 (unlike paclitaxel) did not affect tubulin polymn.  Unlike FR9012208, TSA caused acetylation of tubulin at lysine 40; both sol. tubulin and microtubules were acetylated.  Whereas the induction of p21 reached a max. by 8 h, tubulin was maximally acetylated after only 1 h of TSA treatment.  Tubulin acetylation was detectable after treatment with 12-25 ng/mL TSA although acetylation plateaued at 50 ng/mL TSA, coinciding with G2-M arrest, appearance of cells with a sub-2N DNA content, poly(ADP-ribose) polymerase cleavage, and rapid cell death.  We conclude that HDIs have differential effects on non-histone deacetylases and that rapid acetylation of tubulin caused by TSA is a marker of nontranscriptional effects of TSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3U1Gfsq3t0LVg90H21EOLACvtfcHk0ljPLV7mWojYmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFOntg%253D%253D&md5=eb537e58f3227b5aea93884751d2f839</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DSackett%26aufirst%3DD.%2BL.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DHistone%2520deacetylases%2520inhibitors%2520all%2520induce%2520p21%2520but%2520differentially%2520cause%2520tubulin%2520acetylation%252C%2520mitotic%2520arrest%252C%2520and%2520cytotoxicity%26jtitle%3DMol.%2520Cell%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D937%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khochbin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, P.</span><span> </span><span class="NLM_article-title">HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1093%2Femboj%2Fcdg115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12606581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1yls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1168-1179&author=Y.+Zhangauthor=N.+Liauthor=C.+Caronauthor=G.+Matthiasauthor=D.+Hessauthor=S.+Khochbinauthor=P.+Matthias&title=HDAC-6+interacts+with+and+deacetylates+tubulin+and+microtubules+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo</span></div><div class="casAuthors">Zhang, Yu; Li, Na; Caron, Cecile; Matthias, Gabriele; Hess, Daniel; Khochbin, Saadi; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1168-1179</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Microtubules are cylindrical cytoskeletal structures found in almost all eukaryotic cell types which are involved in a great variety of cellular processes.  Reversible acetylation on the ε-amino group of α-tubulin Lys40 marks stabilized microtubule structures and may contribute to regulating microtubule dynamics.  Yet, the enzymes catalyzing this acetylation/deacetylation have remained unidentified until recently.  Here we report that β-tubulin interacts with histone deacetylase-6 (HDAC-6) in a yeast two-hybrid assay and in vitro.  We find that HDAC-6 is a micro tubule-assocd. protein capable of deacetylating α-tubulin in vivo and in vitro.  HDAC-6's microtubule binding and deacetylation functions both depend on the hdac domains.  Overexpression of HDAC-6 in mammalian cells leads to tubulin hypoacetylation.  In contrast, inhibition of HDAC-6 function by two independent mechanisms-pharmacol. (HDAC inhibitors) or genetic (targeted inactivation of HDAC-6 in embryonic stem cells)-leads to hyperacetylation of tubulin and microtubules.  Taken together, our data provide evidence that HDAC-6 might act as a dual deacetylase for tubulin and histones, and suggest the possibility that acetylated non-histone proteins might represent novel targets for pharmacol. therapy by HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBqjHB5aVYPrVg90H21EOLACvtfcHk0liApMm61cQNtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1yls7c%253D&md5=0d2b6dd552163866b85f14471ac600f7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg115%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCaron%26aufirst%3DC.%26aulast%3DMatthias%26aufirst%3DG.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DKhochbin%26aufirst%3DS.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DHDAC-6%2520interacts%2520with%2520and%2520deacetylates%2520tubulin%2520and%2520microtubules%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1168%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chohan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snapka, R. M.</span><span> </span><span class="NLM_article-title">XK469, a selective topoisomerase IIβ poison</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">12168</span><span class="NLM_x">–</span> <span class="NLM_lpage">12173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12168-12173&author=H.+Gaoauthor=K.+C.+Huangauthor=E.+F.+Yamasakiauthor=K.+K.+Chanauthor=L.+Chohanauthor=R.+M.+Snapka&title=XK469%2C+a+selective+topoisomerase+II%CE%B2+poison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DYamasaki%26aufirst%3DE.%2BF.%26aulast%3DChan%26aufirst%3DK.%2BK.%26aulast%3DChohan%26aufirst%3DL.%26aulast%3DSnapka%26aufirst%3DR.%2BM.%26atitle%3DXK469%252C%2520a%2520selective%2520topoisomerase%2520II%25CE%25B2%2520poison%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12168%26epage%3D12173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span> </span><span class="NLM_article-title">Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteosome</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12370758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=1081-1085&issue=5&author=K.+Kiyomiyaauthor=J.+Satohauthor=H.+Horieauthor=M.+Kurebeauthor=H.+Nakagawaauthor=S.+Matsuo&title=Correlation+between+nuclear+action+of+anthracycline+anticancer+agents+and+their+binding+affinity+to+the+proteosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome</span></div><div class="casAuthors">Kiyomiya, Ken-ichi; Satoh, Jun; Horie, Hiroshi; Kurebe, Masaru; Nakagawa, Hiroshi; Matsuo, Saburou</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1081-1085</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">4'-O-tetrahydropyranyladriamycin (THP) showed an approx. 10-fold greater inhibitory effect on DNA synthesis in L1210 mouse leukemia cells than adriamycin (ADM).  The intracellular transfer rate and nuclear accumulation of THP were approx. 5-fold higher than those of ADM.  The intensity of in vitro inhibition of topoisomerase II activity by ADM was almost the same as that by THP.  There were no significant differences between the uptake of either of these agents by the isolated nuclei of L1210 cells.  The nuclear uptake of both agents in the presence of the cytosolic fraction of L1210 cells consisted of both simple diffusion and carrier-mediated components, and the carrier-mediated component of THP was approx. 2-fold higher than that of ADM.  THP showed approx. 5-fold higher affinity to the proteasome than ADM, and interfered with ADM binding in a competitive manner.  These results suggest that the binding affinity of these anticancer agents to the proteasome is an important factor in their transport to the nucleus and dets. their specificity of action for the nuclear DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVSdLYYCdWQbVg90H21EOLACvtfcHk0liApMm61cQNtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSrtrw%253D&md5=0d039cdc186747eb6e08a6c88097ae66</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DJ.%26aulast%3DHorie%26aufirst%3DH.%26aulast%3DKurebe%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DS.%26atitle%3DCorrelation%2520between%2520nuclear%2520action%2520of%2520anthracycline%2520anticancer%2520agents%2520and%2520their%2520binding%2520affinity%2520to%2520the%2520proteosome%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2002%26volume%3D21%26issue%3D5%26spage%3D1081%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Marbeuf-Gueye, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier-Suillerot, A.</span><span> </span><span class="NLM_article-title">Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1450</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1450&publication_year=1999&pages=374-384&issue=3&author=C.+Marbeuf-Gueyeauthor=D.+Ettoriauthor=W.+Priebeauthor=H.+Kozlowskiauthor=A.+Garnier-Suillerot&title=Correlation+between+the+kinetics+of+anthracycline+uptake+and+the+resistance+factor+in+cancer+cells+expressing+the+multidrug+resistance+protein+or+the+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarbeuf-Gueye%26aufirst%3DC.%26aulast%3DEttori%26aufirst%3DD.%26aulast%3DPriebe%26aufirst%3DW.%26aulast%3DKozlowski%26aufirst%3DH.%26aulast%3DGarnier-Suillerot%26aufirst%3DA.%26atitle%3DCorrelation%2520between%2520the%2520kinetics%2520of%2520anthracycline%2520uptake%2520and%2520the%2520resistance%2520factor%2520in%2520cancer%2520cells%2520expressing%2520the%2520multidrug%2520resistance%2520protein%2520or%2520the%2520P-glycoprotein%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1450%26issue%3D3%26spage%3D374%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Klyatskaya, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretyakov, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilevsky, S. F.</span><span> </span><span class="NLM_article-title">Cross-coupling of aryl iodides with paramagnetic terminal acetylenes derived from 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide</span> <span class="citation_source-journal">Russ. Chem. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1023%2FA%3A1015026200647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVOhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=128-134&author=S.+V.+Klyatskayaauthor=E.+V.+Tretyakovauthor=S.+F.+Vasilevsky&title=Cross-coupling+of+aryl+iodides+with+paramagnetic+terminal+acetylenes+derived+from+4%2C4%2C5%2C5-tetramethyl-2-imidazoline-1-oxyl+3-oxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-coupling of aryl iodides with paramagnetic terminal acetylenes derived from 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide</span></div><div class="casAuthors">Klyatskaya, S. V.; Tretyakov, E. V.; Vasilevsky, S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya Khimicheskaya)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">RCBUEY</span>;
        ISSN:<span class="NLM_cas:issn">1066-5285</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">2-(Arylylethynylphenyl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxides were synthesized by cross-coupling of aryl iodides with 1-alkynes contg. the 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide fragment.  A procedure was developed for the prepn. of 3- and 4-ethynylbenzaldehydes with the use of 2-methylbut-3-yn-2-ol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoVvaBnQTQ7Vg90H21EOLACvtfcHk0lhp77noJFkbxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVOhur4%253D&md5=db12f0deb92e1cd57c7ab10a9ca66008</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015026200647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015026200647%26sid%3Dliteratum%253Aachs%26aulast%3DKlyatskaya%26aufirst%3DS.%2BV.%26aulast%3DTretyakov%26aufirst%3DE.%2BV.%26aulast%3DVasilevsky%26aufirst%3DS.%2BF.%26atitle%3DCross-coupling%2520of%2520aryl%2520iodides%2520with%2520paramagnetic%2520terminal%2520acetylenes%2520derived%2520from%25204%252C4%252C5%252C5-tetramethyl-2-imidazoline-1-oxyl%25203-oxide%26jtitle%3DRuss.%2520Chem.%2520Bull.%26date%3D2002%26volume%3D51%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbardella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S.</span><span> </span><span class="NLM_article-title">A new facile and expeditious synthesis of <i>N</i>-hydroxy-<i>N</i>′-phenyloctanediamide, a potent inducer of terminal cytodifferentiation</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1080%2F00304940109356608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVaqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=391-394&issue=4&author=A.+Maiauthor=M.+Espositoauthor=G.+Sbardellaauthor=S.+Massa&title=A+new+facile+and+expeditious+synthesis+of+N-hydroxy-N%E2%80%B2-phenyloctanediamide%2C+a+potent+inducer+of+terminal+cytodifferentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A new facile and expeditious synthesis of N-hydroxy-N'-phenyloctanediamide, a potent inducer of terminal cytodifferentiation</span></div><div class="casAuthors">Mai, Antonello; Esposito, Monica; Sbardella, Gianluca; Massa, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-394</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">The title compd. (I) was prepd. by reacting suberic acid with acetic anhydride to give suberic anhydride.  The latter was condensed with aniline to give suberanilic acid, which reacted with ClCO2Et and NH2OH to give I in 58% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_uUH35G2SrVg90H21EOLACvtfcHk0lhp77noJFkbxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVaqt7c%253D&md5=60ecb3db854b004252f20f4819459bb5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1080%2F00304940109356608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940109356608%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DEsposito%26aufirst%3DM.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMassa%26aufirst%3DS.%26atitle%3DA%2520new%2520facile%2520and%2520expeditious%2520synthesis%2520of%2520N-hydroxy-N%25E2%2580%25B2-phenyloctanediamide%252C%2520a%2520potent%2520inducer%2520of%2520terminal%2520cytodifferentiation%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2001%26volume%3D33%26issue%3D4%26spage%3D391%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 97 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tingting Liu, Yichao Wan, Yuliang Xiao, Chengcai Xia, <span class="NLM_string-name hlFld-ContribAuthor">Guiyun Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8977-9002. <a href="https://doi.org/10.1021/acs.jmedchem.0c00491" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00491%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-Target%252BInhibitors%252BBased%252Bon%252BHDACs%25253A%252BNovel%252BAntitumor%252BAgents%252Bfor%252BCancer%252BTherapy%26aulast%3DLiu%26aufirst%3DTingting%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D23032020%26date%3D30042020%26date%3D22042020%26volume%3D63%26issue%3D17%26spage%3D8977%26epage%3D9002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Victoriano Corpas-López, Mavys Tabraue-Chávez, Yudibeth Sixto-López, Sonia Panadero-Fajardo, Fernando Alves de Lima Franco, José F. Domínguez-Seglar, Francisco Morillas-Márquez, Francisco Franco-Montalbán, Mónica Díaz-Gavilán, José Correa-Basurto, Julián López-Viota, Margarita López-Viota, José Pérez del Palacio, Mercedes de la Cruz, Nuria de Pedro, Joaquina Martín-Sánchez, <span class="NLM_string-name hlFld-ContribAuthor">José A. Gómez-Vidal</span>. </span><span class="cited-content_cbyCitation_article-title">O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5734-5751. <a href="https://doi.org/10.1021/acs.jmedchem.9b02016" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DO-Alkyl%252BHydroxamates%252BDisplay%252BPotent%252Band%252BSelective%252BAntileishmanial%252BActivity%26aulast%3DCorpas-L%25C3%25B3pez%26aufirst%3DVictoriano%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D05122019%26date%3D26052020%26date%3D11052020%26volume%3D63%26issue%3D11%26spage%3D5734%26epage%3D5751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Žiga Skok, Nace Zidar, Danijel Kikelj, <span class="NLM_string-name hlFld-ContribAuthor">Janez Ilaš</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (3)
                                     , 884-904. <a href="https://doi.org/10.1021/acs.jmedchem.9b00726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BInhibitors%252Bof%252BHuman%252BDNA%252BTopoisomerase%252BII%252Band%252BOther%252BCancer-Related%252BTargets%26aulast%3DSkok%26aufirst%3D%25C5%25BDiga%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D03052019%26date%3D21102019%26date%3D08102019%26volume%3D63%26issue%3D3%26spage%3D884%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcian E.  Van Dort</span>, <span class="hlFld-ContribAuthor ">Stefanie  Galbán</span>, <span class="hlFld-ContribAuthor ">Charles A.  Nino</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">April A.  Apfelbaum</span>, <span class="hlFld-ContribAuthor ">Gary D.  Luker</span>, <span class="hlFld-ContribAuthor ">Greg M.  Thurber</span>, <span class="hlFld-ContribAuthor ">Lydia  Atangcho</span>, <span class="hlFld-ContribAuthor ">Cagri G.  Besirli</span>, and <span class="hlFld-ContribAuthor ">Brian D.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design and Initial Studies of a Bifunctional MEK/PI3K Inhibitor (ST-168). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 808-813. <a href="https://doi.org/10.1021/acsmedchemlett.7b00111" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00111%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Guided%252BDesign%252Band%252BInitial%252BStudies%252Bof%252Ba%252BBifunctional%252BMEK%25252FPI3K%252BInhibitor%252B%252528ST-168%252529%26aulast%3DVan%2BDort%26aufirst%3DMarcian%2BE.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15032017%26date%3D24072017%26date%3D25072017%26date%3D10082017%26date%3D24072017%26volume%3D8%26issue%3D8%26spage%3D808%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcian E.  Van Dort</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Hanxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Charles A.  Nino</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Lombardi</span>, <span class="hlFld-ContribAuthor ">Avery E.  Blanks</span>, <span class="hlFld-ContribAuthor ">Stefanie  Galbán</span>, and <span class="hlFld-ContribAuthor ">Brian D.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3-Kinase (PI3K). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2512-2522. <a href="https://doi.org/10.1021/acs.jmedchem.5b01655" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01655%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBifunctional%252BOncogenic%252BTarget%252BInhibitors%252Bagainst%252BAllosteric%252BMitogen-Activated%252BProtein%252BKinase%252B%252528MEK1%252529%252Band%252BPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%26aulast%3DVan%2BDort%26aufirst%3DMarcian%2BE.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22102015%26date%3D15032016%26date%3D24032016%26date%3D04032016%26volume%3D59%26issue%3D6%26spage%3D2512%26epage%3D2522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shipeng  He</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Zhibin  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengang  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Yao</span>, <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, and <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 239-243. <a href="https://doi.org/10.1021/ml500327q" title="DOI URL">https://doi.org/10.1021/ml500327q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500327q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500327q%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BNovel%252BMultiacting%252BTopoisomerase%252BI%25252FII%252Band%252BHistone%252BDeacetylase%252BInhibitors%26aulast%3DHe%26aufirst%3DShipeng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05082014%26date%3D14012015%26date%3D20012015%26date%3D12032015%26date%3D14012015%26volume%3D6%26issue%3D3%26spage%3D239%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Berkley E.  Gryder</span>, <span class="hlFld-ContribAuthor ">Michael K.  Rood</span>, <span class="hlFld-ContribAuthor ">Kenyetta A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Vishal  Patil</span>, <span class="hlFld-ContribAuthor ">Eric D.  Raftery</span>, <span class="hlFld-ContribAuthor ">Li-Pan D.  Yao</span>, <span class="hlFld-ContribAuthor ">Marcie  Rice</span>, <span class="hlFld-ContribAuthor ">Bahareh  Azizi</span>, <span class="hlFld-ContribAuthor ">Donald F.  Doyle</span>, and <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>  . </span><span class="cited-content_cbyCitation_article-title">Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (14)
                                     , 5782-5796. <a href="https://doi.org/10.1021/jm400467w" title="DOI URL">https://doi.org/10.1021/jm400467w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400467w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400467w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252BDeacetylase%252BInhibitors%252BEquipped%252Bwith%252BEstrogen%252BReceptor%252BModulation%252BActivity%26aulast%3DGryder%26aufirst%3DBerkley%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D30032013%26date%3D03072013%26date%3D25072013%26date%3D20062013%26volume%3D56%26issue%3D14%26spage%3D5782%26epage%3D5796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonghao  Jin</span>, <span class="hlFld-ContribAuthor ">Mark D.  Roycik</span>, <span class="hlFld-ContribAuthor ">Dale B.  Bosco</span>, <span class="hlFld-ContribAuthor ">Qiang  Cao</span>, <span class="hlFld-ContribAuthor ">Manuel H.  Constantino</span>, <span class="hlFld-ContribAuthor ">Martin A.  Schwartz</span>, and <span class="hlFld-ContribAuthor ">Qing-Xiang Amy  Sang</span>  . </span><span class="cited-content_cbyCitation_article-title">Matrix Metalloproteinase Inhibitors Based on the 3-Mercaptopyrrolidine Core. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4357-4373. <a href="https://doi.org/10.1021/jm400529f" title="DOI URL">https://doi.org/10.1021/jm400529f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400529f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400529f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMatrix%252BMetalloproteinase%252BInhibitors%252BBased%252Bon%252Bthe%252B3-Mercaptopyrrolidine%252BCore%26aulast%3DJin%26aufirst%3DYonghao%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D08012013%26date%3D16052013%26date%3D13062013%26date%3D30042013%26volume%3D56%26issue%3D11%26spage%3D4357%26epage%3D4373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishal  Patil</span>, <span class="hlFld-ContribAuthor ">Quaovi H.  Sodji</span>, <span class="hlFld-ContribAuthor ">James R.  Kornacki</span>, <span class="hlFld-ContribAuthor ">Milan  Mrksich</span>, and <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>  . </span><span class="cited-content_cbyCitation_article-title">3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (9)
                                     , 3492-3506. <a href="https://doi.org/10.1021/jm301769u" title="DOI URL">https://doi.org/10.1021/jm301769u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301769u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301769u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-Hydroxypyridin-2-thione%252Bas%252BNovel%252BZinc%252BBinding%252BGroup%252Bfor%252BSelective%252BHistone%252BDeacetylase%252BInhibition%26aulast%3DPatil%26aufirst%3DVishal%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D30112012%26date%3D18042013%26date%3D09052013%26date%3D02042013%26volume%3D56%26issue%3D9%26spage%3D3492%26epage%3D3506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jhih-Bin  Chen</span>, <span class="hlFld-ContribAuthor ">Ting-Rong  Chern</span>, <span class="hlFld-ContribAuthor ">Tzu-Tang  Wei</span>, <span class="hlFld-ContribAuthor ">Ching-Chow  Chen</span>, <span class="hlFld-ContribAuthor ">Jung-Hsin  Lin</span>, and <span class="hlFld-ContribAuthor ">Jim-Min  Fang</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (9)
                                     , 3645-3655. <a href="https://doi.org/10.1021/jm400179b" title="DOI URL">https://doi.org/10.1021/jm400179b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400179b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400179b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BDual-Action%252BInhibitors%252BTargeting%252BHistone%252BDeacetylases%252Band%252B3-Hydroxy-3-methylglutaryl%252BCoenzyme%252BA%252BReductase%252Bfor%252BCancer%252BTreatment%26aulast%3DChen%26aufirst%3DJhih-Bin%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03022013%26date%3D22042013%26date%3D09052013%26date%3D09042013%26volume%3D56%26issue%3D9%26spage%3D3645%26epage%3D3655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewelina  Russjan</span>, <span class="hlFld-ContribAuthor ">Dominika  Zając</span>, <span class="hlFld-ContribAuthor ">Dorota  Sulejczak</span>, <span class="hlFld-ContribAuthor ">Patrycja  Kleczkowska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kaczyńska</span>. </span><span class="cited-content_cbyCitation_article-title">Contribution of opioid and neurotensin receptors in the anti‐inflammatory activity of PK20 hybrid compound in murine airways. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Experimental Pharmacology and Physiology</span><span> <strong>2021,</strong> <em>48 </em>
                                    (8)
                                     , 1162-1170. <a href="https://doi.org/10.1111/1440-1681.13505" title="DOI URL">https://doi.org/10.1111/1440-1681.13505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1440-1681.13505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1440-1681.13505%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Experimental%2520Pharmacology%2520and%2520Physiology%26atitle%3DContribution%252Bof%252Bopioid%252Band%252Bneurotensin%252Breceptors%252Bin%252Bthe%252Banti%2525E2%252580%252590inflammatory%252Bactivity%252Bof%252BPK20%252Bhybrid%252Bcompound%252Bin%252Bmurine%252Bairways%26aulast%3DRussjan%26aufirst%3DEwelina%26date%3D2021%26date%3D2021%26volume%3D48%26issue%3D8%26spage%3D1162%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang-Yong  Lee</span>, <span class="hlFld-ContribAuthor ">Vigneshwaran  Namasivayam</span>, <span class="hlFld-ContribAuthor ">Nader M.  Boshta</span>, <span class="hlFld-ContribAuthor ">Arianna  Perotti</span>, <span class="hlFld-ContribAuthor ">Salahuddin  Mirza</span>, <span class="hlFld-ContribAuthor ">Silvia  Bua</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1187-1206. <a href="https://doi.org/10.1039/D1MD00117E" title="DOI URL">https://doi.org/10.1039/D1MD00117E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00117E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00117E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Bnucleotide%252Bpyrophosphatase%25252Fphosphodiesterase3%252B%252528NPP3%252529%252Binhibitors%252Bwith%252Bancillary%252Bcarbonic%252Banhydrase%252Binhibition%252Bfor%252Bcancer%252B%252528immuno%252529therapy%26aulast%3DLee%26aufirst%3DSang-Yong%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1187%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kriti  Kashyap</span>, <span class="hlFld-ContribAuthor ">Rita  Kakkar</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              study of the synergistic anti-tumor effect of hybrid topoisomerase-HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Pure and Applied Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/pac-2021-0111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fpac-2021-0111%26sid%3Dliteratum%253Aachs%26jtitle%3DPure%2520and%2520Applied%2520Chemistry%26atitle%3DIn%252Bsilico%252Bstudy%252Bof%252Bthe%252Bsynergistic%252Banti-tumor%252Beffect%252Bof%252Bhybrid%252Btopoisomerase-HDAC%252Binhibitors%26aulast%3DKashyap%26aufirst%3DKriti%26date%3D2021%26date%3D2021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiting  Zhang</span>, <span class="hlFld-ContribAuthor ">Ziyan  Wang</span>, <span class="hlFld-ContribAuthor ">Xinyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Haoxiang  Qiu</span>, <span class="hlFld-ContribAuthor ">Yifan  Gu</span>, <span class="hlFld-ContribAuthor ">Ning  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Ze  Wang</span>, <span class="hlFld-ContribAuthor ">Huabin  Ma</span>, <span class="hlFld-ContribAuthor ">Yufen  Zhao</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (11)
                                     , 5516. <a href="https://doi.org/10.3390/ijms22115516" title="DOI URL">https://doi.org/10.3390/ijms22115516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22115516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22115516%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3D8a%25252C%252Ba%252BNew%252BAcridine%252BAntiproliferative%252Band%252BPro-Apoptotic%252BAgent%252BTargeting%252BHDAC1%25252FDNMT1%26aulast%3DZhang%26aufirst%3DQiting%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D11%26spage%3D5516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Chrabąszcz</span>, <span class="hlFld-ContribAuthor ">Andrzej  Błauż</span>, <span class="hlFld-ContribAuthor ">Martyna  Gruchała</span>, <span class="hlFld-ContribAuthor ">Marcin  Wachulec</span>, <span class="hlFld-ContribAuthor ">Błażej  Rychlik</span>, <span class="hlFld-ContribAuthor ">Damian  Plażuk</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Activity of Ferrocenyl and Ruthenocenyl Analogues of Etoposide: Discovery of a Novel Dual Inhibitor of Topoisomerase II Activity and Tubulin Polymerization. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (20)
                                     , 6254-6262. <a href="https://doi.org/10.1002/chem.202005133" title="DOI URL">https://doi.org/10.1002/chem.202005133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202005133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202005133%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSynthesis%252Band%252BBiological%252BActivity%252Bof%252BFerrocenyl%252Band%252BRuthenocenyl%252BAnalogues%252Bof%252BEtoposide%25253A%252BDiscovery%252Bof%252Ba%252BNovel%252BDual%252BInhibitor%252Bof%252BTopoisomerase%252BII%252BActivity%252Band%252BTubulin%252BPolymerization%26aulast%3DChrab%25C4%2585szcz%26aufirst%3DKarolina%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D20%26spage%3D6254%26epage%3D6262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Jenke</span>, <span class="hlFld-ContribAuthor ">Nina  Reßing</span>, <span class="hlFld-ContribAuthor ">Finn K.  Hansen</span>, <span class="hlFld-ContribAuthor ">Achim  Aigner</span>, <span class="hlFld-ContribAuthor ">Thomas  Büch</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 634. <a href="https://doi.org/10.3390/cancers13040634" title="DOI URL">https://doi.org/10.3390/cancers13040634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13040634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13040634%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DAnticancer%252BTherapy%252Bwith%252BHDAC%252BInhibitors%25253A%252BMechanism-Based%252BCombination%252BStrategies%252Band%252BFuture%252BPerspectives%26aulast%3DJenke%26aufirst%3DRobert%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gargi Nikhil  Vaidya</span>, <span class="hlFld-ContribAuthor ">Pooja  Rana</span>, <span class="hlFld-ContribAuthor ">Ashwini  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Deep Rohan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Darshan  Contractor</span>, <span class="hlFld-ContribAuthor ">Dinesh Parshuram  Satpute</span>, <span class="hlFld-ContribAuthor ">Mithilesh  Nagpure</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Paradigm shift of “classical” HDAC inhibitors to “hybrid” HDAC inhibitors in therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112844. <a href="https://doi.org/10.1016/j.ejmech.2020.112844" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112844%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DParadigm%252Bshift%252Bof%252B%2525E2%252580%25259Cclassical%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bto%252B%2525E2%252580%25259Chybrid%2525E2%252580%25259D%252BHDAC%252Binhibitors%252Bin%252Btherapeutic%252Binterventions%26aulast%3DVaidya%26aufirst%3DGargi%2BNikhil%26date%3D2021%26volume%3D209%26spage%3D112844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr K.A.  Bass</span>, <span class="hlFld-ContribAuthor ">Mona S.  El-Zoghbi</span>, <span class="hlFld-ContribAuthor ">El-Shimaa M.  Nageeb</span>, <span class="hlFld-ContribAuthor ">Mamdouh F.A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Mohamed  Badr</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112904. <a href="https://doi.org/10.1016/j.ejmech.2020.112904" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112904%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComprehensive%252Breview%252Bfor%252Banticancer%252Bhybridized%252Bmultitargeting%252BHDAC%252Binhibitors%26aulast%3DBass%26aufirst%3DAmr%2BK.A.%26date%3D2021%26volume%3D209%26spage%3D112904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhasish  Tapadar</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Fathi</span>, <span class="hlFld-ContribAuthor ">Bocheng  Wu</span>, <span class="hlFld-ContribAuthor ">Carrie Q.  Sun</span>, <span class="hlFld-ContribAuthor ">Idris  Raji</span>, <span class="hlFld-ContribAuthor ">Samuel G.  Moore</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Arnold</span>, <span class="hlFld-ContribAuthor ">David A.  Gaul</span>, <span class="hlFld-ContribAuthor ">John A.  Petros</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3095. <a href="https://doi.org/10.3390/cancers12113095" title="DOI URL">https://doi.org/10.3390/cancers12113095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113095%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DLiver-Targeting%252BClass%252BI%252BSelective%252BHistone%252BDeacetylase%252BInhibitors%252BPotently%252BSuppress%252BHepatocellular%252BTumor%252BGrowth%252Bas%252BStandalone%252BAgents%26aulast%3DTapadar%26aufirst%3DSubhasish%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua P.  Smalley</span>, <span class="hlFld-ContribAuthor ">Shaun M.  Cowley</span>, <span class="hlFld-ContribAuthor ">James T.  Hodgkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional HDAC Therapeutics: One Drug to Rule Them All?. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (19)
                                     , 4394. <a href="https://doi.org/10.3390/molecules25194394" title="DOI URL">https://doi.org/10.3390/molecules25194394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25194394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25194394%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBifunctional%252BHDAC%252BTherapeutics%25253A%252BOne%252BDrug%252Bto%252BRule%252BThem%252BAll%25253F%26aulast%3DSmalley%26aufirst%3DJoshua%2BP.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D19%26spage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angel R.  de Lera</span>, <span class="hlFld-ContribAuthor ">A.  Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Two-hit wonders: The expanding universe of multitargeting epigenetic agents. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2020,</strong> <em>57 </em>, 135-154. <a href="https://doi.org/10.1016/j.cbpa.2020.05.009" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTwo-hit%252Bwonders%25253A%252BThe%252Bexpanding%252Buniverse%252Bof%252Bmultitargeting%252Bepigenetic%252Bagents%26aulast%3Dde%2BLera%26aufirst%3DAngel%2BR.%26date%3D2020%26volume%3D57%26spage%3D135%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita E.  Neganova</span>, <span class="hlFld-ContribAuthor ">Sergey G.  Klochkov</span>, <span class="hlFld-ContribAuthor ">Yulia R.  Aleksandrova</span>, <span class="hlFld-ContribAuthor ">Gjumrakch  Aliev</span>. </span><span class="cited-content_cbyCitation_article-title">Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2020,</strong> <em>42 </em><a href="https://doi.org/10.1016/j.semcancer.2020.07.015" title="DOI URL">https://doi.org/10.1016/j.semcancer.2020.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2020.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2020.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DHistone%252Bmodifications%252Bin%252Bepigenetic%252Bregulation%252Bof%252Bcancer%25253A%252BPerspectives%252Band%252Bachieved%252Bprogress%26aulast%3DNeganova%26aufirst%3DMargarita%2BE.%26date%3D2020%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Morgen</span>, <span class="hlFld-ContribAuthor ">Raphael R.  Steimbach</span>, <span class="hlFld-ContribAuthor ">Magalie  Géraldy</span>, <span class="hlFld-ContribAuthor ">Lars  Hellweg</span>, <span class="hlFld-ContribAuthor ">Peter  Sehr</span>, <span class="hlFld-ContribAuthor ">Johannes  Ridinger</span>, <span class="hlFld-ContribAuthor ">Olaf  Witt</span>, <span class="hlFld-ContribAuthor ">Ina  Oehme</span>, <span class="hlFld-ContribAuthor ">Corey J.  Herbst‐Gervasoni</span>, <span class="hlFld-ContribAuthor ">Jeremy D.  Osko</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Porter</span>, <span class="hlFld-ContribAuthor ">David W.  Christianson</span>, <span class="hlFld-ContribAuthor ">Nikolas  Gunkel</span>, <span class="hlFld-ContribAuthor ">Aubry K.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (13)
                                     , 1163-1174. <a href="https://doi.org/10.1002/cmdc.202000149" title="DOI URL">https://doi.org/10.1002/cmdc.202000149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000149%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BDihydroxamic%252BAcids%252Bas%252BHDAC6%25252F8%25252F10%252BInhibitors%26aulast%3DMorgen%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D13%26spage%3D1163%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yefang  Zou</span>, <span class="hlFld-ContribAuthor ">Zhuoxian  Cao</span>, <span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoxue  Chen</span>, <span class="hlFld-ContribAuthor ">Yan-qin  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Jingzi  Liu</span>, <span class="hlFld-ContribAuthor ">Yonglong  Zhao</span>, <span class="hlFld-ContribAuthor ">Aimin  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  He</span>. </span><span class="cited-content_cbyCitation_article-title">A Series of Novel HDAC Inhibitors with Anthraquinone as a Cap Group. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2020,</strong> <em>68 </em>
                                    (7)
                                     , 613-617. <a href="https://doi.org/10.1248/cpb.c20-00206" title="DOI URL">https://doi.org/10.1248/cpb.c20-00206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c20-00206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c20-00206%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DA%252BSeries%252Bof%252BNovel%252BHDAC%252BInhibitors%252Bwith%252BAnthraquinone%252Bas%252Ba%252BCap%252BGroup%26aulast%3DZou%26aufirst%3DYefang%26date%3D2020%26volume%3D68%26issue%3D7%26spage%3D613%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manvendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Gaurav  Joshi</span>, <span class="hlFld-ContribAuthor ">Joydeep  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (12)
                                     , 1105-1123. <a href="https://doi.org/10.2174/1568026620666200207100227" title="DOI URL">https://doi.org/10.2174/1568026620666200207100227</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026620666200207100227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026620666200207100227%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DEpidermal%252BGrowth%252BFactor%252BReceptor%252Band%252Bits%252BTrafficking%252BRegulation%252Bby%252BAcetylation%25253A%252BImplication%252Bin%252BResistance%252Band%252BExploring%252Bthe%252BNewer%252BTherapeutic%252BAvenues%252Bin%252BCancer%26aulast%3DKumar%26aufirst%3DManvendra%26date%3D2020%26volume%3D20%26issue%3D12%26spage%3D1105%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Jingxian  Zhou</span>, <span class="hlFld-ContribAuthor ">Fengjun  He</span>, <span class="hlFld-ContribAuthor ">Liang  Gao</span>, <span class="hlFld-ContribAuthor ">Yu  Wen</span>, <span class="hlFld-ContribAuthor ">Lina  Gao</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Di  Kang</span>, <span class="hlFld-ContribAuthor ">Lihong  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112189. <a href="https://doi.org/10.1016/j.ejmech.2020.112189" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112189%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bindazole-based%252Bderivatives%252Bas%252Bpotent%252BHDAC%252Binhibitors%252Bvia%252Bfragment-based%252Bvirtual%252Bscreening%26aulast%3DLiu%26aufirst%3DJian%26date%3D2020%26volume%3D192%26spage%3D112189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Regina  Martínez</span>, <span class="hlFld-ContribAuthor ">Bruno  Di Geronimo</span>, <span class="hlFld-ContribAuthor ">Miryam  Pastor</span>, <span class="hlFld-ContribAuthor ">José María  Zapico</span>, <span class="hlFld-ContribAuthor ">Claire  Coderch</span>, <span class="hlFld-ContribAuthor ">Rostyslav  Panchuk</span>, <span class="hlFld-ContribAuthor ">Nadia  Skorokhyd</span>, <span class="hlFld-ContribAuthor ">Maciej  Maslyk</span>, <span class="hlFld-ContribAuthor ">Ana  Ramos</span>, <span class="hlFld-ContribAuthor ">Beatriz  de Pascual-Teresa</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1497. <a href="https://doi.org/10.3390/molecules25071497" title="DOI URL">https://doi.org/10.3390/molecules25071497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071497%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMultitarget%252BAnticancer%252BAgents%252BBased%252Bon%252BHistone%252BDeacetylase%252Band%252BProtein%252BKinase%252BCK2%252BInhibitors%26aulast%3DMart%25C3%25ADnez%26aufirst%3DRegina%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feifei  Yang</span>, <span class="hlFld-ContribAuthor ">Lina  Han</span>, <span class="hlFld-ContribAuthor ">Na  Zhao</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Di  Ge</span>, <span class="hlFld-ContribAuthor ">Hua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yihua  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of thiophene-based hydroxamate derivatives as HDACis with antitumor activities. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 655-672. <a href="https://doi.org/10.4155/fmc-2019-0343" title="DOI URL">https://doi.org/10.4155/fmc-2019-0343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0343%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthiophene-based%252Bhydroxamate%252Bderivatives%252Bas%252BHDACis%252Bwith%252Bantitumor%252Bactivities%26aulast%3DYang%26aufirst%3DFeifei%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D655%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaorui  Xie</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Yunfei  Wei</span>, <span class="hlFld-ContribAuthor ">Heliang  Du</span>, <span class="hlFld-ContribAuthor ">Yuanbo  Xu</span>, <span class="hlFld-ContribAuthor ">Qihao  Xu</span>, <span class="hlFld-ContribAuthor ">Yongkui  Jing</span>, <span class="hlFld-ContribAuthor ">Linxiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 111991. <a href="https://doi.org/10.1016/j.ejmech.2019.111991" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111991%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bconjugate%252Bwith%252BVorinostat%252Bdegrades%252BHDAC3%252Band%252BHDAC6%252Bwith%252Bimproved%252Bantitumor%252Beffects%26aulast%3DHuang%26aufirst%3DMin%26date%3D2020%26volume%3D188%26spage%3D111991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valery K.  Brel</span>, <span class="hlFld-ContribAuthor ">Oleg I.  Artyushin</span>, <span class="hlFld-ContribAuthor ">Aleksandra A.  Moiseeva</span>, <span class="hlFld-ContribAuthor ">Elena V.  Sharova</span>, <span class="hlFld-ContribAuthor ">Anastasiya G.  Buyanovskaya</span>, <span class="hlFld-ContribAuthor ">Yulia V.  Nelyubina</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of bioactive substrates with a F
              5
              SCH = CH moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sulfur Chemistry</span><span> <strong>2020,</strong> <em>41 </em>
                                    (1)
                                     , 29-43. <a href="https://doi.org/10.1080/17415993.2019.1662906" title="DOI URL">https://doi.org/10.1080/17415993.2019.1662906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17415993.2019.1662906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17415993.2019.1662906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sulfur%2520Chemistry%26atitle%3DFunctionalization%252Bof%252Bbioactive%252Bsubstrates%252Bwith%252Ba%252BF%252B5%252BSCH%2525E2%252580%252589%25253D%2525E2%252580%252589CH%252Bmoiety%26aulast%3DBrel%26aufirst%3DValery%2BK.%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D1%26spage%3D29%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Tomaselli</span>, <span class="hlFld-ContribAuthor ">Alessia  Lucidi</span>, <span class="hlFld-ContribAuthor ">Dante  Rotili</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic polypharmacology: A new frontier for epi‐drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 190-244. <a href="https://doi.org/10.1002/med.21600" title="DOI URL">https://doi.org/10.1002/med.21600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21600%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEpigenetic%252Bpolypharmacology%25253A%252BA%252Bnew%252Bfrontier%252Bfor%252Bepi%2525E2%252580%252590drug%252Bdiscovery%26aulast%3DTomaselli%26aufirst%3DDaniela%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D190%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vânia  Camilo</span>, <span class="hlFld-ContribAuthor ">Carmen  Jerónimo</span>. </span><span class="cited-content_cbyCitation_article-title">Present and future perspectives for targeting histone modifications in therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 415-457. <a href="https://doi.org/10.1016/B978-0-12-816422-8.00018-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-816422-8.00018-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816422-8.00018-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816422-8.00018-0%26sid%3Dliteratum%253Aachs%26atitle%3DPresent%252Band%252Bfuture%252Bperspectives%252Bfor%252Btargeting%252Bhistone%252Bmodifications%252Bin%252Btherapy%26aulast%3DCamilo%26aufirst%3DV%25C3%25A2nia%26date%3D2020%26spage%3D415%26epage%3D457%26pub%3DElsevier%26atitle%3DHistone%252BModifications%252Bin%252BTherapy%26date%3D2020%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Mehndiratta</span>, <span class="hlFld-ContribAuthor ">Mei-Hsiang  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Chun-Han  Chen</span>, <span class="hlFld-ContribAuthor ">Tung-Yun  Wu</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiang  Chuang</span>, <span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Yi-Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>185 </em>, 111725. <a href="https://doi.org/10.1016/j.ejmech.2019.111725" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111725%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-alkyl-hydroxybenzoyl%252Banilide%252Bhydroxamates%252Bas%252Bdual%252Binhibitors%252Bof%252BHDAC%252Band%252BHSP90%25252C%252Bdownregulating%252BIFN-%2525CE%2525B3%252Binduced%252BPD-L1%252Bexpression%26aulast%3DMehndiratta%26aufirst%3DSamir%26date%3D2020%26volume%3D185%26spage%3D111725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangyi  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongxia  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design opportunities presented by solvent‐exposed regions of target proteins. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (6)
                                     , 2194-2238. <a href="https://doi.org/10.1002/med.21581" title="DOI URL">https://doi.org/10.1002/med.21581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21581%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMolecular%252Bdesign%252Bopportunities%252Bpresented%252Bby%252Bsolvent%2525E2%252580%252590exposed%252Bregions%252Bof%252Btarget%252Bproteins%26aulast%3DJiang%26aufirst%3DXiangyi%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D2194%26epage%3D2238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Guoliang  Gong</span>, <span class="hlFld-ContribAuthor ">Xinyang  Chen</span>, <span class="hlFld-ContribAuthor ">Ruihu  Song</span>, <span class="hlFld-ContribAuthor ">Mei  Duan</span>, <span class="hlFld-ContribAuthor ">Ruizhi  Qiao</span>, <span class="hlFld-ContribAuthor ">Yu  Jiao</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Qi</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2019,</strong> <em>67 </em>
                                    (10)
                                     , 1116-1122. <a href="https://doi.org/10.1248/cpb.c19-00425" title="DOI URL">https://doi.org/10.1248/cpb.c19-00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c19-00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c19-00425%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BBenzoylimidazole%252BDerivatives%252Bas%252BRaf%252Band%252BHistone%252BDeacetylases%252BDual%252BInhibitors%26aulast%3DChen%26aufirst%3DXin%26date%3D2019%26volume%3D67%26issue%3D10%26spage%3D1116%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baolei  Wang</span>, <span class="hlFld-ContribAuthor ">Xuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Jianjun  Gao</span>, <span class="hlFld-ContribAuthor ">Li  Su</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Xu</span>, <span class="hlFld-ContribAuthor ">Yepeng  Luan</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2638-2645. <a href="https://doi.org/10.1016/j.bmcl.2019.07.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnti-tumor%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Btubulin%252Band%252BHDAC%252Bdual-targeting%252Binhibitors%26aulast%3DWang%26aufirst%3DBaolei%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2638%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for Hydroxamic Acid Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 978-993. <a href="https://doi.org/10.2174/1385272823666190424142821" title="DOI URL">https://doi.org/10.2174/1385272823666190424142821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190424142821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190424142821%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DMethods%252Bfor%252BHydroxamic%252BAcid%252BSynthesis%26aulast%3DAlam%26aufirst%3DMohammad%2BA.%26date%3D2019%26volume%3D23%26issue%3D9%26spage%3D978%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harbinder  Singh</span>, <span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-Targeting Anticancer Agents: Rational Approaches, Synthetic Routes and Structure Activity Relationship. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 842-874. <a href="https://doi.org/10.2174/1871520619666190118120708" title="DOI URL">https://doi.org/10.2174/1871520619666190118120708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190118120708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190118120708%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DMulti-Targeting%252BAnticancer%252BAgents%25253A%252BRational%252BApproaches%25252C%252BSynthetic%252BRoutes%252Band%252BStructure%252BActivity%252BRelationship%26aulast%3DSingh%26aufirst%3DHarbinder%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D842%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Shangxian  Luan</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Zhixiang  Yuan</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 129-168. <a href="https://doi.org/10.1016/j.ejmech.2019.03.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bof%252Btopoisomerase%252Binhibitors%252Bas%252Banticancer%252Bagents%252Bin%252Bthe%252Bpast%252Bdecade%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2019%26volume%3D171%26spage%3D129%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suvankar  Banerjee</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Sk Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 214-240. <a href="https://doi.org/10.1016/j.ejmech.2018.12.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHistone%252Bdeacetylase%252B8%252B%252528HDAC8%252529%252Band%252Bits%252Binhibitors%252Bwith%252Bselectivity%252Bto%252Bother%252Bisoforms%25253A%252BAn%252Boverview%26aulast%3DBanerjee%26aufirst%3DSuvankar%26date%3D2019%26volume%3D164%26spage%3D214%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rekha  Sangwan</span>, <span class="hlFld-ContribAuthor ">Remya  Rajan</span>, <span class="hlFld-ContribAuthor ">Pintu Kumar  Mandal</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 620-706. <a href="https://doi.org/10.1016/j.ejmech.2018.08.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHDAC%252Bas%252Bonco%252Btarget%25253A%252BReviewing%252Bthe%252Bsynthetic%252Bapproaches%252Bwith%252BSAR%252Bstudy%252Bof%252Btheir%252Binhibitors%26aulast%3DSangwan%26aufirst%3DRekha%26date%3D2018%26volume%3D158%26spage%3D620%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Xumeng  Yu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Shen</span>, <span class="hlFld-ContribAuthor ">Qiumeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">A series of camptothecin prodrugs exhibit HDAC inhibition activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (16)
                                     , 4706-4715. <a href="https://doi.org/10.1016/j.bmc.2018.08.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.08.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.08.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bseries%252Bof%252Bcamptothecin%252Bprodrugs%252Bexhibit%252BHDAC%252Binhibition%252Bactivity%26aulast%3DZhu%26aufirst%3DQiwen%26date%3D2018%26volume%3D26%26issue%3D16%26spage%3D4706%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiwei  Chen</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Wenlu  Li</span>, <span class="hlFld-ContribAuthor ">Jingxian  Yin</span>, <span class="hlFld-ContribAuthor ">Yueying  Zhang</span>, <span class="hlFld-ContribAuthor ">Zigao  Yuan</span>, <span class="hlFld-ContribAuthor ">Chunmei  Gao</span>, <span class="hlFld-ContribAuthor ">Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (14)
                                     , 3958-3966. <a href="https://doi.org/10.1016/j.bmc.2018.06.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bacridine%252Bhydroxamic%252Bacid%252Bderivatives%252Bas%252Bdual%252BTopo%252Band%252BHDAC%252Binhibitors%26aulast%3DChen%26aufirst%3DJiwei%26date%3D2018%26volume%3D26%26issue%3D14%26spage%3D3958%26epage%3D3966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Smith</span>, <span class="hlFld-ContribAuthor ">Mercy  Pawar</span>, <span class="hlFld-ContribAuthor ">Marcian E.  Van Dort</span>, <span class="hlFld-ContribAuthor ">Stefanie  Galbán</span>, <span class="hlFld-ContribAuthor ">Amanda R.  Welton</span>, <span class="hlFld-ContribAuthor ">Greg M.  Thurber</span>, <span class="hlFld-ContribAuthor ">Brian D.  Ross</span>, <span class="hlFld-ContribAuthor ">Cagri G.  Besirli</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ocular Pharmacology and Therapeutics</span><span> <strong>2018,</strong> <em>34 </em>
                                    (6)
                                     , 477-485. <a href="https://doi.org/10.1089/jop.2017.0126" title="DOI URL">https://doi.org/10.1089/jop.2017.0126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/jop.2017.0126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fjop.2017.0126%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ocular%2520Pharmacology%2520and%2520Therapeutics%26atitle%3DOcular%252BToxicity%252BProfile%252Bof%252BST-162%252Band%252BST-168%252Bas%252BNovel%252BBifunctional%252BMEK%25252FPI3K%252BInhibitors%26aulast%3DSmith%26aufirst%3DAndrew%26date%3D2018%26volume%3D34%26issue%3D6%26spage%3D477%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chin Soon  Chee</span>, <span class="hlFld-ContribAuthor ">Danny  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Epigenetic Modifiers for Cancer Treatments. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmacology Reports</span><span> <strong>2018,</strong> <em>4 </em>
                                    (3)
                                     , 193-201. <a href="https://doi.org/10.1007/s40495-018-0130-9" title="DOI URL">https://doi.org/10.1007/s40495-018-0130-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40495-018-0130-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40495-018-0130-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmacology%2520Reports%26atitle%3DTargeting%252BEpigenetic%252BModifiers%252Bfor%252BCancer%252BTreatments%26aulast%3DChee%26aufirst%3DChin%2BSoon%26date%3D2018%26date%3D2018%26volume%3D4%26issue%3D3%26spage%3D193%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mitsuaki  Yamashita</span>, <span class="hlFld-ContribAuthor ">Teruyuki  Tahara</span>, <span class="hlFld-ContribAuthor ">Shinya  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Hironobu  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Shun-ichi  Wada</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Tomioka</span>, <span class="hlFld-ContribAuthor ">Akira  Iida</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1920-1928. <a href="https://doi.org/10.1016/j.bmc.2018.02.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bhistone%252Bdeacetylase%252Band%252BDNA%252Btopoisomerase%252BII-Targeted%252Binhibitors%26aulast%3DYamashita%26aufirst%3DMitsuaki%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1920%26epage%3D1928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ritu  Ojha</span>, <span class="hlFld-ContribAuthor ">Han-Li  Huang</span>, <span class="hlFld-ContribAuthor ">Wei-Chun  HuangFu</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Chih-Jou  Su</span>, <span class="hlFld-ContribAuthor ">Ting-Yi  Sung</span>, <span class="hlFld-ContribAuthor ">Yi-Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 667-677. <a href="https://doi.org/10.1016/j.ejmech.2018.03.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1-Aroylindoline-hydroxamic%252Bacids%252Bas%252Banticancer%252Bagents%25252C%252Binhibitors%252Bof%252BHSP90%252Band%252BHDAC%26aulast%3DOjha%26aufirst%3DRitu%26date%3D2018%26volume%3D150%26spage%3D667%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Hsueh-Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Tsui-Chin  Huang</span>, <span class="hlFld-ContribAuthor ">Tony E.  Lin</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Ting-Yi  Sung</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>, <span class="hlFld-ContribAuthor ">Wendy W.  Hwang-Verslues</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Wei-Chun  HuangFu</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00205" title="DOI URL">https://doi.org/10.3389/fphar.2018.00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00205%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BNovel%252BDual%252BHDAC6%252Band%252BTubulin%252BInhibitor%25252C%252BMPT0B451%25252C%252BDisplays%252BAnti-tumor%252BAbility%252Bin%252BHuman%252BCancer%252BCells%252Bin%252BVitro%252Band%252Bin%252BVivo%26aulast%3DWu%26aufirst%3DYi-Wen%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Hydroxamates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 435-480. <a href="https://doi.org/10.1002/9781118686263.ch12" title="DOI URL">https://doi.org/10.1002/9781118686263.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DHydroxamates%26date%3D2018%26date%3D2018%26spage%3D435%26epage%3D480%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nulgumnalli Manjunathaiah  Raghavendra</span>, <span class="hlFld-ContribAuthor ">Divya  Pingili</span>, <span class="hlFld-ContribAuthor ">Sundeep  Kadasi</span>, <span class="hlFld-ContribAuthor ">Akhila  Mettu</span>, <span class="hlFld-ContribAuthor ">S.V.U.M.  Prasad</span>. </span><span class="cited-content_cbyCitation_article-title">Dual or multi-targeting inhibitors: The next generation anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1277-1300. <a href="https://doi.org/10.1016/j.ejmech.2017.10.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bor%252Bmulti-targeting%252Binhibitors%25253A%252BThe%252Bnext%252Bgeneration%252Banticancer%252Bagents%26aulast%3DRaghavendra%26aufirst%3DNulgumnalli%2BManjunathaiah%26date%3D2018%26volume%3D143%26spage%3D1277%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 449-463. <a href="https://doi.org/10.1016/j.ejmech.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bpolypharmacology%252Bfor%252Bimproving%252Btherapeutic%252Boutcome%252Bof%252Bkinase%252Binhibitors%252B%252528KIs%252529%25253A%252BAn%252Bupdate%252Bof%252Brecent%252Bmedicinal%252Bchemistry%252Befforts%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D143%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoye  Jiang</span>, <span class="hlFld-ContribAuthor ">Shiyou  Sun</span>, <span class="hlFld-ContribAuthor ">Yongqiong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel quinolone derivatives dual targeting histone deacetylase and tubulin polymerization as antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (30)
                                     , 16494-16502. <a href="https://doi.org/10.1039/C8RA02578A" title="DOI URL">https://doi.org/10.1039/C8RA02578A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02578A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02578A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bquinolone%252Bderivatives%252Bdual%252Btargeting%252Bhistone%252Bdeacetylase%252Band%252Btubulin%252Bpolymerization%252Bas%252Bantiproliferative%252Bagents%26aulast%3DWang%26aufirst%3DXuan%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D30%26spage%3D16494%26epage%3D16502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sk Abdul  Amin</span>, <span class="hlFld-ContribAuthor ">Nilanjan  Adhikari</span>, <span class="hlFld-ContribAuthor ">Tarun  Jha</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (18)
                                     , 2211-2237. <a href="https://doi.org/10.4155/fmc-2017-0130" title="DOI URL">https://doi.org/10.4155/fmc-2017-0130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0130%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bhydroxamate-based%252Bhistone%252Bdeacetylase-8%252Binhibitors%25253A%252Breality%252Bbehind%252Banticancer%252Bdrug%252Bdiscovery%26aulast%3DAmin%26aufirst%3DSk%2BAbdul%26date%3D2017%26volume%3D9%26issue%3D18%26spage%3D2211%26epage%3D2237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Chun  HuangFu</span>, <span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Chun-Chun  Cheng</span>, <span class="hlFld-ContribAuthor ">Yu-Chieh  Wei</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>, <span class="hlFld-ContribAuthor ">George  Hsiao</span>, <span class="hlFld-ContribAuthor ">Yu-Ching  Lee</span>, <span class="hlFld-ContribAuthor ">Chia-Ron  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep42291" title="DOI URL">https://doi.org/10.1038/srep42291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep42291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep42291%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAnti-leukemia%252Beffects%252Bof%252Bthe%252Bnovel%252Bsynthetic%252B1-benzylindole%252Bderivative%252B21-900%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DHuangFu%26aufirst%3DWei-Chun%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-geng  Fu</span>, <span class="hlFld-ContribAuthor ">Yuan  Sun</span>, <span class="hlFld-ContribAuthor ">Wen-bing  Sheng</span>, <span class="hlFld-ContribAuthor ">Duan-fang  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 195-211. <a href="https://doi.org/10.1016/j.ejmech.2017.05.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252Bmulti-targeted%252Bagents%25253A%252BAn%252Bemerging%252Banticancer%252Bdrug%252Bdiscovery%252Bparadigm%26aulast%3DFu%26aufirst%3DRong-geng%26date%3D2017%26volume%3D136%26spage%3D195%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingliu  Lu</span>, <span class="hlFld-ContribAuthor ">Jianqi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4-piperazinyl-containing Chidamide derivatives as HDACs inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3162-3166. <a href="https://doi.org/10.1016/j.bmcl.2017.05.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-piperazinyl-containing%252BChidamide%252Bderivatives%252Bas%252BHDACs%252Binhibitors%26aulast%3DZhang%26aufirst%3DQingwei%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3162%26epage%3D3166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Millard</span>, <span class="hlFld-ContribAuthor ">Peter J.  Watson</span>, <span class="hlFld-ContribAuthor ">Louise  Fairall</span>, <span class="hlFld-ContribAuthor ">John W.R.  Schwabe</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Class I Histone Deacetylases in a “Complex” Environment. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2017,</strong> <em>38 </em>
                                    (4)
                                     , 363-377. <a href="https://doi.org/10.1016/j.tips.2016.12.006" title="DOI URL">https://doi.org/10.1016/j.tips.2016.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2016.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2016.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTargeting%252BClass%252BI%252BHistone%252BDeacetylases%252Bin%252Ba%252B%2525E2%252580%25259CComplex%2525E2%252580%25259D%252BEnvironment%26aulast%3DMillard%26aufirst%3DChristopher%2BJ.%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D363%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Idris  Raji</span>, <span class="hlFld-ContribAuthor ">Fatima  Yadudu</span>, <span class="hlFld-ContribAuthor ">Emily  Janeira</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Fathi</span>, <span class="hlFld-ContribAuthor ">Lindsey  Szymczak</span>, <span class="hlFld-ContribAuthor ">James Richard  Kornacki</span>, <span class="hlFld-ContribAuthor ">Kensei  Komatsu</span>, <span class="hlFld-ContribAuthor ">Jian-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Milan  Mrksich</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 1202-1218. <a href="https://doi.org/10.1016/j.bmc.2016.12.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBifunctional%252Bconjugates%252Bwith%252Bpotent%252Binhibitory%252Bactivity%252Btowards%252Bcyclooxygenase%252Band%252Bhistone%252Bdeacetylase%26aulast%3DRaji%26aufirst%3DIdris%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D1202%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir A.  D'yakonov</span>, <span class="hlFld-ContribAuthor ">Lilya U.  Dzhemileva</span>, <span class="hlFld-ContribAuthor ">Usein M.  Dzhemilev</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of Natural and Semisynthetic Topoisomerase I/II Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 21-86. <a href="https://doi.org/10.1016/B978-0-444-63929-5.00002-4" title="DOI URL">https://doi.org/10.1016/B978-0-444-63929-5.00002-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63929-5.00002-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63929-5.00002-4%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252BNatural%252Band%252BSemisynthetic%252BTopoisomerase%252BI%25252FII%252BInhibitors%26aulast%3DD%2527yakonov%26aufirst%3DVladimir%2BA.%26date%3D2017%26spage%3D21%26epage%3D86%26pub%3DElsevier%26date%3D2017%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Ding</span>, <span class="hlFld-ContribAuthor ">Shaopeng  Chen</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangnan  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lulu  Li</span>, <span class="hlFld-ContribAuthor ">Yu Zong  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 27-37. <a href="https://doi.org/10.1016/j.bmc.2016.10.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Binvestigation%252Bof%252Bnovel%252B6-%2525281%25252C2%25252C3-triazol-4-yl%252529-4-aminoquinazolin%252Bderivatives%252Bpossessing%252Bhydroxamic%252Bacid%252Bmoiety%252Bfor%252Bcancer%252Btherapy%26aulast%3DDing%26aufirst%3DChao%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D27%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hsueh-Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Jiann-Fong  Lee</span>, <span class="hlFld-ContribAuthor ">Sunil  Kumar</span>, <span class="hlFld-ContribAuthor ">Yi-Wen  Wu</span>, <span class="hlFld-ContribAuthor ">Wei-Chun  HuangFu</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Yu-Hsuan  Li</span>, <span class="hlFld-ContribAuthor ">Hsiang-Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Fei-Chiao  Kuo</span>, <span class="hlFld-ContribAuthor ">Che-Jen  Hsiao</span>, <span class="hlFld-ContribAuthor ">Chun-Chun  Cheng</span>, <span class="hlFld-ContribAuthor ">Chia-Ron  Yang</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 1268-1278. <a href="https://doi.org/10.1016/j.ejmech.2016.11.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-Aroylindoles%252Bdisplay%252Bantitumor%252Bactivity%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%25253A%252BEffects%252Bof%252BN1-substituents%252Bon%252Bbiological%252Bactivity%26aulast%3DLee%26aufirst%3DHsueh-Yun%26date%3D2017%26volume%3D125%26spage%3D1268%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikrant  Abbot</span>, <span class="hlFld-ContribAuthor ">Poonam  Sharma</span>, <span class="hlFld-ContribAuthor ">Saurabh  Dhiman</span>, <span class="hlFld-ContribAuthor ">Malleshappa N.  Noolvi</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Varun  Bhardwaj</span>. </span><span class="cited-content_cbyCitation_article-title">Small hybrid heteroaromatics: resourceful biological tools in cancer research. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (45)
                                     , 28313-28349. <a href="https://doi.org/10.1039/C6RA24662A" title="DOI URL">https://doi.org/10.1039/C6RA24662A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA24662A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA24662A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSmall%252Bhybrid%252Bheteroaromatics%25253A%252Bresourceful%252Bbiological%252Btools%252Bin%252Bcancer%252Bresearch%26aulast%3DAbbot%26aufirst%3DVikrant%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D45%26spage%3D28313%26epage%3D28349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angel R.  de Lera</span>, <span class="hlFld-ContribAuthor ">A.  Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic polypharmacology: from combination therapy to multitargeted drugs. </span><span class="cited-content_cbyCitation_journal-name">Clinical Epigenetics</span><span> <strong>2016,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13148-016-0271-9" title="DOI URL">https://doi.org/10.1186/s13148-016-0271-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13148-016-0271-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13148-016-0271-9%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Epigenetics%26atitle%3DEpigenetic%252Bpolypharmacology%25253A%252Bfrom%252Bcombination%252Btherapy%252Bto%252Bmultitargeted%252Bdrugs%26aulast%3Dde%2BLera%26aufirst%3DAngel%2BR.%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malihe  Hassanzadeh</span>, <span class="hlFld-ContribAuthor ">Kowsar  Bagherzadeh</span>, <span class="hlFld-ContribAuthor ">Massoud  Amanlou</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>70 </em>, 170-180. <a href="https://doi.org/10.1016/j.jmgm.2016.10.007" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DA%252Bcomparative%252Bstudy%252Bbased%252Bon%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%252Bover%252BHDAC-tubulin%252Bdual%252Binhibitors%26aulast%3DHassanzadeh%26aufirst%3DMalihe%26date%3D2016%26volume%3D70%26spage%3D170%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joëlle  Roche</span>, <span class="hlFld-ContribAuthor ">Philippe  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Inside HDACs with more selective HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>121 </em>, 451-483. <a href="https://doi.org/10.1016/j.ejmech.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInside%252BHDACs%252Bwith%252Bmore%252Bselective%252BHDAC%252Binhibitors%26aulast%3DRoche%26aufirst%3DJo%25C3%25ABlle%26date%3D2016%26volume%3D121%26spage%3D451%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmei  Sun</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Zhao</span>, <span class="hlFld-ContribAuthor ">Lifeng  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(II) polypyridyl complexes with 1,8-naphthalimide group as DNA binder, photonuclease, and dual inhibitors of topoisomerases I and IIα. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2016,</strong> <em>163 </em>, 88-94. <a href="https://doi.org/10.1016/j.jinorgbio.2016.04.028" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2016.04.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2016.04.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2016.04.028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DRuthenium%252528II%252529%252Bpolypyridyl%252Bcomplexes%252Bwith%252B1%25252C8-naphthalimide%252Bgroup%252Bas%252BDNA%252Bbinder%25252C%252Bphotonuclease%25252C%252Band%252Bdual%252Binhibitors%252Bof%252Btopoisomerases%252BI%252Band%252BII%2525CE%2525B1%26aulast%3DSun%26aufirst%3DYanmei%26date%3D2016%26volume%3D163%26spage%3D88%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changhao  Li</span>, <span class="hlFld-ContribAuthor ">Chu  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Chenxi  Zhao</span>, <span class="hlFld-ContribAuthor ">Chenlu  Li</span>, <span class="hlFld-ContribAuthor ">Silong  Zhang</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (13)
                                     , 3062-3074. <a href="https://doi.org/10.1016/j.bmc.2016.05.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnovel%252Bhybrid%252Bferrocenyl%252Bcompounds%252Bbased%252Bon%252Ba%252Bbicyclic%252Bcore%252Bskeleton%252Bfor%252Bbreast%252Bcancer%252Btherapy%26aulast%3DLi%26aufirst%3DChanghao%26date%3D2016%26volume%3D24%26issue%3D13%26spage%3D3062%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Ganesan</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Drugs: an Epigenetic Epiphany. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1227-1241. <a href="https://doi.org/10.1002/cmdc.201500394" title="DOI URL">https://doi.org/10.1002/cmdc.201500394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500394%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMultitarget%252BDrugs%25253A%252Ban%252BEpigenetic%252BEpiphany%26aulast%3DGanesan%26aufirst%3DA.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D12%26spage%3D1227%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabete P.  Carreiro</span>, <span class="hlFld-ContribAuthor ">Ana R.  Costa</span>, <span class="hlFld-ContribAuthor ">Maria M.  Cordeiro</span>, <span class="hlFld-ContribAuthor ">Rute  Martins</span>, <span class="hlFld-ContribAuthor ">Tiago O.  Pires</span>, <span class="hlFld-ContribAuthor ">Mafalda  Saraiva</span>, <span class="hlFld-ContribAuthor ">Célia M.  Antunes</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Novel hydroxyamides and amides containing d -glucopyranose or d -fructose units: Biological assays in MCF-7 and MDST8 cell lines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 1039-1043. <a href="https://doi.org/10.1016/j.bmcl.2015.12.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bhydroxyamides%252Band%252Bamides%252Bcontaining%252Bd%252B-glucopyranose%252Bor%252Bd%252B-fructose%252Bunits%25253A%252BBiological%252Bassays%252Bin%252BMCF-7%252Band%252BMDST8%252Bcell%252Blines%26aulast%3DCarreiro%26aufirst%3DElisabete%2BP.%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D1039%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Semira  Sheikh</span>, <span class="hlFld-ContribAuthor ">Mina  Bekheet</span>, <span class="hlFld-ContribAuthor ">Heidi  Olzscha</span>, <span class="hlFld-ContribAuthor ">Nicholas B.  La Thangue</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting and Monitoring Responses to Epigenetic Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 373-406. <a href="https://doi.org/10.1016/B978-0-12-802208-5.00015-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-802208-5.00015-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802208-5.00015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802208-5.00015-1%26sid%3Dliteratum%253Aachs%26atitle%3DPredicting%252Band%252BMonitoring%252BResponses%252Bto%252BEpigenetic%252BDrugs%26aulast%3DSheikh%26aufirst%3DSemira%26date%3D2016%26spage%3D373%26epage%3D406%26pub%3DElsevier%26atitle%3DDrug%252BDiscovery%252Bin%252BCancer%252BEpigenetics%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Purwin</span>, <span class="hlFld-ContribAuthor ">J.  Hernández-Toribio</span>, <span class="hlFld-ContribAuthor ">C.  Coderch</span>, <span class="hlFld-ContribAuthor ">R.  Panchuk</span>, <span class="hlFld-ContribAuthor ">N.  Skorokhyd</span>, <span class="hlFld-ContribAuthor ">K.  Filipiak</span>, <span class="hlFld-ContribAuthor ">B.  de Pascual-Teresa</span>, <span class="hlFld-ContribAuthor ">A.  Ramos</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel dual-target agents for HDAC1 and CK2 inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (71)
                                     , 66595-66608. <a href="https://doi.org/10.1039/C6RA09717K" title="DOI URL">https://doi.org/10.1039/C6RA09717K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA09717K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA09717K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bdual-target%252Bagents%252Bfor%252BHDAC1%252Band%252BCK2%252Binhibition%26aulast%3DPurwin%26aufirst%3DM.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D71%26spage%3D66595%26epage%3D66608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yichao  Wu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2-amino-N-(2-aminophenyl)thiazole-5-carboxamide derivatives as novel Bcr-Abl and histone deacetylase dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (105)
                                     , 103178-103184. <a href="https://doi.org/10.1039/C6RA21271A" title="DOI URL">https://doi.org/10.1039/C6RA21271A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA21271A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA21271A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-amino-N-%2525282-aminophenyl%252529thiazole-5-carboxamide%252Bderivatives%252Bas%252Bnovel%252BBcr-Abl%252Band%252Bhistone%252Bdeacetylase%252Bdual%252Binhibitors%26aulast%3DChen%26aufirst%3DXin%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D105%26spage%3D103178%26epage%3D103184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhu</span>, <span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Niu</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhao</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Weifang  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of 1-(2-Aminophenyl)-3-arylurea Derivatives as Potential EphA2 and HDAC Dual Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2016,</strong> <em>64 </em>
                                    (8)
                                     , 1136-1141. <a href="https://doi.org/10.1248/cpb.c16-00154" title="DOI URL">https://doi.org/10.1248/cpb.c16-00154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00154%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B1-%2525282-Aminophenyl%252529-3-arylurea%252BDerivatives%252Bas%252BPotential%252BEphA2%252Band%252BHDAC%252BDual%252BInhibitors%26aulast%3DZhu%26aufirst%3DYong%26date%3D2016%26volume%3D64%26issue%3D8%26spage%3D1136%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Mendoza-Sanchez</span>, <span class="hlFld-ContribAuthor ">David  Cotnoir-White</span>, <span class="hlFld-ContribAuthor ">Justyna  Kulpa</span>, <span class="hlFld-ContribAuthor ">Isabel  Jutras</span>, <span class="hlFld-ContribAuthor ">Joshua  Pottel</span>, <span class="hlFld-ContribAuthor ">Nicolas  Moitessier</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mader</span>, <span class="hlFld-ContribAuthor ">James L.  Gleason</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (24)
                                     , 7597-7606. <a href="https://doi.org/10.1016/j.bmc.2015.11.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bantiestrogen%252Band%252Bhistone%252Bdeacetylase%252Binhibitor%252Bmolecular%252Bhybrids%26aulast%3DMendoza-Sanchez%26aufirst%3DRodrigo%26date%3D2015%26volume%3D23%26issue%3D24%26spage%3D7597%26epage%3D7606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Franco  Zunino</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives in the development of hybrid bifunctional antitumour agents. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>96 </em>
                                    (4)
                                     , 297-305. <a href="https://doi.org/10.1016/j.bcp.2015.06.006" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DPerspectives%252Bin%252Bthe%252Bdevelopment%252Bof%252Bhybrid%252Bbifunctional%252Bantitumour%252Bagents%26aulast%3DMusso%26aufirst%3DLoana%26date%3D2015%26volume%3D96%26issue%3D4%26spage%3D297%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Ho  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibitors Against Topoisomerases and Histone Deacetylases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Prevention</span><span> <strong>2015,</strong> <em>20 </em>
                                    (2)
                                     , 85-91. <a href="https://doi.org/10.15430/JCP.2015.20.2.85" title="DOI URL">https://doi.org/10.15430/JCP.2015.20.2.85</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15430/JCP.2015.20.2.85&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15430%2FJCP.2015.20.2.85%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Prevention%26atitle%3DDual%252BInhibitors%252BAgainst%252BTopoisomerases%252Band%252BHistone%252BDeacetylases%26aulast%3DSeo%26aufirst%3DYoung%2BHo%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D85%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clemens  Zwergel</span>, <span class="hlFld-ContribAuthor ">Sergio  Valente</span>, <span class="hlFld-ContribAuthor ">Claus  Jacob</span>, <span class="hlFld-ContribAuthor ">Antonello  Mai</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging approaches for histone deacetylase inhibitor drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , 599-613. <a href="https://doi.org/10.1517/17460441.2015.1038236" title="DOI URL">https://doi.org/10.1517/17460441.2015.1038236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1038236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1038236%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DEmerging%252Bapproaches%252Bfor%252Bhistone%252Bdeacetylase%252Binhibitor%252Bdrug%252Bdiscovery%26aulast%3DZwergel%26aufirst%3DClemens%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D6%26spage%3D599%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Carlisi</span>, <span class="hlFld-ContribAuthor ">Marianna  Lauricella</span>, <span class="hlFld-ContribAuthor ">Antonella  D'Anneo</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Buttitta</span>, <span class="hlFld-ContribAuthor ">Sonia  Emanuele</span>, <span class="hlFld-ContribAuthor ">Riccardo  di Fiore</span>, <span class="hlFld-ContribAuthor ">Roberta  Martinez</span>, <span class="hlFld-ContribAuthor ">Christian  Rolfo</span>, <span class="hlFld-ContribAuthor ">Renza  Vento</span>, <span class="hlFld-ContribAuthor ">Giovanni  Tesoriere</span>. </span><span class="cited-content_cbyCitation_article-title">The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2015,</strong> <em>230 </em>
                                    (6)
                                     , 1276-1289. <a href="https://doi.org/10.1002/jcp.24863" title="DOI URL">https://doi.org/10.1002/jcp.24863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.24863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.24863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DThe%252BSynergistic%252BEffect%252Bof%252BSAHA%252Band%252BParthenolide%252Bin%252BMDA-MB231%252BBreast%252BCancer%252BCells%26aulast%3DCarlisi%26aufirst%3DDaniela%26date%3D2015%26date%3D2015%26volume%3D230%26issue%3D6%26spage%3D1276%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hardik G.  Bhatt</span>, <span class="hlFld-ContribAuthor ">Yadvendra K.  Agrawal</span>, <span class="hlFld-ContribAuthor ">Manish J.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Amino- and fluoro-substituted quinoline-4-carboxylic acid derivatives: MWI synthesis, cytotoxic activity, apoptotic DNA fragmentation and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (4)
                                     , 1662-1671. <a href="https://doi.org/10.1007/s00044-014-1248-x" title="DOI URL">https://doi.org/10.1007/s00044-014-1248-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1248-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1248-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DAmino-%252Band%252Bfluoro-substituted%252Bquinoline-4-carboxylic%252Bacid%252Bderivatives%25253A%252BMWI%252Bsynthesis%25252C%252Bcytotoxic%252Bactivity%25252C%252Bapoptotic%252BDNA%252Bfragmentation%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DBhatt%26aufirst%3DHardik%2BG.%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D1662%26epage%3D1671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcian E.  Van Dort</span>, <span class="hlFld-ContribAuthor ">Stefanie  Galbán</span>, <span class="hlFld-ContribAuthor ">Hanxiao  Wang</span>, <span class="hlFld-ContribAuthor ">Judith  Sebolt-Leopold</span>, <span class="hlFld-ContribAuthor ">Christopher  Whitehead</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Alnawaz  Rehemtulla</span>, <span class="hlFld-ContribAuthor ">Brian D.  Ross</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (7)
                                     , 1386-1394. <a href="https://doi.org/10.1016/j.bmc.2015.02.053" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.02.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.02.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDual%252Binhibition%252Bof%252Ballosteric%252Bmitogen-activated%252Bprotein%252Bkinase%252B%252528MEK%252529%252Band%252Bphosphatidylinositol%252B3-kinase%252B%252528PI3K%252529%252Boncogenic%252Btargets%252Bwith%252Ba%252Bbifunctional%252Binhibitor%26aulast%3DVan%2BDort%26aufirst%3DMarcian%2BE.%26date%3D2015%26volume%3D23%26issue%3D7%26spage%3D1386%26epage%3D1394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramineni  Venkatesh</span>, <span class="hlFld-ContribAuthor ">M. Janaki  Ramaiah</span>, <span class="hlFld-ContribAuthor ">Hanmant K.  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Sridhara  Janardhan</span>, <span class="hlFld-ContribAuthor ">Rajashaker  Bantu</span>, <span class="hlFld-ContribAuthor ">Lingaiah  Nagarapu</span>, <span class="hlFld-ContribAuthor ">G. Narahari  Sastry</span>, <span class="hlFld-ContribAuthor ">A. Raksha  Ganesh</span>, <span class="hlFld-ContribAuthor ">Manikapal  Bhadra</span>. </span><span class="cited-content_cbyCitation_article-title">Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 87-101. <a href="https://doi.org/10.1016/j.ejmech.2015.02.057" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.057%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLuotonin-A%252Bbased%252Bquinazolinones%252Bcause%252Bapoptosis%252Band%252Bsenescence%252Bvia%252BHDAC%252Binhibition%252Band%252Bactivation%252Bof%252Btumor%252Bsuppressor%252Bproteins%252Bin%252BHeLa%252Bcells%26aulast%3DVenkatesh%26aufirst%3DRamineni%26date%3D2015%26volume%3D94%26spage%3D87%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anil  Rana</span>, <span class="hlFld-ContribAuthor ">Jimi Marin  Alex</span>, <span class="hlFld-ContribAuthor ">Monika  Chauhan</span>, <span class="hlFld-ContribAuthor ">Gaurav  Joshi</span>, <span class="hlFld-ContribAuthor ">Raj  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A review on pharmacophoric designs of antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (3)
                                     , 903-920. <a href="https://doi.org/10.1007/s00044-014-1196-5" title="DOI URL">https://doi.org/10.1007/s00044-014-1196-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1196-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1196-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DA%252Breview%252Bon%252Bpharmacophoric%252Bdesigns%252Bof%252Bantiproliferative%252Bagents%26aulast%3DRana%26aufirst%3DAnil%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D903%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Namita  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Martin  Tenniswood</span>. </span><span class="cited-content_cbyCitation_article-title">The potential of histone deacetylase inhibitors in breast cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Management</span><span> <strong>2015,</strong> <em>4 </em>
                                    (2)
                                     , 85-97. <a href="https://doi.org/10.2217/bmt.14.56" title="DOI URL">https://doi.org/10.2217/bmt.14.56</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/bmt.14.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fbmt.14.56%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Management%26atitle%3DThe%252Bpotential%252Bof%252Bhistone%252Bdeacetylase%252Binhibitors%252Bin%252Bbreast%252Bcancer%252Btherapy%26aulast%3DChatterjee%26aufirst%3DNamita%26date%3D2015%26volume%3D4%26issue%3D2%26spage%3D85%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yantao  Han</span>, <span class="hlFld-ContribAuthor ">Qixiao  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunbo  Wang</span>, <span class="hlFld-ContribAuthor ">Xuehong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Li</span>, <span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Yuqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (1)
                                     , 63-84. <a href="https://doi.org/10.1002/med.21320" title="DOI URL">https://doi.org/10.1002/med.21320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21320%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTrend%252Bof%252BHistone%252BDeacetylase%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BIsoform%252BSelectivity%252Bor%252BMultitargeted%252BStrategy%26aulast%3DZhang%26aufirst%3DLei%26date%3D2015%26date%3D2014%26volume%3D35%26issue%3D1%26spage%3D63%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiren  Patel</span>, <span class="hlFld-ContribAuthor ">Irina  Chuckowree</span>, <span class="hlFld-ContribAuthor ">Peter  Coxhead</span>, <span class="hlFld-ContribAuthor ">Matthew  Guille</span>, <span class="hlFld-ContribAuthor ">Minghua  Wang</span>, <span class="hlFld-ContribAuthor ">Alexandra  Zuckermann</span>, <span class="hlFld-ContribAuthor ">Robin S. B.  Williams</span>, <span class="hlFld-ContribAuthor ">Mariangela  Librizzi</span>, <span class="hlFld-ContribAuthor ">Ronald M.  Paranal</span>, <span class="hlFld-ContribAuthor ">James E.  Bradner</span>, <span class="hlFld-ContribAuthor ">John  Spencer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (12)
                                     , 1829-1833. <a href="https://doi.org/10.1039/C4MD00211C" title="DOI URL">https://doi.org/10.1039/C4MD00211C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00211C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00211C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Bof%252Bhybrid%252Banticancer%252Bagents%252Bbased%252Bon%252Bkinase%252Band%252Bhistone%252Bdeacetylase%252Binhibitors%26aulast%3DPatel%26aufirst%3DHiren%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D12%26spage%3D1829%26epage%3D1833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katrina J.  Falkenberg</span>, <span class="hlFld-ContribAuthor ">Ricky W.  Johnstone</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (9)
                                     , 673-691. <a href="https://doi.org/10.1038/nrd4360" title="DOI URL">https://doi.org/10.1038/nrd4360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4360%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DHistone%252Bdeacetylases%252Band%252Btheir%252Binhibitors%252Bin%252Bcancer%25252C%252Bneurological%252Bdiseases%252Band%252Bimmune%252Bdisorders%26aulast%3DFalkenberg%26aufirst%3DKatrina%2BJ.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D9%26spage%3D673%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sartaj  Tabassum</span>, <span class="hlFld-ContribAuthor ">Mohd  Afzal</span>, <span class="hlFld-ContribAuthor ">Farukh  Arjmand</span>. </span><span class="cited-content_cbyCitation_article-title">New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII–SnIV complex as potential topoisomerase II inhibitor: In vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>74 </em>, 694-702. <a href="https://doi.org/10.1016/j.ejmech.2013.09.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.09.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.09.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.09.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bmodulated%252Bdesign%25252C%252Bdocking%252Band%252Bsynthesis%252Bof%252Bcarbohydrate-conjugate%252Bheterobimetallic%252BCuII%2525E2%252580%252593SnIV%252Bcomplex%252Bas%252Bpotential%252Btopoisomerase%252BII%252Binhibitor%25253A%252BIn%2525C2%2525A0vitro%252BDNA%252Bbinding%25252C%252Bcleavage%252Band%252Bcytotoxicity%252Bagainst%252Bhuman%252Bcancer%252Bcell%252Blines%26aulast%3DTabassum%26aufirst%3DSartaj%26date%3D2014%26volume%3D74%26spage%3D694%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Konstantinos A  Papavassiliou</span>, <span class="hlFld-ContribAuthor ">Athanasios G  Papavassiliou</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases inhibitors: conjugation to other anti-tumour pharmacophores provides novel tools for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (3)
                                     , 291-294. <a href="https://doi.org/10.1517/13543784.2014.857401" title="DOI URL">https://doi.org/10.1517/13543784.2014.857401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.857401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.857401%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DHistone%252Bdeacetylases%252Binhibitors%25253A%252Bconjugation%252Bto%252Bother%252Banti-tumour%252Bpharmacophores%252Bprovides%252Bnovel%252Btools%252Bfor%252Bcancer%252Btreatment%26aulast%3DPapavassiliou%26aufirst%3DKonstantinos%2BA%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D291%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiu  Tan</span>, <span class="hlFld-ContribAuthor ">Zhitao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Hui</span>, <span class="hlFld-ContribAuthor ">Yu  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (1)
                                     , 358-365. <a href="https://doi.org/10.1016/j.bmc.2013.11.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivities%252Bof%252Bthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bas%252Bnovel%252BHDAC%252Binhibitors%26aulast%3DTan%26aufirst%3DQiu%26date%3D2014%26volume%3D22%26issue%3D1%26spage%3D358%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Bao</span>, <span class="hlFld-ContribAuthor ">Xiuhua  Yu</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Qingqing  Huang</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Xiongwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (22)
                                     , 6981-6995. <a href="https://doi.org/10.1016/j.bmc.2013.09.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bdual%252Binhibitors%252Bof%252Btopoisomerase%252Bii%252Band%252Bhistone%252Bdeacetylase%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26volume%3D21%26issue%3D22%26spage%3D6981%26epage%3D6995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhu-Ping  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhi-Yun  Peng</span>, <span class="hlFld-ContribAuthor ">Jing-Jun  Dong</span>, <span class="hlFld-ContribAuthor ">Rui-Cheng  Deng</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Ouyang</span>, <span class="hlFld-ContribAuthor ">Pan  Yang</span>, <span class="hlFld-ContribAuthor ">Juan  He</span>, <span class="hlFld-ContribAuthor ">Yuan-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Man  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-Chun  Peng</span>, <span class="hlFld-ContribAuthor ">Wan-Xi  Peng</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>68 </em>, 212-221. <a href="https://doi.org/10.1016/j.ejmech.2013.07.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.07.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.07.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%252Band%252Bkinetic%252Bproperties%252Bof%252B%2525CE%2525B2-hydroxy-%2525CE%2525B2-phenylpropionyl-hydroxamic%252Bacids%252Bas%252BHelicobacter%252Bpylori%252Burease%252Binhibitors%26aulast%3DXiao%26aufirst%3DZhu-Ping%26date%3D2013%26volume%3D68%26spage%3D212%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Liang  Chen</span>, <span class="hlFld-ContribAuthor ">Li-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Kang  Chen</span>, <span class="hlFld-ContribAuthor ">Man  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhao-Zhu  Sun</span>, <span class="hlFld-ContribAuthor ">Shuang  Wang</span>, <span class="hlFld-ContribAuthor ">Hong-Li  Zheng</span>, <span class="hlFld-ContribAuthor ">Jing-Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Chun-Fu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a small molecular compound simultaneously targeting RXR and HADC: Design, synthesis, molecular docking and bioassay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (13)
                                     , 3891-3895. <a href="https://doi.org/10.1016/j.bmcl.2013.04.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bsmall%252Bmolecular%252Bcompound%252Bsimultaneously%252Btargeting%252BRXR%252Band%252BHADC%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bdocking%252Band%252Bbioassay%26aulast%3DChen%26aufirst%3DGuo-Liang%26date%3D2013%26volume%3D23%26issue%3D13%26spage%3D3891%26epage%3D3895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Yu  Luo</span>, <span class="hlFld-ContribAuthor ">Mingbo  Su</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of colchicine-SAHA hybrids as a new class of antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (11)
                                     , 3240-3244. <a href="https://doi.org/10.1016/j.bmc.2013.03.049" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bdiscovery%252Bof%252Bcolchicine-SAHA%252Bhybrids%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Bantitumor%252Bagents%26aulast%3DZhang%26aufirst%3DXuan%26date%3D2013%26volume%3D21%26issue%3D11%26spage%3D3240%26epage%3D3244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Guerrant</span>, <span class="hlFld-ContribAuthor ">Vishal  Patil</span>, <span class="hlFld-ContribAuthor ">Joshua C.  Canzoneri</span>, <span class="hlFld-ContribAuthor ">Li-Pan  Yao</span>, <span class="hlFld-ContribAuthor ">Rebecca  Hood</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-acting histone deacetylase-topoisomerase I inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3283-3287. <a href="https://doi.org/10.1016/j.bmcl.2013.03.108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDual-acting%252Bhistone%252Bdeacetylase-topoisomerase%252BI%252Binhibitors%26aulast%3DGuerrant%26aufirst%3DWilliam%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3283%26epage%3D3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinquan  Wang</span>, <span class="hlFld-ContribAuthor ">Huaiyi  Huang</span>, <span class="hlFld-ContribAuthor ">Liping  Qiao</span>, <span class="hlFld-ContribAuthor ">Liangnian  Ji</span>, <span class="hlFld-ContribAuthor ">Hui  Chao</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral ruthenium(ii) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2013,</strong> <em>42 </em>
                                    (24)
                                     , 8907. <a href="https://doi.org/10.1039/c3dt50472g" title="DOI URL">https://doi.org/10.1039/c3dt50472g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3dt50472g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3dt50472g%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DChiral%252Bruthenium%252528ii%252529%252Bcomplexes%252Bwith%252Bphenolic%252Bhydroxyl%252Bgroups%252Bas%252Bdual%252Bpoisons%252Bof%252Btopoisomerases%252BI%252Band%252BII%2525CE%2525B1%26aulast%3DZhang%26aufirst%3DPingyu%26date%3D2013%26volume%3D42%26issue%3D24%26spage%3D8907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geneviève P  Delcuve</span>, <span class="hlFld-ContribAuthor ">Dilshad H  Khan</span>, <span class="hlFld-ContribAuthor ">James R  Davie</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting class I histone deacetylases in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2013,</strong> <em>17 </em>
                                    (1)
                                     , 29-41. <a href="https://doi.org/10.1517/14728222.2013.729042" title="DOI URL">https://doi.org/10.1517/14728222.2013.729042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2013.729042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2013.729042%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bclass%252BI%252Bhistone%252Bdeacetylases%252Bin%252Bcancer%252Btherapy%26aulast%3DDelcuve%26aufirst%3DGenevi%25C3%25A8ve%2BP%26date%3D2013%26date%3D2012%26volume%3D17%26issue%3D1%26spage%3D29%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  New</span>, <span class="hlFld-ContribAuthor ">Heidi  Olzscha</span>, <span class="hlFld-ContribAuthor ">Nicholas B.  La Thangue</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC inhibitor-based therapies: Can we interpret the code?. </span><span class="cited-content_cbyCitation_journal-name">Molecular Oncology</span><span> <strong>2012,</strong> <em>6 </em>
                                    (6)
                                     , 637-656. <a href="https://doi.org/10.1016/j.molonc.2012.09.003" title="DOI URL">https://doi.org/10.1016/j.molonc.2012.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molonc.2012.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molonc.2012.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Oncology%26atitle%3DHDAC%252Binhibitor-based%252Btherapies%25253A%252BCan%252Bwe%252Binterpret%252Bthe%252Bcode%25253F%26aulast%3DNew%26aufirst%3DMaria%26date%3D2012%26date%3D2012%26volume%3D6%26issue%3D6%26spage%3D637%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of anthracycline antibiotics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of dual-acting Topo II–HDAC inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the SAHA-Based Dual-Acting Topo II–HDAC Inhibitor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the SAHA-Like, Triazole-Based Topo II–HDACi</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docked structure of Topo II–HDACi conjugates at HDAC 1 active site. (a) Superposition of low energy conformations of <b>12a</b> (teal) and <b>12c</b> (pink). (b) Overlay of low energy conformations of <b>12c</b> (pink) and <b>7</b> (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Topoisomerase II decatenation assay. Lanes 1–3: (1) KDNA, (2) decatenated KDNA marker, (3) KDNA and Topo II. Lanes 4–9: KDNA, Topo II, and 50 μM (4) DAU, (5) <b>12c</b>, (6) <b>12b</b>, (7) <b>12d</b>, (8) <b>12a</b>, (9) <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Immunoblot detection of cellular HDACi Markers. DU-145 cells were dosed for 24 h at the indicated concentrations to probe for acetylated histones H4 and H3, and p21<sup>waf1</sup>. Actin was also probed to show equal loading of protein. Lane: (1) control; SAHA (2) 2.5 μM, (3) 5 μM; DAU (4) 0.1 μM, (5) 0.5 μM; <b>7</b> (6) 0.5 μM, (7) 1 μM; <b>12b</b> (8) 2.5 μM, (9) 5 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Tubulin acetylation in response to TopoII–HDACi. DU-145 cells were dosed for 4 h with: (1) control (0.1% DMSO), (2) DAU 90 nM, (3) DAU 500 nM, (4) <b>7</b> 130 nM, (5) <b>7</b> 500 nM, (6) <b>12b</b> 1.31 μM, (7) <b>12b</b> 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Intracellular Topo II Inhibition. DU-145 cells were probed for stabilized DNA–Topo II cleavage complexes upon (a) 30 min treatment; (b) 72 h treatment with bifunctional compounds: (1) control, (2) 90 nM DAU, (3) 130 nM <b>7</b>, (4) 1.6 μM <b>12b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/medium/jm-2011-00799p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cellular localization of dual-acting inhibitors. (a) DAU, (b) <b>7</b>, (c) <b>12b</b>. DU-145 cells were dosed at 1 μM for 4 h with indicated compounds and visualized by confocal microscopy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-4/jm200799p/production/images/large/jm-2011-00799p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200799p&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0licOflmwsLzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed Multiple Ligands. An Emerging Drug Discovery Paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+Multiple+Ligands.+An+Emerging+Drug+Discovery+Paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0licOflmwsLzrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520Multiple%2520Ligands.%2520An%2520Emerging%2520Drug%2520Discovery%2520Paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0liRfNom4jjQBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cmeserly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: The network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Cmeserlyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+The+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCmeserly%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520The%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fray, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stobie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakenhut, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, G. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-(1,2-Diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4345</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4345-4348&author=M.+J.+Frayauthor=G.+Bishauthor=A.+D.+Brownauthor=P.+V.+Fishauthor=A.+Stobieauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=N-%281%2C2-Diphenylethyl%29piperazines%3A+a+new+class+of+dual+serotonin%2Fnoradrenaline+reuptake+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFray%26aufirst%3DM.%2BJ.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DStobie%26aufirst%3DA.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DN-%25281%252C2-Diphenylethyl%2529piperazines%253A%2520a%2520new%2520class%2520of%2520dual%2520serotonin%252Fnoradrenaline%2520reuptake%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4345%26epage%3D4348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Neumeyer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidlack, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvadori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balboni, G.</span><span> </span><span class="NLM_article-title">New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5640</span><span class="NLM_x">–</span> <span class="NLM_lpage">5643</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605785" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5640-5643&author=J.+L.+Neumeyerauthor=X.+Pengauthor=B.+I.+Knappauthor=J.+M.+Bidlackauthor=L.+H.+Lazarusauthor=S.+Salvadoriauthor=C.+Trapellaauthor=G.+Balboni&title=New+opioid+designed+multiple+ligand+from+Dmt-Tic+and+morphinan+pharmacophores"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm0605785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605785%26sid%3Dliteratum%253Aachs%26aulast%3DNeumeyer%26aufirst%3DJ.%2BL.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DB.%2BI.%26aulast%3DBidlack%26aufirst%3DJ.%2BM.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DBalboni%26aufirst%3DG.%26atitle%3DNew%2520opioid%2520designed%2520multiple%2520ligand%2520from%2520Dmt-Tic%2520and%2520morphinan%2520pharmacophores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5640%26epage%3D5643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jones, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baylin, S. B.</span><span> </span><span class="NLM_article-title">The epigenomics of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.cell.2007.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17320506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=683-692&author=P.+A.+Jonesauthor=S.+B.+Baylin&title=The+epigenomics+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The epigenomics of cancer</span></div><div class="casAuthors">Jones, Peter A.; Baylin, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Aberrant gene function and altered patterns of gene expression are key features of cancer.  Growing evidence shows that acquired epigenetic abnormalities participate with genetic alterations to cause this dysregulation.  Here, we review recent advances in understanding how epigenetic alterations participate in the earliest stages of neoplasia, including stem/precursor cell contributions, and discuss the growing implications of these advances for strategies to control cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBpHNAkcSPbVg90H21EOLACvtfcHk0lhYXuDbViQQUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7k%253D&md5=78eac8ecc093f1aed0acbfd578f34717</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%2BA.%26aulast%3DBaylin%26aufirst%3DS.%2BB.%26atitle%3DThe%2520epigenomics%2520of%2520cancer%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D683%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Chromatin modifications and their function</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.cell.2007.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17320507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=693-705&author=T.+Kouzarides&title=Chromatin+modifications+and+their+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications and their function</span></div><div class="casAuthors">Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The surface of nucleosomes is studded with a multiplicity of modifications.  At least eight different classes have been characterized to date and many different sites have been identified for each class.  Operationally, modifications function either by disrupting chromatin contacts or by affecting the recruitment of nonhistone proteins to chromatin.  Their presence on histones can dictate the higher-order chromatin structure in which DNA is packaged and can orchestrate the ordered recruitment of enzyme complexes to manipulate DNA.  In this way, histone modifications have the potential to influence many fundamental biol. processes, some of which may be epigenetically inherited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAH9AX2dGicbVg90H21EOLACvtfcHk0ligF5oiNC4NpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXis12ju7Y%253D&md5=c5995fe68fd9473f4268d59c01d3b9de</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DChromatin%2520modifications%2520and%2520their%2520function%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D693%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Shilatifard, A.</span><span> </span><span class="NLM_article-title">Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1146%2Fannurev.biochem.75.103004.142422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16756492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2006&pages=243-269&author=A.+Shilatifard&title=Chromatin+modifications+by+methylation+and+ubiquitination%3A+implications+in+the+regulation+of+gene+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression</span></div><div class="casAuthors">Shilatifard, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">243-269</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  It is more evident now than ever that nucleosomes can transmit epigenetic information from one cell generation to the next.  It has been demonstrated during the past decade that the posttranslational modifications of histone proteins within the chromosome impact chromatin structure, gene transcription, and epigenetic information.  Multiple modifications decorate each histone tail within the nucleosome, including some amino acids that can be modified in several different ways.  Covalent modifications of histone tails known thus far include acetylation, phosphorylation, sumoylation, ubiquitination, and methylation.  A large body of exptl. evidence compiled during the past several years has demonstrated the impact of histone acetylation on transcriptional control.  Although histone modification by methylation and ubiquitination was discovered long ago, it was only recently that functional roles for these modifications in transcriptional regulation began to surface.  Highlighted in this review are the recent biochem., mol., cellular, and physiol. functions of histone methylation and ubiquitination involved in the regulation of gene expression as detd. by a combination of enzymol., structural, and genetic methodologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSKFyMGk_4zrVg90H21EOLACvtfcHk0ligF5oiNC4NpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKhs74%253D&md5=5175ea223985f921afac8353634e8a5c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.75.103004.142422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.75.103004.142422%26sid%3Dliteratum%253Aachs%26aulast%3DShilatifard%26aufirst%3DA.%26atitle%3DChromatin%2520modifications%2520by%2520methylation%2520and%2520ubiquitination%253A%2520implications%2520in%2520the%2520regulation%2520of%2520gene%2520expression%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2006%26volume%3D75%26spage%3D243%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ropero, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteller, M.</span><span> </span><span class="NLM_article-title">The role of histone deacetylases (HDACs) in human cancer</span> <span class="citation_source-journal">Mol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2Fj.molonc.2007.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=19383284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOitbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=19-25&author=S+Roperoauthor=M.+Esteller&title=The+role+of+histone+deacetylases+%28HDACs%29+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The role of histone deacetylases (HDACs) in human cancer</span></div><div class="casAuthors">Ropero, Santiago; Esteller, Manel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-25</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The balance of histone acetylation and deacetylation is an epigenetic layer with a crit. role in the regulation of gene expression.  Histone acetylation induced by histone acetyl transferases (HATs) is assocd. with gene transcription, while histone hypoacetylation induced by histone deacetylase (HDAC) activity is assocd. with gene silencing.  Altered expression and mutations of genes that encode HDACs have been linked to tumor development since they both induce the aberrant transcription of key genes regulating important cellular functions such as cell proliferation, cell-cycle regulation and apoptosis.  Thus, HDACs are among the most promising therapeutic targets for cancer treatment, and they have inspired researchers to study and develop HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvbJD8bqroSLVg90H21EOLACvtfcHk0ligF5oiNC4NpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOitbnI&md5=d925bcde258dce7d53cbb98563e1f2ae</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2007.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2007.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DRopero%26aufirst%3DS%26aulast%3DEsteller%26aufirst%3DM.%26atitle%3DThe%2520role%2520of%2520histone%2520deacetylases%2520%2528HDACs%2529%2520in%2520human%2520cancer%26jtitle%3DMol.%2520Oncol.%26date%3D2007%26volume%3D1%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">1210</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1093%2Fjnci%2F92.15.1210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=10922406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFyhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2000&pages=1210-1216&author=P.+A.+Marksauthor=V.+M.+Richonauthor=R.+A.+Rifkind&title=Histone+deacetylase+inhibitors%3A+inducers+of+differentiation+or+apoptosis+of+transformed+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells</span></div><div class="casAuthors">Marks, Paul A.; Richon, Victoria M.; Rifkind, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1210-1216</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 84 refs.  Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death of transformed cells in vitro and in vivo.  One class of HDAC inhibitors, hydroxamic acid-based hybrid polar compds. (HPCs), induce differentiation at micromolar or lower concns.  Studies (x-ray crystallog.) showed that the catalytic site of HDAC has a tubular structure with a zinc atom at its base and that these HDAC inhibitors, such as suberoylanilide hydroxamic acid and trichostatin A, fit into this structure with the hydroxamic moiety of the inhibitor binding to the zinc.  HDAC inhibitors cause acetylated histones to accumulate in both tumor and normal tissues, and this accumulation can be used as a marker of the biol. activity of the HDAC inhibitors.  Hydroxamic acid-based HPCs act selectively to inhibit tumor cell growth at levels that have little or no toxicity for normal cells.  These compds. also act selectively on gene expression, altering the expression of only about 2% of the genes expressed in cultured tumor cells.  In general, chromatin fractions enriched in actively transcribed genes are also enriched in highly acetylated core histones, whereas silent genes are assocd. with nucleosomes with a low level of acetylation.  However, HDACs can also acetylate proteins other than histones in nucleosomes.  The role that these other targets play in the induction of cell growth arrest, differentiation, and/or apoptotic cell death has not been detd.  Our working hypothesis is that inhibition of HDAC activity leads to the modulation of expression of a specific set of genes that, in turn, result in growth arrest, differentiation, and/or apoptotic cell death.  The hydroxamic acid-based HPCs are potentially effective agents for cancer therapy and, possibly, cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa7JHGYu0fJLVg90H21EOLACvtfcHk0ljxGr65fN-76g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFyhsb8%253D&md5=413775f266f555bfc6539d052b4d2b15</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F92.15.1210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F92.15.1210%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520inducers%2520of%2520differentiation%2520or%2520apoptosis%2520of%2520transformed%2520cells%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2000%26volume%3D92%26spage%3D1210%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Saito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, O.</span><span> </span><span class="NLM_article-title">A synthetic inhibitor of histone deacetylase, MS-275, with marked in vivo antitumor activity against human tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4592</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4592-4597&author=A.+Saitoauthor=T.+Yamashitaauthor=Y.+Marikoauthor=Y.+Nosakaauthor=K.+Tsuchiyaauthor=T.+Andoauthor=T.+Suzukiauthor=T.+Tsuruoauthor=O.+Nakanishi&title=A+synthetic+inhibitor+of+histone+deacetylase%2C+MS-275%2C+with+marked+in+vivo+antitumor+activity+against+human+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DA.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DMariko%26aufirst%3DY.%26aulast%3DNosaka%26aufirst%3DY.%26aulast%3DTsuchiya%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTsuruo%26aufirst%3DT.%26aulast%3DNakanishi%26aufirst%3DO.%26atitle%3DA%2520synthetic%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520MS-275%252C%2520with%2520marked%2520in%2520vivo%2520antitumor%2520activity%2520against%2520human%2520tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4592%26epage%3D4597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Glick, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swindemen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Quaglia, M. P.</span><span> </span><span class="NLM_article-title">Hybrid polar histone deacetylase induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4392-4399&author=R.+D.+Glickauthor=S.+L.+Swindemenauthor=D.+C.+Coffeyauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=V.+M.+Richonauthor=M.+P.+La+Quaglia&title=Hybrid+polar+histone+deacetylase+induces+apoptosis+and+CD95%2FCD95+ligand+expression+in+human+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlick%26aufirst%3DR.%2BD.%26aulast%3DSwindemen%26aufirst%3DS.%2BL.%26aulast%3DCoffey%26aufirst%3DD.%2BC.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DLa%2BQuaglia%26aufirst%3DM.%2BP.%26atitle%3DHybrid%2520polar%2520histone%2520deacetylase%2520induces%2520apoptosis%2520and%2520CD95%252FCD95%2520ligand%2520expression%2520in%2520human%2520neuroblastoma%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4392%26epage%3D4399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Butler, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaler, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span> </span><span class="NLM_article-title">Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5165</span><span class="NLM_x">–</span> <span class="NLM_lpage">5170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=11016644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5165-5170&author=L.+M.+Butlerauthor=D.+B.+Agusauthor=H.+I.+Scherauthor=B.+Higginsauthor=A.+Roseauthor=C.+Cordon-Cardoauthor=H.+T.+Thalerauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=V.+M.+Richon&title=Suberoylanilide+hydroxamic+acid%2C+an+inhibitor+of+histone+deacetylase%2C+suppresses+the+growth+of+prostate+cancer+cells+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo</span></div><div class="casAuthors">Butler, Lisa M.; Agus, David B.; Scher, Howard I.; Higgins, Brian; Rose, Adam; Cordon-Cardo, Carlos; Thaler, Howard T.; Rifkind, Richard A.; Marks, Paul A.; Richon, Victoria M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5165-5170</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Suberoylanilide hydroxamic acid (SAHA) is the prototype of a family of hybrid polar compds. that induce growth arrest in transformed cells and show promise for the treatment of cancer.  SAHA induces differentiation and/or apoptosis in certain transformed cells in culture and is a potent inhibitor of histone deacetylases.  In this study, we examd. the effects of SAHA on the growth of human prostate cancer cells in culture and on the growth of the CWR22 human prostate xenograft in nude mice.  SAHA suppressed the growth of the LNCaP, PC-3, and TSU-Pr1 cell lines at micromolar concns. (2.5-7.5 μM).  SAHA induced dose-dependent cell death in the LNCaP cells.  In mice with transplanted CWR22 human prostate tumors, SAHA (25, 50, and 100 mg/kg/day) caused significant suppression of tumor growth compared with mice receiving vehicle alone; treatment with 50 mg/kg/day resulted in a 97% redn. in the mean final tumor vol. compared with controls.  At this dose, there was no detectable toxicity as evaluated by wt. gain and necropsy examn.  Increased accumulation of acetylated core histones was detected in the CWR22 tumors within 6 h of SAHA administration.  SAHA induced prostate-specific antigen mRNA expression in CWR22 prostate cancer cells, resulting in higher levels of serum prostate-specific antigen than predicted from tumor vol. alone.  The results suggest that hydroxamic acid-based hybrid polar compds. inhibit prostate cancer cell growth and may be useful, relatively nontoxic agents for the treatment of prostate carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2lQ8o4-KsH7Vg90H21EOLACvtfcHk0lgiyjifSM-Bmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVamur0%253D&md5=6aa59edaa70517a0269aee0540e08dbf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DL.%2BM.%26aulast%3DAgus%26aufirst%3DD.%2BB.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DHiggins%26aufirst%3DB.%26aulast%3DRose%26aufirst%3DA.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DThaler%26aufirst%3DH.%2BT.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26atitle%3DSuberoylanilide%2520hydroxamic%2520acid%252C%2520an%2520inhibitor%2520of%2520histone%2520deacetylase%252C%2520suppresses%2520the%2520growth%2520of%2520prostate%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5165%26epage%3D5170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Oyelere, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span> </span><span class="NLM_article-title">Non-peptide macrocyclic histone deacetylases inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801128g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=456-468&author=A.+K.+Oyelereauthor=P.+C.+Chenauthor=W.+Guerrantauthor=S.+C.+Mwakwariauthor=R.+Hoodauthor=Y.+Zhangauthor=Y.+Fan&title=Non-peptide+macrocyclic+histone+deacetylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm801128g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801128g%26sid%3Dliteratum%253Aachs%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DHood%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26atitle%3DNon-peptide%2520macrocyclic%2520histone%2520deacetylases%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D456%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gu, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R. G.</span><span> </span><span class="NLM_article-title">Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS0092-8674%2800%2980521-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=9288740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFKmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=595-606&author=W+Guauthor=R.+G.+Roeder&title=Activation+of+p53+sequence-specific+DNA+binding+by+acetylation+of+the+p53+C-terminal+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain</span></div><div class="casAuthors">Gu, Wei; Roeder, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-606</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The tumor suppressor p53 exerts antiproliferation effects through its ability to function as a sequence-specific DNA-binding transcription factor.  Here, we demonstrate that p53 can be modified by acetylation both in vivo and in vitro.  Remarkably, the site of p53 that is acetylated by its coactivator, p300, resides in a C-terminal domain known to be crit. for the regulation of p53 DNA binding.  Furthermore, the acetylation of p53 can dramatically stimulate its sequence-specific DNA-binding activity, possibly as a result of an acetylation-induced conformational change.  These observations clearly indicate a novel pathway for p53 activation and, importantly, provide an example of an acetylation-mediated change in the function of a nonhistone regulatory protein.  These results have significant implications regarding the mol. mechanisms of various acetyltransferase-contg. transcriptional coactivators, whose primary targets have been presumed to be histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB5s91q-kuJ7Vg90H21EOLACvtfcHk0lgiyjifSM-Bmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFKmtLc%253D&md5=79ca277f5512ced39149f79b27b0b700</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980521-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980521-8%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DW%26aulast%3DRoeder%26aufirst%3DR.%2BG.%26atitle%3DActivation%2520of%2520p53%2520sequence-specific%2520DNA%2520binding%2520by%2520acetylation%2520of%2520the%2520p53%2520C-terminal%2520domain%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D595%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Martinez-Balbás, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brehm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Regulation of E2F1 activity by acetylation</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=662-671&author=M.+A.+Martinez-Balb%C3%A1sauthor=U.+M.+Bauerauthor=S.+J.+Nielsenauthor=A.+Brehmauthor=T.+Kouzarides&title=Regulation+of+E2F1+activity+by+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Balb%25C3%25A1s%26aufirst%3DM.%2BA.%26aulast%3DBauer%26aufirst%3DU.%2BM.%26aulast%3DNielsen%26aufirst%3DS.%2BJ.%26aulast%3DBrehm%26aufirst%3DA.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520E2F1%2520activity%2520by%2520acetylation%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26spage%3D662%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Marzio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacca, M.</span><span> </span><span class="NLM_article-title">E2F family members are differentially regulated by reversible acetylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">10887</span><span class="NLM_x">–</span> <span class="NLM_lpage">10892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=10887-10892&author=G.+Marzioauthor=C.+Wagenerauthor=M.+I.+Gutierrezauthor=P.+Cartwrightauthor=K.+Helinauthor=M.+Giacca&title=E2F+family+members+are+differentially+regulated+by+reversible+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzio%26aufirst%3DG.%26aulast%3DWagener%26aufirst%3DC.%26aulast%3DGutierrez%26aufirst%3DM.%2BI.%26aulast%3DCartwright%26aufirst%3DP.%26aulast%3DHelin%26aufirst%3DK.%26aulast%3DGiacca%26aufirst%3DM.%26atitle%3DE2F%2520family%2520members%2520are%2520differentially%2520regulated%2520by%2520reversible%2520acetylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D10887%26epage%3D10892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hubbert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guardiola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">HDAC6 is a microtubule-associated deacetylase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=455-458&author=C.+Hubbertauthor=A.+Guardiolaauthor=R.+Shaoauthor=Y.+Kawaguchiauthor=A.+Itoauthor=A.+Nixonauthor=M.+Yoshidaauthor=X.+F.+Wangauthor=T.+P.+Yao&title=HDAC6+is+a+microtubule-associated+deacetylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHubbert%26aufirst%3DC.%26aulast%3DGuardiola%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DR.%26aulast%3DKawaguchi%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DNixon%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520is%2520a%2520microtubule-associated%2520deacetylase%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D455%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kovacs, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=601-607&author=J.+J.+Kovacsauthor=P.+J.+Murphyauthor=S.+Gaillardauthor=X.+Zhaoauthor=J.+T.+Wuauthor=C.+V.+Nicchittaauthor=M.+Yoshidaauthor=D.+O.+Toftauthor=W.+B.+Prattauthor=T.+P.+Yao&title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKovacs%26aufirst%3DJ.%2BJ.%26aulast%3DMurphy%26aufirst%3DP.%2BJ.%26aulast%3DGaillard%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%2BT.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DToft%26aufirst%3DD.%2BO.%26aulast%3DPratt%26aufirst%3DW.%2BB.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DHDAC6%2520regulates%2520Hsp90%2520acetylation%2520and%2520chaperone-dependent%2520activation%2520of%2520glucocorticoid%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mann, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Justice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padzur, R.</span><span> </span><span class="NLM_article-title">FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1247-1252&author=B.+S.+Mannauthor=J.+R.+Johnsonauthor=M.+H.+Cohenauthor=R.+Justiceauthor=R.+Padzur&title=FDA+approval+summary%3A+vorinostat+for+treatment+of+advanced+primary+cutaneous+T-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DB.%2BS.%26aulast%3DJohnson%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DM.%2BH.%26aulast%3DJustice%26aufirst%3DR.%26aulast%3DPadzur%26aufirst%3DR.%26atitle%3DFDA%2520approval%2520summary%253A%2520vorinostat%2520for%2520treatment%2520of%2520advanced%2520primary%2520cutaneous%2520T-cell%2520lymphoma%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D1247%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piekarz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Romidepsin; a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1586%2Fera.10.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=20645688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=997-1008&author=C.+Grantauthor=F.+Rahmanauthor=R.+Piekarzauthor=C.+Peerauthor=R.+Fryeauthor=R.+W.+Robeyauthor=E.+R.+Gardnerauthor=W.+D.+Figgauthor=S.+E.+Bates&title=Romidepsin%3B+a+new+therapy+for+cutaneous+T-cell+lymphoma+and+a+potential+therapy+for+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors</span></div><div class="casAuthors">Grant, Cliona; Rahman, Fahd; Piekarz, Richard; Peer, Cody; Frye, Robin; Robey, Robert W.; Gardner, Erin R.; Figg, William D.; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">997-1008</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Romidepsin is a histone deacetylase inhibitor (HDI), approved by the US FDA for the treatment of cutaneous T-cell lymphoma (CTCL).  Although various mechanisms have been proposed for the activity of HDIs, including induction of genes controlling cell cycle, acetylation of cytoplasmic proteins and direct induction of apoptosis, the mechanism underlying activity of romidepsin and other HDIs in CTCL is not known.  Romidepsin induces long-lasting responses.  The side-effect profile is similar to that of other HDIs, causing fatigue, nausea and thrombocytopenia.  Management of the CTCL population requires vigilence to prevent infection with skin contaminants, and monitoring of potassium and magnesium, electrolytes found to be low in a large proportion of patients.  Electrocardiog. (ECG) changes are common but are not assocd. with myocardial damage.  When mol. end points were evaluated in 61 patients enrolled on a Phase II trial with romidepsin, response was assocd. with persistence of acetylated histone H3, suggesting that drug exposure is important in effective therapy with romidepsin.  Future studies will endeavor to identify combination strategies to increase the efficacy both in resistant CTCL and in solid tumors and to identify biomarkers of response that will allow selection of patients most likely to benefit from the therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhGXcIbdqpk7Vg90H21EOLACvtfcHk0lj2xI9nMad1mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFWqs74%253D&md5=b28fd17c77991e4662f7c0e08d6d7297</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1586%2Fera.10.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.88%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DRahman%26aufirst%3DF.%26aulast%3DPiekarz%26aufirst%3DR.%26aulast%3DPeer%26aufirst%3DC.%26aulast%3DFrye%26aufirst%3DR.%26aulast%3DRobey%26aufirst%3DR.%2BW.%26aulast%3DGardner%26aufirst%3DE.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DRomidepsin%253B%2520a%2520new%2520therapy%2520for%2520cutaneous%2520T-cell%2520lymphoma%2520and%2520a%2520potential%2520therapy%2520for%2520solid%2520tumors%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2010%26volume%3D10%26spage%3D997%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Macrocyclic histone deacetylases inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.2174%2F156802610792232079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=20536416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFajurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=1423-1440&author=S.+C.+Mwakwariauthor=V.+Patilauthor=W.+Guerrantauthor=A.+K.+Oyelere&title=Macrocyclic+histone+deacetylases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic histone deacetylase inhibitors</span></div><div class="casAuthors">Mwakwari, Sandra C.; Patil, Vishal; Guerrant, William; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1423-1440</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACi) are an emerging class of novel anti-cancer drugs that cause growth arrest, differentiation, and apoptosis of tumor cells.  In addn., they have shown promise as anti-parasitic, anti-neurodegenerative, anti-rheumatol. and immunosuppressant agents.  To date, several structurally distinct small mol. HDACi have been reported including aryl hydroxamates, benzamides, short-chain fatty acids, electrophilic ketones, and macrocyclic peptides.  Macrocyclic HDACi possess the most complex cap-groups which interact with HDAC enzyme's outer rim and have demonstrated excellent HDAC inhibition potency and isoform selectivity.  This review focuses on the recent progress and current state of macrocyclic HDACi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXzgRmfQBx27Vg90H21EOLACvtfcHk0lg4s-uvQLnG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFajurrF&md5=d027b0380e04f364fb0985a350e99c60</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F156802610792232079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610792232079%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DMacrocyclic%2520histone%2520deacetylases%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D1423%26epage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kelly, W. K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors: from target to clinical trials</span> <span class="citation_source-journal">Expert. Opin. Invest. Drugs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1695</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1517%2F13543784.11.12.1695" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12457432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFCjs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=1695-1713&author=W.+K+Kellyauthor=O.+A.+O%E2%80%99Connorauthor=P.+A.+Marks&title=Histone+deacetylase+inhibitors%3A+from+target+to+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors: from target to clinical trials</span></div><div class="casAuthors">Kelly, William K.; O'Connor, Owen A.; Marks, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1695-1713</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Transformed cells, characterized by inappropriate cell proliferation, do not necessarily lose the capacity to undergo growth arrest under certain stimuli.  DNA, genetic information, is packaged in chromatin proteins, for example, histones.  The structure of chromatin may be altered by post-translational modifications (e.g., acetylation, phosphorylation, methylation and ubiquitylation) which play a role in regulating gene expression.  Two groups of enzymes, histone deacetylases (HDACs) and acetyl transferases, det. the acetylation status of histones.  This review focuses on compds. that inhibit HDAC activity.  These agents have been shown to be active in vitro and in vivo in causing cancer cell growth arrest, differentiation and/or apoptosis.  Several HDAC inhibitors are currently in clin. trials as anticancer agents and, in particular, hydroxamic acid-based HDAC inhibitors have shown activity against cancers at well-tolerated doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1tCC-H5caxbVg90H21EOLACvtfcHk0lg4s-uvQLnG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFCjs7s%253D&md5=713b9afb7d101869e8c203d0d0c0ee60</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F13543784.11.12.1695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.11.12.1695%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DW.%2BK%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DO.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitors%253A%2520from%2520target%2520to%2520clinical%2520trials%26jtitle%3DExpert.%2520Opin.%2520Invest.%2520Drugs.%26date%3D2002%26volume%3D11%26spage%3D1695%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Rosato, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in clinical development</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1517%2F13543784.13.1.21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14680450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=21-38&author=R.+R.+Rosatoauthor=S.+Grant&title=Histone+deacetylase+inhibitors+in+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors in clinical development</span></div><div class="casAuthors">Rosato, Roberto R.; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to a variety of other novel agents, interest in histone deacetylase inhibitors (HDACIs) as antineoplastic drugs has recently accelerated and increasing nos. of these compds. have entered clin. trials in humans.  HDACIs represent a prototype of molecularly targeted agents that perturb signal transduction, cell cycle-regulatory and survival-related pathways.  Newer generation HDACIs have been introduced into the clin. arena that are considerably more potent on a molar basis than their predecessors and are beginning to show early evidence of activity, particularly in hematopoietic malignancies.  In addn., there is an increasing appreciation of the fact that HDACIs may act through mechanisms other than induction of histone acetylation and, as in the case of other molecularly-targeted agents, it is conceivable that the ultimate role of HDACIs in cancer therapy will be as modulators of apoptosis induced by other cytotoxic agents.  One particularly promising strategy involves attempts to combine HDACIs with other novel agents to promote tumor cell differentiation or apoptosis.  The present review focuses on recent insights into the mechanisms by which HDACIs exert their anticancer effects, either alone or in combination with other compds., as well as attempts to translate these findings into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tg9iWnHF3bVg90H21EOLACvtfcHk0lg4s-uvQLnG5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVequ7s%253D&md5=3e8dcec235cc2ebc828265dce839733a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1517%2F13543784.13.1.21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.13.1.21%26sid%3Dliteratum%253Aachs%26aulast%3DRosato%26aufirst%3DR.%2BR.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D21%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yoo, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. A.</span><span> </span><span class="NLM_article-title">Epigenetic therapy of cancer: past, present and future</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=37-50&author=C.+B.+Yooauthor=P.+A.+Jones&title=Epigenetic+therapy+of+cancer%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DC.%2BB.%26aulast%3DJones%26aufirst%3DP.%2BA.%26atitle%3DEpigenetic%2520therapy%2520of%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1038%2F43710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=10490031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=188-193&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=A.+Cohenauthor=V.+M.+Richonauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=R.+Breslowauthor=N.+P.+Pavletich&title=Structures+of+a+histone+deacetylase+homologue+bound+to+the+TSA+and+SAHA+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Cohen, Alona; Richon, Victoria M.; Rifkind, Richard A.; Marks, Paul A.; Breslow, Ronald; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6749</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression.  HDACs are involved in cell-cycle progression and differentiation, and their deregulation is assocd. with several cancers.  HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumor effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumors in mice models, and they are effective in the treatment of promyelocytic leukemia.  Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homolog from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA.  The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition.  The residues that make up the active site and contact the inhibitors are conserved across the HDAC family.  These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrG0lsZMMo37Vg90H21EOLACvtfcHk0ljqSO12yLZmjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D&md5=29bbc6d3ba9a9d2a8c330349ae8199a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F43710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43710%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructures%2520of%2520a%2520histone%2520deacetylase%2520homologue%2520bound%2520to%2520the%2520TSA%2520and%2520SAHA%2520inhibitors%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wang, D.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helquist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan-Hargest, H-Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiech, N. L.</span><span> </span><span class="NLM_article-title">On the function of the 14 Å long internal cavity of histone deacetylase-like protein: implication for the design of histone deacetylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3409</span><span class="NLM_x">–</span> <span class="NLM_lpage">3417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498497" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3409-3417&author=D.-F.+Wangauthor=O.+Wiestauthor=P.+Helquistauthor=H-Y+Lan-Hargestauthor=N.+L.+Wiech&title=On+the+function+of+the+14+%C3%85+long+internal+cavity+of+histone+deacetylase-like+protein%3A+implication+for+the+design+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0498497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498497%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.-F.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DHelquist%26aufirst%3DP.%26aulast%3DLan-Hargest%26aufirst%3DH-Y%26aulast%3DWiech%26aufirst%3DN.%2BL.%26atitle%3DOn%2520the%2520function%2520of%2520the%252014%2520%25C3%2585%2520long%2520internal%2520cavity%2520of%2520histone%2520deacetylase-like%2520protein%253A%2520implication%2520for%2520the%2520design%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3409%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6691</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070864w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6685-6691&issue=26&author=L.+Chenauthor=D.+Wilsonauthor=H.+N.+Jayaramauthor=K.+W.+Pankiewicz&title=Dual+inhibitors+of+inosine+monophosphate+dehydrogenase+and+histone+deacetylases+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm070864w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070864w%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DD.%26aulast%3DJayaram%26aufirst%3DH.%2BN.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDual%2520inhibitors%2520of%2520inosine%2520monophosphate%2520dehydrogenase%2520and%2520histone%2520deacetylases%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D26%26spage%3D6685%26epage%3D6691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dove, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichhorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of iminatib hybrids as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rβ, and histone deacetylases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2265</span><span class="NLM_x">–</span> <span class="NLM_lpage">2279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800988r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2265-2279&issue=8&author=S.+Mahboobiauthor=S.+Doveauthor=A.+Sellmerauthor=M.+Winklerauthor=E.+Eichhornauthor=H.+Pongratzauthor=T.+Ciossekauthor=T.+Baerauthor=T.+Maierauthor=T.+Beckers&title=Design+of+chimeric+histone+deacetylase-+and+tyrosine+kinase-inhibitors%3A+a+series+of+iminatib+hybrids+as+potent+inhibitors+of+wild-type+and+mutant+BCR-ABL%2C+PDGF-R%CE%B2%2C+and+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800988r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800988r%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DWinkler%26aufirst%3DM.%26aulast%3DEichhorn%26aufirst%3DE.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBaer%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DDesign%2520of%2520chimeric%2520histone%2520deacetylase-%2520and%2520tyrosine%2520kinase-inhibitors%253A%2520a%2520series%2520of%2520iminatib%2520hybrids%2520as%2520potent%2520inhibitors%2520of%2520wild-type%2520and%2520mutant%2520BCR-ABL%252C%2520PDGF-R%25CE%25B2%252C%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D8%26spage%3D2265%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng-Jung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&issue=5&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=L.+Cheng-Jungauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+potent+multi-acting+HDAC%2C+EGFR%2C+and+HER2+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DCheng-Jung%26aufirst%3DL.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520potent%2520multi-acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D5%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Piccart-Gebhart, M. J.</span><span> </span><span class="NLM_article-title">Anthracyclines and the tailoring of treatment for early breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">2177</span><span class="NLM_x">–</span> <span class="NLM_lpage">2179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1056%2FNEJMe068065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16707755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2006&pages=2177-2179&author=M.+J.+Piccart-Gebhart&title=Anthracyclines+and+the+tailoring+of+treatment+for+early+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracyclines and the tailoring of treatment for early breast cancer</span></div><div class="casAuthors">Piccart-Gebhart, Martine J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2177-2179</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXtDD4dhRJ-7Vg90H21EOLACvtfcHk0lhJeklULPiY0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCrtr4%253D&md5=d6b3aee4890c808e8311a8e23630bb68</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMe068065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe068065%26sid%3Dliteratum%253Aachs%26aulast%3DPiccart-Gebhart%26aufirst%3DM.%2BJ.%26atitle%3DAnthracyclines%2520and%2520the%2520tailoring%2520of%2520treatment%2520for%2520early%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D354%26spage%3D2177%26epage%3D2179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baek, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrier, F.</span><span> </span><span class="NLM_article-title">Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">7291</span><span class="NLM_x">–</span> <span class="NLM_lpage">7300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14612526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVGlt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7291-7300&author=M.+S.+Kimauthor=M.+Blakeauthor=J.+H.+Baekauthor=G.+Kohlhagenauthor=Y.+Pommierauthor=F.+Carrier&title=Inhibition+of+histone+deacetylase+increases+cytotoxicity+to+anticancer+drugs+targeting+DNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Histone Deacetylase Increases Cytotoxicity to Anticancer Drugs Targeting DNA</span></div><div class="casAuthors">Kim, Myoung Sook; Blake, Mellissa; Baek, Jin Hyen; Kohlhagen, Glenda; Pommier, Yves; Carrier, France</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7291-7300</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Several anticancer drugs target DNA or enzymes acting on the DNA.  Because chromatin DNA is tightly compacted, accessibility to the drug target may reduce the efficiency of these anticancer drugs.  We thus treated four human cancer cell lines and two normal epithelial cell lines with either trichostatin A (TSA) or SAHA, two histone deacetylase inhibitors, before exposing the cells to VP-16, ellipticine, camptothecin, doxorubicin, cisplatin, 5-fluorouracil, or cyclophosphamide.  Pretreatment with TSA or SAHA increased the killing efficiency of VP-16, ellipticine, doxorubicin, and cisplatin.  The magnitude of sensitization is cell type specific and is >10-fold for VP-16 in D54, a brain tumor cell line intrinsically resistant to topoisomerase II inhibitors.  Topoisomerase II levels and activity were not affected by this treatment, but p53, p21, and Gadd45 protein levels were markedly induced.  Moreover, pretreatment with TSA also increased VP-16-induced apoptosis in a p53-dependent and -independent manner.  Treating the cells in the reverse order (anticancer drug first, followed by TSA or SAHA) had no more cytotoxic effect than the drug alone.  These data suggest that loosening-up the chromatin structure by histone acetylation can increase the efficiency of several anticancer drugs targeting DNA.  This may be advantageous for treating tumors intrinsically resistant to these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24HjggpPirLVg90H21EOLACvtfcHk0lhJeklULPiY0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVGlt70%253D&md5=6fe3bc8b32550917fc8f80ac648e680b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DBlake%26aufirst%3DM.%26aulast%3DBaek%26aufirst%3DJ.%2BH.%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DCarrier%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%2520increases%2520cytotoxicity%2520to%2520anticancer%2520drugs%2520targeting%2520DNA%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7291%26epage%3D7300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Catalano, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortunati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugliese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosco, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrocola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aragno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocuzzi, G.</span><span> </span><span class="NLM_article-title">Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1677%2Fjoe.1.06970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=17088416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlejsLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2006&pages=465-472&issue=2&author=M.+G.+Catalanoauthor=N.+Fortunatiauthor=M.+Puglieseauthor=R.+Poliauthor=O.+Boscoauthor=R.+Mastrocolaauthor=M.+Aragnoauthor=G.+Bocuzzi&title=Valproic+acid%2C+a+histone+deacetylase+inhibitor%2C+enhances+sensitivity+to+doxorubicin+in+anaplastic+thyroid+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells</span></div><div class="casAuthors">Catalano, Maria G.; Fortunati, Nicoletta; Pugliese, Mariateresa; Poli, Roberta; Bosco, Ornella; Mastrocola, Raffaella; Aragno, Manuela; Boccuzzi, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-472</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">Multimodality treatments (i.e. surgery, chemotherapy, and radiotherapy) are recommended for anaplastic thyroid carcinoma (ATC), an extremely lethal human cancer, but to date there is little evidence that such approaches improve survival rates.  It is thus necessary to seek new therapeutic tools.  Histone deacetylase (HDAC) inhibitors are a promising class of antineoplastic agents that induce differentiation and apoptosis.  Moreover, they may enhance the cytotoxicity of drugs targeting DNA through acetylation of histones.  Using two ATC cell lines (CAL-62 and ARO), we show here that valproic acid (VPA), a clin. available HDAC inhibitor, enhances the activity of doxorubicin, whose antitumor properties involve binding to DNA and inhibiting topoisomerase II.  A meager 0·7 mM VPA, which corresponds to serum concns. in patients treated for epilepsy, is able to increase the cytotoxicity of doxorubicin about threefold in CAL-62 cells and twofold in ARO cells.  The sensitizing effect, which is through histone acetylation, involves increased apoptosis, which is also shown by the increased caspase 3 activation and the enhancement of doxorubicin-induced G2 cell cycle arrest.  These results might offer a rationale for clin. studies of a new combined therapy in an effort to improve the outcome of patients with anaplastic thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmTtQReyIxnrVg90H21EOLACvtfcHk0lhNYwKQElhLig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlejsLrM&md5=c5f3780cd38d2ca4b53c7812f9e49836</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1677%2Fjoe.1.06970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.1.06970%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DM.%2BG.%26aulast%3DFortunati%26aufirst%3DN.%26aulast%3DPugliese%26aufirst%3DM.%26aulast%3DPoli%26aufirst%3DR.%26aulast%3DBosco%26aufirst%3DO.%26aulast%3DMastrocola%26aufirst%3DR.%26aulast%3DAragno%26aufirst%3DM.%26aulast%3DBocuzzi%26aufirst%3DG.%26atitle%3DValproic%2520acid%252C%2520a%2520histone%2520deacetylase%2520inhibitor%252C%2520enhances%2520sensitivity%2520to%2520doxorubicin%2520in%2520anaplastic%2520thyroid%2520cancer%2520cells%26jtitle%3DJ.%2520Endocrinol.%26date%3D2006%26volume%3D191%26issue%3D2%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Johnson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padget, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. M.</span><span> </span><span class="NLM_article-title">Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4539</span><span class="NLM_x">–</span> <span class="NLM_lpage">4542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=4539-4542&issue=7&author=C.+A.+Johnsonauthor=K.+Padgetauthor=C.+A.+Austinauthor=B.+M.+Turner&title=Deacetylase+activity+associates+with+topoisomerase+II+and+is+necessary+for+etoposide-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BA.%26aulast%3DPadget%26aufirst%3DK.%26aulast%3DAustin%26aufirst%3DC.%2BA.%26aulast%3DTurner%26aufirst%3DB.%2BM.%26atitle%3DDeacetylase%2520activity%2520associates%2520with%2520topoisomerase%2520II%2520and%2520is%2520necessary%2520for%2520etoposide-induced%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D7%26spage%3D4539%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Marchion, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicaku, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daud, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munster, P. N.</span><span> </span><span class="NLM_article-title">Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid</span> <span class="citation_source-journal">J. Cell Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2004&pages=223-237&issue=2&author=D.+C.+Marchionauthor=E.+Bicakuauthor=A.+I.+Daudauthor=V.+Richonauthor=D.+M.+Sullivanauthor=P.+N.+Munster&title=Sequence-specific+potentiation+of+topoisomerase+II+inhibitors+by+the+histone+deacetylase+inhibitor+suberoylanilide+hydroxamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchion%26aufirst%3DD.%2BC.%26aulast%3DBicaku%26aufirst%3DE.%26aulast%3DDaud%26aufirst%3DA.%2BI.%26aulast%3DRichon%26aufirst%3DV.%26aulast%3DSullivan%26aufirst%3DD.%2BM.%26aulast%3DMunster%26aufirst%3DP.%2BN.%26atitle%3DSequence-specific%2520potentiation%2520of%2520topoisomerase%2520II%2520inhibitors%2520by%2520the%2520histone%2520deacetylase%2520inhibitor%2520suberoylanilide%2520hydroxamic%2520acid%26jtitle%3DJ.%2520Cell%2520Biochem.%26date%3D2004%26volume%3D92%26issue%3D2%26spage%3D223%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Tewey, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. F.</span><span> </span><span class="NLM_article-title">Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">226</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1126%2Fscience.6093249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=6093249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaL2cXmt1ahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=466-468&author=K.+M.+Teweyauthor=T.+C.+Roweauthor=L.+Yangauthor=B.+D.+Halliganauthor=L.+F.+Liu&title=Adriamycin-induced+DNA+damage+mediated+by+mammalian+DNA+topoisomerase+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II</span></div><div class="casAuthors">Tewey, K. M.; Rowe, T. C.; Yang, L.; Halligan, B. D.; Liu, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4673</span>),
    <span class="NLM_cas:pages">466-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Results from in vitro studies with purified calf thymus DNA topoisomerase  [80449-01-0] II showed that mammalian DNA topoisomerase II mediates DNA damage by adriamycin  [23214-92-8] and other related antitumor drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMQQc-o8E-1rVg90H21EOLACvtfcHk0lhg0a_R6U6sWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmt1ahs7g%253D&md5=3ad5aebab04c9a92535d1717033373f4</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093249%26sid%3Dliteratum%253Aachs%26aulast%3DTewey%26aufirst%3DK.%2BM.%26aulast%3DRowe%26aufirst%3DT.%2BC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHalligan%26aufirst%3DB.%2BD.%26aulast%3DLiu%26aufirst%3DL.%2BF.%26atitle%3DAdriamycin-induced%2520DNA%2520damage%2520mediated%2520by%2520mammalian%2520DNA%2520topoisomerase%2520II%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D466%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Binaschi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipollone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggi, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capranico, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Animati, F.</span><span> </span><span class="NLM_article-title">Anthracyclines: selected new developments</span> <span class="citation_source-journal">Curr. Med. Chem. Anti-Cancer Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=113-130&issue=2&author=M.+Binaschiauthor=M.+Bigioniauthor=A.+Cipolloneauthor=C.+Rossiauthor=C.+Gosoauthor=C.+A.+Maggiauthor=G.+Capranicoauthor=F.+Animati&title=Anthracyclines%3A+selected+new+developments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBinaschi%26aufirst%3DM.%26aulast%3DBigioni%26aufirst%3DM.%26aulast%3DCipollone%26aufirst%3DA.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DGoso%26aufirst%3DC.%26aulast%3DMaggi%26aufirst%3DC.%2BA.%26aulast%3DCapranico%26aufirst%3DG.%26aulast%3DAnimati%26aufirst%3DF.%26atitle%3DAnthracyclines%253A%2520selected%2520new%2520developments%26jtitle%3DCurr.%2520Med.%2520Chem.%2520Anti-Cancer%2520Agents%26date%3D2001%26volume%3D1%26issue%3D2%26spage%3D113%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Pommier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwelling, L. A.</span><span> </span><span class="NLM_article-title">Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated nuclei by antineoplastic intercalating agents</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3194</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00309a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1984&pages=3194-3201&author=Y.+Pommierauthor=R.+E.+Schwartzauthor=K.+W.+Kohnauthor=L.+A.+Zwelling&title=Formation+and+rejoining+of+deoxyribonucleic+acid+double-strand+breaks+induced+in+isolated+nuclei+by+antineoplastic+intercalating+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fbi00309a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00309a013%26sid%3Dliteratum%253Aachs%26aulast%3DPommier%26aufirst%3DY.%26aulast%3DSchwartz%26aufirst%3DR.%2BE.%26aulast%3DKohn%26aufirst%3DK.%2BW.%26aulast%3DZwelling%26aufirst%3DL.%2BA.%26atitle%3DFormation%2520and%2520rejoining%2520of%2520deoxyribonucleic%2520acid%2520double-strand%2520breaks%2520induced%2520in%2520isolated%2520nuclei%2520by%2520antineoplastic%2520intercalating%2520agents%26jtitle%3DBiochemistry%26date%3D1984%26volume%3D23%26spage%3D3194%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span> </span><span class="NLM_article-title">Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">1853</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1998&pages=1853-1860&issue=20&author=K.+Kiyomiyaauthor=S.+Matsuoauthor=M.+Kurebe&title=Proteasome+is+a+carrier+to+translocate+doxorubicin+from+cytoplasm+into+nucleus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DS.%26aulast%3DKurebe%26aufirst%3DM.%26atitle%3DProteasome%2520is%2520a%2520carrier%2520to%2520translocate%2520doxorubicin%2520from%2520cytoplasm%2520into%2520nucleus%26jtitle%3DLife%2520Sci.%26date%3D1998%26volume%3D62%26issue%3D20%26spage%3D1853%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span> </span><span class="NLM_article-title">Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin–proteasome complex</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2467</span><span class="NLM_x">–</span> <span class="NLM_lpage">2471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2467-2471&author=K.+Kiyomiyaauthor=S.+Matsuoauthor=M.+Kurebe&title=Mechanism+of+specific+nuclear+transport+of+adriamycin%3A+the+mode+of+nuclear+translocation+of+adriamycin%E2%80%93proteasome+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DMatsuo%26aufirst%3DS.%26aulast%3DKurebe%26aufirst%3DM.%26atitle%3DMechanism%2520of%2520specific%2520nuclear%2520transport%2520of%2520adriamycin%253A%2520the%2520mode%2520of%2520nuclear%2520translocation%2520of%2520adriamycin%25E2%2580%2593proteasome%2520complex%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2467%26epage%3D2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Tong, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. W.</span><span> </span><span class="NLM_article-title">Adriamycin analogs. 3. Synthesis of <i>N</i>-alkylated anthracyclines with enhanced efficacy and reduced toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">912</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00194a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=912-918&author=G.+L.+Tongauthor=H.+Y.+Wuauthor=T.+H.+Smithauthor=D.+W.+Henry&title=Adriamycin+analogs.+3.+Synthesis+of+N-alkylated+anthracyclines+with+enhanced+efficacy+and+reduced+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00194a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00194a005%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DG.%2BL.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DT.%2BH.%26aulast%3DHenry%26aufirst%3DD.%2BW.%26atitle%3DAdriamycin%2520analogs.%25203.%2520Synthesis%2520of%2520N-alkylated%2520anthracyclines%2520with%2520enhanced%2520efficacy%2520and%2520reduced%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D912%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Martín, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaquero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portugal, J.</span><span> </span><span class="NLM_article-title">Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiated in vitro</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3402</span><span class="NLM_x">–</span> <span class="NLM_lpage">3409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1999&pages=3402-3409&author=B.+Mart%C3%ADnauthor=A.+Vaqueroauthor=W.+Priebeauthor=J.+Portugal&title=Bisanthracycline+WP631+inhibits+basal+and+Sp1-activated+transcription+initiated+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMart%25C3%25ADn%26aufirst%3DB.%26aulast%3DVaquero%26aufirst%3DA.%26aulast%3DPriebe%26aufirst%3DW.%26aulast%3DPortugal%26aufirst%3DJ.%26atitle%3DBisanthracycline%2520WP631%2520inhibits%2520basal%2520and%2520Sp1-activated%2520transcription%2520initiated%2520in%2520vitro%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1999%26volume%3D27%26spage%3D3402%26epage%3D3409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lothstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatman, T. W.</span><span> </span><span class="NLM_article-title">Anthracycline drug targeting: cytoplasmic versus nuclear—a fork in the road</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1054%2Fdrup.2001.0201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=11768330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1Wlt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=169-177&author=L.+Lothsteinauthor=M.+Israelauthor=T.+W.+Sweatman&title=Anthracycline+drug+targeting%3A+cytoplasmic+versus+nuclear%E2%80%94a+fork+in+the+road"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracycline drug targeting: Cytoplasmic versus nuclear - a fork in the road</span></div><div class="casAuthors">Lothstein, Leonard; Israel, Mervyn; Sweatman, Trevor W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-177</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Harcourt Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The anthracycline antibiotics doxorubicin (Adriamycin; DOX) and daunorubicin (DNR) continue to be essential components of first-line chemotherapy in the treatment of a variety of solid and hematopoietic tumors.  The overall efficacies of DOX and DNR are, however, impeded by serious dose-limiting toxicities, including cardiotoxicity, and the selection of multiple mechanisms of cellular drug resistance.  These limitations have necessitated the development of newer anthracyclines whose structural and functional modifications circumvent these impediments.  In this review, we will present recent strategies in anthracycline design and assess their potential therapeutic merits.  Current anthracycline design has diverged to target either cytoplasmic or nuclear sites.  Nuclear targets have been broadened to include not only topoisomerase II (topo II) inhibition through ternary complex stabilization and catalytic inhibition, but also topoisomerase I (topo I) inhibition and transcriptional inhibition.  In contrast, cytoplasmic targeting focuses on anthracycline binding to protein kinase C (PKC) regulatory domain with consequent modulation of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-lYuQBgFf2rVg90H21EOLACvtfcHk0lix_QWQ1e8FsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1Wlt7w%253D&md5=9af6a048b82b46c3119d6d97c91d2571</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1054%2Fdrup.2001.0201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fdrup.2001.0201%26sid%3Dliteratum%253Aachs%26aulast%3DLothstein%26aufirst%3DL.%26aulast%3DIsrael%26aufirst%3DM.%26aulast%3DSweatman%26aufirst%3DT.%2BW.%26atitle%3DAnthracycline%2520drug%2520targeting%253A%2520cytoplasmic%2520versus%2520nuclear%25E2%2580%2594a%2520fork%2520in%2520the%2520road%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2001%26volume%3D4%26spage%3D169%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gate, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couvreur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen-Ba, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapiero, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-Methylation of anthracyclines modulates their cytotoxicity and pharmacokinetics in wild type and multidrug resistant cells</span> <span class="citation_source-journal">Biomed. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS0753-3322%2803%2900037-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=14499178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Gntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2003&pages=301-308&author=L.+Gateauthor=P.+Couvreurauthor=G.+Nguyen-Baauthor=H.+Tapiero&title=N-Methylation+of+anthracyclines+modulates+their+cytotoxicity+and+pharmacokinetics+in+wild+type+and+multidrug+resistant+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells</span></div><div class="casAuthors">Gate, L.; Couvreur, P.; Nguyen-Ba, G.; Tapiero, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Anthracyclines are the most commonly used classes of anticancer agents in chemotherapy.  Development of resistance to these mols. is one of the major reasons for treatment failure.  The overexpression of the membrane transporter P-glycoprotein (P-gp) is among the principal mechanisms involved in this phenomenon.  This pump, which is responsible for the multidrug resistance (MDR) phenotype, decreases the toxicity of a wide range of unrelated anticancer drugs by increasing their cellular efflux.  Structure-activity relationship expts. have shown that the pos. charged amino group of the anthracyclines could be responsible for their transport by P-gp.  Here, we used three new anthracyclines that shared the same chromophore but differed by the degree of N-methylation of their sugar moiety.  Oxaunomycin (OXN) possessed a non-methylated amino group, while LB-1 was monomethylated and β-clamycin T (BCT) was dimethylated.  In sensitive cells (FLC), reduced cytotoxicity was related to the level of N-methylation; whereas in resistant cells (DOX-RFLC1 and DOX-RFLC2) overexpressing different levels of P-gp, increased N-methylation enhanced anthracycline cytotoxicity.  Decreased resistance in DOX-RFLCs was assocd. with an increased drug accumulation due to a reduced cellular efflux.  As expected, the MDR modulator verapamil decreased resistance to these anthracyclines by increasing the cellular accumulation.  These results suggest that N-methylation of anthracyclines circumvents resistance by diminishing drug transport by P-gp in MDR-pos. cells.  These observations could be the consequence of the steric hindrance created by the Me group(s) which may impair the interaction between the pos. charged amino group and the active site of P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9VHSQL3ZU7Vg90H21EOLACvtfcHk0ljx6RcV3Jc6qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Gntb8%253D&md5=e529327a6bf43cb830f914afffb0e6c9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS0753-3322%2803%2900037-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0753-3322%252803%252900037-4%26sid%3Dliteratum%253Aachs%26aulast%3DGate%26aufirst%3DL.%26aulast%3DCouvreur%26aufirst%3DP.%26aulast%3DNguyen-Ba%26aufirst%3DG.%26aulast%3DTapiero%26aufirst%3DH.%26atitle%3DN-Methylation%2520of%2520anthracyclines%2520modulates%2520their%2520cytotoxicity%2520and%2520pharmacokinetics%2520in%2520wild%2520type%2520and%2520multidrug%2520resistant%2520cells%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2003%26volume%3D57%26spage%3D301%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mwakwari, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurard-Levin, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrksich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Non-peptide histone deacetylases inhibitors derived from tricyclic ketolide skeleton</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6100</span><span class="NLM_x">–</span> <span class="NLM_lpage">6111</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100507q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=6100-6111&author=S.+C.+Mwakwariauthor=W.+Guerrantauthor=V.+Patilauthor=S.+I.+Khanauthor=B.+L.+Tekwaniauthor=Z.+A.+Gurard-Levinauthor=M.+Mrksichauthor=A.+K.+Oyelere&title=Non-peptide+histone+deacetylases+inhibitors+derived+from+tricyclic+ketolide+skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1021%2Fjm100507q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100507q%26sid%3Dliteratum%253Aachs%26aulast%3DMwakwari%26aufirst%3DS.%2BC.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DGurard-Levin%26aufirst%3DZ.%2BA.%26aulast%3DMrksich%26aufirst%3DM.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DNon-peptide%2520histone%2520deacetylases%2520inhibitors%2520derived%2520from%2520tricyclic%2520ketolide%2520skeleton%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D6100%26epage%3D6111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyelere, A. K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4839-4853&author=P.+C.+Chenauthor=V.+Patilauthor=W.+Guerrantauthor=P.+Greenauthor=A.+K.+Oyelere&title=Synthesis+and+structure%E2%80%93activity+relationship+of+histone+deacetylase+%28HDAC%29+inhibitors+with+triazole-linked+cap+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%2BC.%26aulast%3DPatil%26aufirst%3DV.%26aulast%3DGuerrant%26aufirst%3DW.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520histone%2520deacetylase%2520%2528HDAC%2529%2520inhibitors%2520with%2520triazole-linked%2520cap%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4839%26epage%3D4853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, O</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimoto, H.</span><span> </span><span class="NLM_article-title">Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=251-253&author=J.+Luauthor=O+Yoshidaauthor=S.+Hayashiauthor=H.+Arimoto&title=Synthesis+of+rigidly-linked+vancomycin+dimers+and+their+in+vivo+efficacy+against+resistant+bacteria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DYoshida%26aufirst%3DO%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DArimoto%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520rigidly-linked%2520vancomycin%2520dimers%2520and%2520their%2520in%2520vivo%2520efficacy%2520against%2520resistant%2520bacteria%26jtitle%3DChem.%2520Commun.%26date%3D2007%26spage%3D251%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Preobrazhenskaya, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsufyeva, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solovieva, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tevyashova, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznikova, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzikov, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terekhova, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trenin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galatenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treshalin, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirchink, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhman, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sletta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotchev, S. B.</span><span> </span><span class="NLM_article-title">Chemical modification and biological evaluation of new semi-synthetic derivatives of 28, 29-didehydronystatin A<sub>1</sub> (S44HP), a genetically engineered anti-fungal polyene macrolide antibiotic</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800695k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=189-196&author=M.+N.+Preobrazhenskayaauthor=E.+N.+Olsufyevaauthor=S.+E.+Solovievaauthor=A.+N.+Tevyashovaauthor=M.+I.+Reznikovaauthor=Y.+N.+Luzikovauthor=L.+P.+Terekhovaauthor=A.+S.+Treninauthor=O.+A.+Galatenkoauthor=I.+D.+Treshalinauthor=E.+P.+Mirchinkauthor=V.+M.+Bukhmanauthor=H.+Slettaauthor=S.+B.+Zotchev&title=Chemical+modification+and+biological+evaluation+of+new+semi-synthetic+derivatives+of+28%2C+29-didehydronystatin+A1+%28S44HP%29%2C+a+genetically+engineered+anti-fungal+polyene+macrolide+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm800695k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800695k%26sid%3Dliteratum%253Aachs%26aulast%3DPreobrazhenskaya%26aufirst%3DM.%2BN.%26aulast%3DOlsufyeva%26aufirst%3DE.%2BN.%26aulast%3DSolovieva%26aufirst%3DS.%2BE.%26aulast%3DTevyashova%26aufirst%3DA.%2BN.%26aulast%3DReznikova%26aufirst%3DM.%2BI.%26aulast%3DLuzikov%26aufirst%3DY.%2BN.%26aulast%3DTerekhova%26aufirst%3DL.%2BP.%26aulast%3DTrenin%26aufirst%3DA.%2BS.%26aulast%3DGalatenko%26aufirst%3DO.%2BA.%26aulast%3DTreshalin%26aufirst%3DI.%2BD.%26aulast%3DMirchink%26aufirst%3DE.%2BP.%26aulast%3DBukhman%26aufirst%3DV.%2BM.%26aulast%3DSletta%26aufirst%3DH.%26aulast%3DZotchev%26aufirst%3DS.%2BB.%26atitle%3DChemical%2520modification%2520and%2520biological%2520evaluation%2520of%2520new%2520semi-synthetic%2520derivatives%2520of%252028%252C%252029-didehydronystatin%2520A1%2520%2528S44HP%2529%252C%2520a%2520genetically%2520engineered%2520anti-fungal%2520polyene%2520macrolide%2520antibiotic%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D189%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span> </span><span class="NLM_article-title">Mild and efficient lewis acid-promoted detritylation in the synthesis of <i>N</i>-hydroxy amides: a concise synthesis of (−)-cobactin T</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">8123</span><span class="NLM_x">–</span> <span class="NLM_lpage">8126</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo701411d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=8123-8126&issue=21&author=S.+Yangauthor=B.+Laguauthor=L.+Wilson&title=Mild+and+efficient+lewis+acid-promoted+detritylation+in+the+synthesis+of+N-hydroxy+amides%3A+a+concise+synthesis+of+%28%E2%88%92%29-cobactin+T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjo701411d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo701411d%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DLagu%26aufirst%3DB.%26aulast%3DWilson%26aufirst%3DL.%26atitle%3DMild%2520and%2520efficient%2520lewis%2520acid-promoted%2520detritylation%2520in%2520the%2520synthesis%2520of%2520N-hydroxy%2520amides%253A%2520a%2520concise%2520synthesis%2520of%2520%2528%25E2%2588%2592%2529-cobactin%2520T%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D21%26spage%3D8123%26epage%3D8126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Morris, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodsell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halliday, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belew, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">–</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=1639-1662&author=G.+M.+Morrisauthor=D.+S.+Goodsellauthor=R.+S.+Hallidayauthor=R.+Hueyauthor=W.+E.+Hartauthor=R.+K.+Belewauthor=A.+J.+Olson&title=Automated+docking+using+a+Lamarckian+genetic+algorithm+and+empirical+binding+free+energy+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function</span></div><div class="casAuthors">Morris, Garrett M.; Goodsell, David S.; Halliday, Robert S.; Huey, Ruth; Hart, William E.; Belew, Richard K.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1639-1662</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review, with 81 refs.  A novel and robust automated docking method that predicts the bound conformations of flexible ligands to macromol. targets has been developed and tested, in combination with a new scoring function that ests. the free energy change upon binding.  Interestingly, this method applies a Lamarckian model of genetics, in which environmental adaptations of an individual's phenotype are reverse transcribed into its genotype and become heritable traits (sic).  We consider three search methods, Monte Carlo simulated annealing, a traditional genetic algorithm, and the Lamarckian genetic algorithm, and compare their performance in dockings of seven protein-ligand test systems having known three-dimensional structure.  We show that both the traditional and Lamarckian genetic algorithms can handle ligands with more degrees of freedom than the simulated annealing method used in earlier versions of AuToDOCK, and that the Lamarckian genetic algorithm is the most efficient, reliable, and successful of the three.  The empirical free energy function was calibrated using a set of 30 structurally known protein-ligand complexes with exptl. detd. binding consts.  Linear regression anal. of the obsd. binding consts. in terms of a wide variety of structure-derived mol. properties was performed.  The final model had a residual std. error of 9.11 kJ mol-1 (2.177 kcal mol-1) and was chosen as the new energy function.  The new search methods and empirical free energy function are available in AUTODOCK, version 3.0.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXZfPvnZWcbVg90H21EOLACvtfcHk0lj3qh-wUZmiTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFemur4%253D&md5=804b9f797c0b2cf942444c17b5653659</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%2819981115%2919%3A14%3C1639%3A%3AAID-JCC10%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%252819981115%252919%253A14%253C1639%253A%253AAID-JCC10%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DHalliday%26aufirst%3DR.%2BS.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DW.%2BE.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutomated%2520docking%2520using%2520a%2520Lamarckian%2520genetic%2520algorithm%2520and%2520empirical%2520binding%2520free%2520energy%2520function%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1998%26volume%3D19%26spage%3D1639%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Estiu, G.; Wiest, O.</span><span> </span><span class="NLM_article-title">HDAC1 homology model</span>. <div class="note"><p class="first last">Personal Communication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Estiu%2C+G.%3B+Wiest%2C+O.+HDAC1+homology+model.+Personal+Communication."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DEstiu%26aufirst%3DG.%26atitle%3DHDAC1%2520homology%2520model" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Marini, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englund, P. T.</span><span> </span><span class="NLM_article-title">Decatenation of kinetoplast DNA by topoisomerases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4976</span><span class="NLM_x">–</span> <span class="NLM_lpage">4979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=4976-4979&issue=11&author=J.+C.+Mariniauthor=K.+G.+Millerauthor=P.+T.+Englund&title=Decatenation+of+kinetoplast+DNA+by+topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarini%26aufirst%3DJ.%2BC.%26aulast%3DMiller%26aufirst%3DK.%2BG.%26aulast%3DEnglund%26aufirst%3DP.%2BT.%26atitle%3DDecatenation%2520of%2520kinetoplast%2520DNA%2520by%2520topoisomerases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26issue%3D11%26spage%3D4976%26epage%3D4979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Sahai, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span> </span><span class="NLM_article-title">A quantitative decatenation assay for type II topoisomerases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1986&pages=364-379&issue=2&author=B+Sahaiauthor=J.+Kaplan&title=A+quantitative+decatenation+assay+for+type+II+topoisomerases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DB%26aulast%3DKaplan%26aufirst%3DJ.%26atitle%3DA%2520quantitative%2520decatenation%2520assay%2520for%2520type%2520II%2520topoisomerases%26jtitle%3DAnal.%2520Biochem.%26date%3D1986%26volume%3D156%26issue%3D2%26spage%3D364%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Qu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewail, A. H.</span><span> </span><span class="NLM_article-title">The anticancer drug–DNA complex: femtosecond primary dynamics for anthracycline antibiotics function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">14212</span><span class="NLM_x">–</span> <span class="NLM_lpage">14217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=14212-14217&issue=25&author=X.+Quauthor=C.+Wanauthor=H.+C.+Beckerauthor=D.+Zhongauthor=A.+H.+Zewail&title=The+anticancer+drug%E2%80%93DNA+complex%3A+femtosecond+primary+dynamics+for+anthracycline+antibiotics+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DX.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DH.%2BC.%26aulast%3DZhong%26aufirst%3DD.%26aulast%3DZewail%26aufirst%3DA.%2BH.%26atitle%3DThe%2520anticancer%2520drug%25E2%2580%2593DNA%2520complex%253A%2520femtosecond%2520primary%2520dynamics%2520for%2520anthracycline%2520antibiotics%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26issue%3D25%26spage%3D14212%26epage%3D14217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Kulp, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. S.</span><span> </span><span class="NLM_article-title">Antitumor effects of a novel phenylbutyrate-based histone deacetylases inhibitor, (<i>S</i>)-HDAC-42, in prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5199</span><span class="NLM_x">–</span> <span class="NLM_lpage">5206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1158%2F1078-0432.CCR-06-0429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=16951239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD28XovF2gsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5199-5206&author=S.+K.+Kulpauthor=C.+S.+Chenauthor=D.+S.+Wangauthor=C.+Y.+Chenauthor=C.+S.+Chen&title=Antitumor+effects+of+a+novel+phenylbutyrate-based+histone+deacetylases+inhibitor%2C+%28S%29-HDAC-42%2C+in+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer</span></div><div class="casAuthors">Kulp, Samuel K.; Chen, Chang-Shi; Wang, Da-Sheng; Chen, Ching-Yu; Chen, Ching-Shih</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5199-5206</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To assess the antitumor effects of a novel phenylbutyrate-derived histone deacetylase (HDAC) inhibitor, (S)-HDAC-42, vis-a-vis suberoylanilide hydroxamic acid (SAHA) in in vitro and in vivo models of human prostate cancer.  The in vitro effects of (S)-HDAC-42 and SAHA were evaluated in PC-3, DU-145, or LNCaP human prostate cancer cell lines.  Cell viability, apoptosis, and indicators of HDAC inhibition were assessed.  Effects on Akt and members of the Bcl-2 and inhibitor of apoptosis protein families were detd. by immunoblotting.  Immunocompromised mice bearing established s.c.  PC-3 xenograft tumors were treated orally with (S)-HDAC-42 (50 mg/kg q.o.d. or 25 mg/kg q.d.) or SAHA (50 mg/kg q.d.) for 28 days.  In vivo end points included tumor vols. and intratumoral changes in histone acetylation, phospho-Akt status, and protein levels of Bcl-xL and survivin.  (S)-HDAC-42 was more potent than SAHA in suppressing the viability of all cell lines evaluated with submicromolar IC50 values.  Relative to SAHA, (S)-HDAC-42 exhibited distinctly superior apoptogenic potency, and caused markedly greater decreases in phospho-Akt, Bcl-xL, and survivin in PC-3 cells.  The growth of PC-3 tumor xenografts was suppressed by 52% and 67% after treatment with (S)-HDAC-42 at 25 and 50 mg/kg, resp., whereas SAHA at 50 mg/kg suppressed growth by 31%.  Intratumoral levels of phospho-Akt and Bcl-xL were markedly reduced in (S)-HDAC-42-treated mice, in contrast to mice treated with SAHA.  (S)-HDAC-42 is a potent orally bioavailable inhibitor of HDAC, as well as targets regulating multiple aspects of cancer cell survival, which might have clin. value in prostate cancer chemotherapy and warrants further investigation in this regard.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyU7zubYRr_rVg90H21EOLACvtfcHk0liYVDytaXXOBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovF2gsbY%253D&md5=284eba293f0d70487427dba52123d6f4</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0429%26sid%3Dliteratum%253Aachs%26aulast%3DKulp%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DC.%2BS.%26aulast%3DWang%26aufirst%3DD.%2BS.%26aulast%3DChen%26aufirst%3DC.%2BY.%26aulast%3DChen%26aufirst%3DC.%2BS.%26atitle%3DAntitumor%2520effects%2520of%2520a%2520novel%2520phenylbutyrate-based%2520histone%2520deacetylases%2520inhibitor%252C%2520%2528S%2529-HDAC-42%252C%2520in%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5199%26epage%3D5206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yongming, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=Y.+W.+Abruzzoauthor=T.+Krogmannauthor=G.+Yongmingauthor=A.+K.+Rishiauthor=D.+D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0liYVDytaXXOBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DAbruzzo%26aufirst%3DY.%2BW.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DYongming%26aufirst%3DG.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%2BD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhoff, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitor selectively induces p21<sup>WAF1</sup> expression and gene-associated histone acetylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">10014</span><span class="NLM_x">–</span> <span class="NLM_lpage">10019</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10014-10019&issue=18&author=V.+M.+Richonauthor=T.+W.+Sandhoffauthor=R.+A.+Rifkindauthor=P.+A.+Marks&title=Histone+deacetylase+inhibitor+selectively+induces+p21WAF1+expression+and+gene-associated+histone+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DSandhoff%26aufirst%3DT.%2BW.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DHistone%2520deacetylase%2520inhibitor%2520selectively%2520induces%2520p21WAF1%2520expression%2520and%2520gene-associated%2520histone%2520acetylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26issue%3D18%26spage%3D10014%26epage%3D10019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Gartenhaus, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, P.</span><span> </span><span class="NLM_article-title">Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using the p53-dndependent pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=265-268&author=R.+B.+Gartenhausauthor=P.+Wangauthor=P.+Hoffmann&title=Induction+of+the+WAF1%2FCIP1+protein+and+apoptosis+in+human+T-cell+leukemia+virus+type+I-transformed+lymphocytes+after+treatment+with+adriamycin+by+using+the+p53-dndependent+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGartenhaus%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DP.%26atitle%3DInduction%2520of%2520the%2520WAF1%252FCIP1%2520protein%2520and%2520apoptosis%2520in%2520human%2520T-cell%2520leukemia%2520virus%2520type%2520I-transformed%2520lymphocytes%2520after%2520treatment%2520with%2520adriamycin%2520by%2520using%2520the%2520p53-dndependent%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D265%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">North, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borra, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span> </span><span class="NLM_article-title">The human Sir2 ortholog, SIRT2, is an NAD<sup>+</sup>-dependent tubulin deacetylase</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1016%2FS1097-2765%2803%2900038-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12620231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=437-444&author=B.+J.+Northauthor=B.+L.+Marshallauthor=M.+T.+Borraauthor=J.+M.+Denuauthor=E.+Verdin&title=The+human+Sir2+ortholog%2C+SIRT2%2C+is+an+NAD%2B-dependent+tubulin+deacetylase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase</span></div><div class="casAuthors">North, Brian J.; Marshall, Brett L.; Borra, Margie T.; Denu, John M.; Verdin, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The silent information regulator 2 protein (Sir2p) of Saccharomyces cerevisiae is an NAD-dependent histone deacetylase that plays a crit. role in transcriptional silencing.  Here, we report that a human ortholog of Sir2p, sirtuin type 2 (SIRT2), is a predominantly cytoplasmic protein that colocalizes with microtubules.  SIRT2 deacetylates lysine-40 of α-tubulin both in vitro and in vivo.  Knockdown of SIRT2 via siRNA results in tubulin hyperacetylation.  SIRT2 colocalizes and interacts in vivo with HDAC6, another tubulin deacetylase.  Enzymic anal. of recombinant SIRT2 in comparison to a yeast homolog of Sir2 protein (Hst2p) shows a striking preference of SIRT2 for acetylated tubulin peptide as a substrate relative to acetylated histone H3 peptide.  These observations establish SIRT2 as a bona fide tubulin deacetylase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorrA4k4bpBlrVg90H21EOLACvtfcHk0liSFxeCel3RTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1Wgs7c%253D&md5=622e6bf7b48be1ec6afedf403c56350c</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900038-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900038-8%26sid%3Dliteratum%253Aachs%26aulast%3DNorth%26aufirst%3DB.%2BJ.%26aulast%3DMarshall%26aufirst%3DB.%2BL.%26aulast%3DBorra%26aufirst%3DM.%2BT.%26aulast%3DDenu%26aufirst%3DJ.%2BM.%26aulast%3DVerdin%26aufirst%3DE.%26atitle%3DThe%2520human%2520Sir2%2520ortholog%252C%2520SIRT2%252C%2520is%2520an%2520NAD%252B-dependent%2520tubulin%2520deacetylase%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D437%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Schäfer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickmanns, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlimme, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span> </span><span class="NLM_article-title">Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2011</span><span class="NLM_x">–</span> <span class="NLM_lpage">2033</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2011-2033&author=S.+Sch%C3%A4ferauthor=L.+Saundersauthor=E.+Eliseevaauthor=A.+Velenaauthor=M.+Jungauthor=A.+Schwienhorstauthor=A.+Strasserauthor=A.+Dickmannsauthor=R.+Ficnerauthor=S.+Schlimmeauthor=W.+Sipplauthor=E.+Verdinauthor=M.+Jung&title=Phenylalanine-containing+hydroxamic+acids+as+selective+inhibitors+of+class+IIb+histone+deacetylases+%28HDACs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25A4fer%26aufirst%3DS.%26aulast%3DSaunders%26aufirst%3DL.%26aulast%3DEliseeva%26aufirst%3DE.%26aulast%3DVelena%26aufirst%3DA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DSchwienhorst%26aufirst%3DA.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DDickmanns%26aufirst%3DA.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchlimme%26aufirst%3DS.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DVerdin%26aufirst%3DE.%26aulast%3DJung%26aufirst%3DM.%26atitle%3DPhenylalanine-containing%2520hydroxamic%2520acids%2520as%2520selective%2520inhibitors%2520of%2520class%2520IIb%2520histone%2520deacetylases%2520%2528HDACs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2011%26epage%3D2033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Namdar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of histone deacetylases 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">20003</span><span class="NLM_x">–</span> <span class="NLM_lpage">20008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=20003-20008&author=M.+Namdarauthor=G.+Perezauthor=L.+Ngoauthor=P.+A.+Marks&title=Selective+inhibition+of+histone+deacetylases+6+%28HDAC6%29+induces+DNA+damage+and+sensitizes+transformed+cells+to+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNamdar%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DG.%26aulast%3DNgo%26aufirst%3DL.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520histone%2520deacetylases%25206%2520%2528HDAC6%2529%2520induces%2520DNA%2520damage%2520and%2520sensitizes%2520transformed%2520cells%2520to%2520anticancer%2520agents%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D20003%26epage%3D20008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Blagosklonny, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traganos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darzynkiewicz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Histone deacetylases inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity</span> <span class="citation_source-journal">Mol. Cell Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFOntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=937-941&author=M.+V.+Blagosklonnyauthor=R.+Robeyauthor=D.+L.+Sackettauthor=L.+Duauthor=F.+Traganosauthor=Z.+Darzynkiewiczauthor=T.+Fojoauthor=S.+E.+Bates&title=Histone+deacetylases+inhibitors+all+induce+p21+but+differentially+cause+tubulin+acetylation%2C+mitotic+arrest%2C+and+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity</span></div><div class="casAuthors">Blagosklonny, Mikhail V.; Robey, Robert; Sackett, Dan L.; Du, Litong; Traganos, Frank; Darzynkiewicz, Zbigniew; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">937-941</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">By preventing deacetylation of histones, histone deacetylase inhibitors (HDIs) transcriptionally induce p21.  Here we show that the HDIs sodium butyrate (Bu), trichostatin A (TSA) and depsipeptide (FR901228) all induced p21, but only TSA and FR901228 caused mitotic arrest (in addn. to arrest in G1 and G2).  The ability to cause mitotic arrest correlated with the higher cytotoxicity of these compds.  Although causing mitotic arrest, TSA and FR901228 (unlike paclitaxel) did not affect tubulin polymn.  Unlike FR9012208, TSA caused acetylation of tubulin at lysine 40; both sol. tubulin and microtubules were acetylated.  Whereas the induction of p21 reached a max. by 8 h, tubulin was maximally acetylated after only 1 h of TSA treatment.  Tubulin acetylation was detectable after treatment with 12-25 ng/mL TSA although acetylation plateaued at 50 ng/mL TSA, coinciding with G2-M arrest, appearance of cells with a sub-2N DNA content, poly(ADP-ribose) polymerase cleavage, and rapid cell death.  We conclude that HDIs have differential effects on non-histone deacetylases and that rapid acetylation of tubulin caused by TSA is a marker of nontranscriptional effects of TSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3U1Gfsq3t0LVg90H21EOLACvtfcHk0lgldZB7uel0rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFOntg%253D%253D&md5=eb537e58f3227b5aea93884751d2f839</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlagosklonny%26aufirst%3DM.%2BV.%26aulast%3DRobey%26aufirst%3DR.%26aulast%3DSackett%26aufirst%3DD.%2BL.%26aulast%3DDu%26aufirst%3DL.%26aulast%3DTraganos%26aufirst%3DF.%26aulast%3DDarzynkiewicz%26aufirst%3DZ.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DHistone%2520deacetylases%2520inhibitors%2520all%2520induce%2520p21%2520but%2520differentially%2520cause%2520tubulin%2520acetylation%252C%2520mitotic%2520arrest%252C%2520and%2520cytotoxicity%26jtitle%3DMol.%2520Cell%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D937%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khochbin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthias, P.</span><span> </span><span class="NLM_article-title">HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1093%2Femboj%2Fcdg115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12606581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1yls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1168-1179&author=Y.+Zhangauthor=N.+Liauthor=C.+Caronauthor=G.+Matthiasauthor=D.+Hessauthor=S.+Khochbinauthor=P.+Matthias&title=HDAC-6+interacts+with+and+deacetylates+tubulin+and+microtubules+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo</span></div><div class="casAuthors">Zhang, Yu; Li, Na; Caron, Cecile; Matthias, Gabriele; Hess, Daniel; Khochbin, Saadi; Matthias, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1168-1179</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Microtubules are cylindrical cytoskeletal structures found in almost all eukaryotic cell types which are involved in a great variety of cellular processes.  Reversible acetylation on the ε-amino group of α-tubulin Lys40 marks stabilized microtubule structures and may contribute to regulating microtubule dynamics.  Yet, the enzymes catalyzing this acetylation/deacetylation have remained unidentified until recently.  Here we report that β-tubulin interacts with histone deacetylase-6 (HDAC-6) in a yeast two-hybrid assay and in vitro.  We find that HDAC-6 is a micro tubule-assocd. protein capable of deacetylating α-tubulin in vivo and in vitro.  HDAC-6's microtubule binding and deacetylation functions both depend on the hdac domains.  Overexpression of HDAC-6 in mammalian cells leads to tubulin hypoacetylation.  In contrast, inhibition of HDAC-6 function by two independent mechanisms-pharmacol. (HDAC inhibitors) or genetic (targeted inactivation of HDAC-6 in embryonic stem cells)-leads to hyperacetylation of tubulin and microtubules.  Taken together, our data provide evidence that HDAC-6 might act as a dual deacetylase for tubulin and histones, and suggest the possibility that acetylated non-histone proteins might represent novel targets for pharmacol. therapy by HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBqjHB5aVYPrVg90H21EOLACvtfcHk0lhy_AoR0uD4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1yls7c%253D&md5=0d2b6dd552163866b85f14471ac600f7</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg115%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DCaron%26aufirst%3DC.%26aulast%3DMatthias%26aufirst%3DG.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DKhochbin%26aufirst%3DS.%26aulast%3DMatthias%26aufirst%3DP.%26atitle%3DHDAC-6%2520interacts%2520with%2520and%2520deacetylates%2520tubulin%2520and%2520microtubules%2520in%2520vivo%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1168%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chohan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snapka, R. M.</span><span> </span><span class="NLM_article-title">XK469, a selective topoisomerase IIβ poison</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">12168</span><span class="NLM_x">–</span> <span class="NLM_lpage">12173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=12168-12173&author=H.+Gaoauthor=K.+C.+Huangauthor=E.+F.+Yamasakiauthor=K.+K.+Chanauthor=L.+Chohanauthor=R.+M.+Snapka&title=XK469%2C+a+selective+topoisomerase+II%CE%B2+poison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DYamasaki%26aufirst%3DE.%2BF.%26aulast%3DChan%26aufirst%3DK.%2BK.%26aulast%3DChohan%26aufirst%3DL.%26aulast%3DSnapka%26aufirst%3DR.%2BM.%26atitle%3DXK469%252C%2520a%2520selective%2520topoisomerase%2520II%25CE%25B2%2520poison%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D12168%26epage%3D12173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Kiyomiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurebe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuo, S.</span><span> </span><span class="NLM_article-title">Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteosome</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm200799p&amp;key=12370758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=1081-1085&issue=5&author=K.+Kiyomiyaauthor=J.+Satohauthor=H.+Horieauthor=M.+Kurebeauthor=H.+Nakagawaauthor=S.+Matsuo&title=Correlation+between+nuclear+action+of+anthracycline+anticancer+agents+and+their+binding+affinity+to+the+proteosome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome</span></div><div class="casAuthors">Kiyomiya, Ken-ichi; Satoh, Jun; Horie, Hiroshi; Kurebe, Masaru; Nakagawa, Hiroshi; Matsuo, Saburou</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1081-1085</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">4'-O-tetrahydropyranyladriamycin (THP) showed an approx. 10-fold greater inhibitory effect on DNA synthesis in L1210 mouse leukemia cells than adriamycin (ADM).  The intracellular transfer rate and nuclear accumulation of THP were approx. 5-fold higher than those of ADM.  The intensity of in vitro inhibition of topoisomerase II activity by ADM was almost the same as that by THP.  There were no significant differences between the uptake of either of these agents by the isolated nuclei of L1210 cells.  The nuclear uptake of both agents in the presence of the cytosolic fraction of L1210 cells consisted of both simple diffusion and carrier-mediated components, and the carrier-mediated component of THP was approx. 2-fold higher than that of ADM.  THP showed approx. 5-fold higher affinity to the proteasome than ADM, and interfered with ADM binding in a competitive manner.  These results suggest that the binding affinity of these anticancer agents to the proteasome is an important factor in their transport to the nucleus and dets. their specificity of action for the nuclear DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVSdLYYCdWQbVg90H21EOLACvtfcHk0lhy_AoR0uD4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSrtrw%253D&md5=0d039cdc186747eb6e08a6c88097ae66</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiyomiya%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DJ.%26aulast%3DHorie%26aufirst%3DH.%26aulast%3DKurebe%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMatsuo%26aufirst%3DS.%26atitle%3DCorrelation%2520between%2520nuclear%2520action%2520of%2520anthracycline%2520anticancer%2520agents%2520and%2520their%2520binding%2520affinity%2520to%2520the%2520proteosome%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2002%26volume%3D21%26issue%3D5%26spage%3D1081%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Marbeuf-Gueye, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priebe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnier-Suillerot, A.</span><span> </span><span class="NLM_article-title">Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1450</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1450&publication_year=1999&pages=374-384&issue=3&author=C.+Marbeuf-Gueyeauthor=D.+Ettoriauthor=W.+Priebeauthor=H.+Kozlowskiauthor=A.+Garnier-Suillerot&title=Correlation+between+the+kinetics+of+anthracycline+uptake+and+the+resistance+factor+in+cancer+cells+expressing+the+multidrug+resistance+protein+or+the+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarbeuf-Gueye%26aufirst%3DC.%26aulast%3DEttori%26aufirst%3DD.%26aulast%3DPriebe%26aufirst%3DW.%26aulast%3DKozlowski%26aufirst%3DH.%26aulast%3DGarnier-Suillerot%26aufirst%3DA.%26atitle%3DCorrelation%2520between%2520the%2520kinetics%2520of%2520anthracycline%2520uptake%2520and%2520the%2520resistance%2520factor%2520in%2520cancer%2520cells%2520expressing%2520the%2520multidrug%2520resistance%2520protein%2520or%2520the%2520P-glycoprotein%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1450%26issue%3D3%26spage%3D374%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Klyatskaya, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tretyakov, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilevsky, S. F.</span><span> </span><span class="NLM_article-title">Cross-coupling of aryl iodides with paramagnetic terminal acetylenes derived from 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide</span> <span class="citation_source-journal">Russ. Chem. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1023%2FA%3A1015026200647" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVOhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=128-134&author=S.+V.+Klyatskayaauthor=E.+V.+Tretyakovauthor=S.+F.+Vasilevsky&title=Cross-coupling+of+aryl+iodides+with+paramagnetic+terminal+acetylenes+derived+from+4%2C4%2C5%2C5-tetramethyl-2-imidazoline-1-oxyl+3-oxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-coupling of aryl iodides with paramagnetic terminal acetylenes derived from 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide</span></div><div class="casAuthors">Klyatskaya, S. V.; Tretyakov, E. V.; Vasilevsky, S. F.</div><div class="citationInfo"><span class="NLM_cas:title">Russian Chemical Bulletin (Translation of Izvestiya Akademii Nauk, Seriya Khimicheskaya)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-134</span>CODEN:
                <span class="NLM_cas:coden">RCBUEY</span>;
        ISSN:<span class="NLM_cas:issn">1066-5285</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">2-(Arylylethynylphenyl)-4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxides were synthesized by cross-coupling of aryl iodides with 1-alkynes contg. the 4,4,5,5-tetramethyl-2-imidazoline-1-oxyl 3-oxide fragment.  A procedure was developed for the prepn. of 3- and 4-ethynylbenzaldehydes with the use of 2-methylbut-3-yn-2-ol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoVvaBnQTQ7Vg90H21EOLACvtfcHk0liN19a12XV7qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVOhur4%253D&md5=db12f0deb92e1cd57c7ab10a9ca66008</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015026200647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015026200647%26sid%3Dliteratum%253Aachs%26aulast%3DKlyatskaya%26aufirst%3DS.%2BV.%26aulast%3DTretyakov%26aufirst%3DE.%2BV.%26aulast%3DVasilevsky%26aufirst%3DS.%2BF.%26atitle%3DCross-coupling%2520of%2520aryl%2520iodides%2520with%2520paramagnetic%2520terminal%2520acetylenes%2520derived%2520from%25204%252C4%252C5%252C5-tetramethyl-2-imidazoline-1-oxyl%25203-oxide%26jtitle%3DRuss.%2520Chem.%2520Bull.%26date%3D2002%26volume%3D51%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Mai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sbardella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S.</span><span> </span><span class="NLM_article-title">A new facile and expeditious synthesis of <i>N</i>-hydroxy-<i>N</i>′-phenyloctanediamide, a potent inducer of terminal cytodifferentiation</span> <span class="citation_source-journal">Org. Prep. Proced. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm200799p&amp;key=10.1080%2F00304940109356608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm200799p&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVaqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=391-394&issue=4&author=A.+Maiauthor=M.+Espositoauthor=G.+Sbardellaauthor=S.+Massa&title=A+new+facile+and+expeditious+synthesis+of+N-hydroxy-N%E2%80%B2-phenyloctanediamide%2C+a+potent+inducer+of+terminal+cytodifferentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A new facile and expeditious synthesis of N-hydroxy-N'-phenyloctanediamide, a potent inducer of terminal cytodifferentiation</span></div><div class="casAuthors">Mai, Antonello; Esposito, Monica; Sbardella, Gianluca; Massa, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Preparations and Procedures International</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">391-394</span>CODEN:
                <span class="NLM_cas:coden">OPPIAK</span>;
        ISSN:<span class="NLM_cas:issn">0030-4948</span>.
    
            (<span class="NLM_cas:orgname">Organic Preparations and Procedures, Inc.</span>)
        </div><div class="casAbstract">The title compd. (I) was prepd. by reacting suberic acid with acetic anhydride to give suberic anhydride.  The latter was condensed with aniline to give suberanilic acid, which reacted with ClCO2Et and NH2OH to give I in 58% overall yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_uUH35G2SrVg90H21EOLACvtfcHk0lh_n6_Mhcl66A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVaqt7c%253D&md5=60ecb3db854b004252f20f4819459bb5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1080%2F00304940109356608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00304940109356608%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DEsposito%26aufirst%3DM.%26aulast%3DSbardella%26aufirst%3DG.%26aulast%3DMassa%26aufirst%3DS.%26atitle%3DA%2520new%2520facile%2520and%2520expeditious%2520synthesis%2520of%2520N-hydroxy-N%25E2%2580%25B2-phenyloctanediamide%252C%2520a%2520potent%2520inducer%2520of%2520terminal%2520cytodifferentiation%26jtitle%3DOrg.%2520Prep.%2520Proced.%2520Int.%26date%3D2001%26volume%3D33%26issue%3D4%26spage%3D391%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a href="/doi/suppl/10.1021/jm200799p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67335"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectral information, HPLC traces, and molecular modeling outputs.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200799p/suppl_file/jm200799p_si_001.pdf">jm200799p_si_001.pdf (7.52 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200799p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm200799p" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200799p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b3801e203c88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
